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ABSTRACT 
The ability to manipulate complex genomes in a precise manner is essential for studying 
biological processes in model systems, engineering plant strains for agriculture, or advancing 
human cellular therapies to treat diseases. Genomic alterations are most efficient when a 
double-strand DNA break is introduced at the loci where the modification is desired. 
Different classes of naturally occurring DNA endonucleases, including homing 
endonucleases, have therefore been explored as candidates for genome modification studies 
as they target long stretches of DNA. Homing endonucleases are mobile genetic elements 
whose biological role is to introduce site-specific double-strand breaks into naïve genomes, 
ultimately resulting in the selfish propagation of their own genes. Consequently, homing 
endonucleases are an ideal enzymatic system whose natural properties can be exploited to 
manipulate genes.    
In the present studies, I examine the cleavage mechanism of GIY-YIG family homing 
endonucleases, as until now the method by which they hydrolyze DNA has remained poorly 
understood. Using the GIY-YIG homing endonuclease I-BmoI as a model system, I 
investigate the amino acid, nucleotide, and divalent metal ion requirements of the GIY-YIG 
nuclease domain to generate a double-strand break in DNA. I specifically test models by 
which enzymes with a single active site could nick both strands of DNA, and determine that 
I-BmoI functions as a monomer throughout the reaction pathway. Furthermore, I demonstrate 
that the nuclease domain itself has weak binding affinity, is tethered to DNA by a high 
affinity binding domain, and must reposition across each strand through a series of protein 
and substrate conformational changes to facilitate DNA hydrolysis. 
To explore the relevance of GIY-YIG homing endonucleases as genome editing reagents, I 
fused the nuclease domain of I-TevI to three different re-targetable DNA-binding platforms 
utilized in the field. The engineered nucleases developed within the present studies are 
mechanistically distinct from established technologies, as they function as monomers and 
cleave DNA at a preferred sequence motif. I therefore envision that the engineered GIY-YIG 
nucleases may circumvent complications associated with established technologies, and 
provide an alternative and potentially safer set of genome editing reagents. 
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Chapter 1  
1 Introduction 
Enzymes that hydrolyze nucleic acids, termed nucleases, are ubiquitous and indispensible 
for life. Nucleases are critical components in a variety of cellular processes, including 
nucleotide metabolism and scavenging, DNA repair and recombination, restriction 
defense systems that protect host genomes, and the mobility of genetic elements (1-3). By 
lowering the transition state energy required for phosphodiester bond hydrolysis, 
nucleases act as catalysts to hydrolyze DNA or RNA polynucleotide chains. The focus of 
this thesis is to characterize the mechanism by which one class of nuclease hydrolyzes 
DNA to initiate its own genetic propagation between distinct biological alleles. 
Additionally, the derived molecular understanding provided the necessary insight to 
engineer this nuclease family for targeted genome editing applications.  
Using the GIY-YIG homing endonuclease (GIY-HE) I-BmoI as a model system, I sought 
to investigate the mechanism by which GIY-HEs generate double-strand breaks (DSBs) 
in DNA. To better understand the structure and function of I-BmoI, we developed an 
experimental approach in Chapter 2 that combines bioinformatic, genetic, and structural 
techniques to identify non-conserved residues within an enzyme that affect catalysis. In 
Chapter 3, I present work that investigates the divalent metal ion and base pair 
requirements of the I-BmoI nuclease domain to efficiently cleave its cognate target site. 
After gaining insight into the biology and function of the nuclease domain, I specifically 
test models for cleavage by I-BmoI to elucidate the mechanism of hydrolysis in Chapter 
4. Finally, in Chapter 5 I present data that demonstrates the GIY-YIG nuclease domain 
can be fused to the three common DNA-binding platforms used in the field of genome 
editing to create highly active and targetable chimeric nucleases. By understanding the 
cleavage mechanism of GIY-HEs prior to designing the chimeric nucleases, we hope to 
avoid engineering complications related to other genome editing technologies due to the 
inherent biology of the associated nuclease domain (4).  
2 
 
1.1 DNA endonucleases 
Nuclease nomenclature differs depending on where hydrolysis along the DNA strand 
occurs, what type of nucleic acid is being modified, and whether or not both strands are 
hydrolyzed. Endonucleases cleave within polynucleotide chains, exonucleases catalyze 
the removal of nucleotides from either the 5’ or 3’ end of nucleic acids, and nickases and 
cleavases hydrolyze one or both strands, respectively. Additionally, nucleases can 
hydrolyze polynucleotides chains in non-specific, structure-specific, or sequence-specific 
manners. Non-specific nucleases, such as the Serratia and Anabaena nucleases, act as 
extracellular nucleotide scavengers for their prokaryotic hosts (5,6). The Serratia 
nuclease has a single active site and hydrolyzes single- and double-stranded DNA and 
RNA unless the nucleic acid substrate contains certain polynucleotide tracts (7-9). 
Structure-specific nucleases typically recognize abnormal DNA conformations and are 
common within DNA-repair and recombination pathways. AP endonucleases nick 
adjacent to sites of mismatched or damaged bases to initiate base-excision repair (10-12), 
and T7 endonuclease I recognizes branched DNA to resolve holiday junctions (13-15).  
Finally, examples of sequence-specific (or site-specific) nucleases include endonucleases 
that are involved in host restriction/modification (RM) defense systems (16-18), or 
enzymes that initiate the mobility of selfish genetic elements (19,20). 
1.1.1 Restriction defense systems 
First discovered in the mid 1950’s (21-23), RM systems have revolutionized molecular 
biology as purified recombinant restriction endonucleases (REs) are indispensible for 
many scientific disciplines (18,24). REs constitute half of the RM systems employed by 
prokaryotes to prevent invasion by foreign DNA (18,25). In addition to REs, RM systems 
also encode DNA methyltransferases that utilize S-adenosyl-methionine as a co-factor to 
methylate adenine or cytosine residues, protecting host DNA from self-degradation 
(26,27). Both endonuclease and methyltransferase components of the RM system bind 
the same 3-8 base-pair sequence, with some organisms encoding upwards of 20 RM 
systems that target different sites (28). Since the initial characterization of type II REs 
(29,30), thousands of distinct REs have been identified that bind and cleave unique sites 
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by a vast number of mechanisms, necessitating a unified naming convention with distinct 
subtypes (24,31-33). Type II REs act independently of their associated methyltransferases 
and can be further divided into over 14 subtypes, including Type IIP and IIS classes to 
specify enzymes that recognize palindromic sequences or those that cleave outside of 
their primary recognition site, respectively (24,32). The Type IIP subclass constitutes the 
majority of REs utilized for biochemistry, while the nuclease domain of the Type IIS RE 
FokI has been used extensively for genome editing applications due to the challenges 
associated with reengineering of the natural binding specificities of Type IIP REs (see 
also Chapter 1.2.5) (34-37). Detailed studies of RM systems from each subclass have 
provided insight into the distinct properties and molecular mechanisms by which REs 
hydrolyze DNA (Table 1.1) (38). Interestingly, the conserved motifs that constitute RE 
active sites have also been identified in other classes of site-specific DNA endonucleases 
that act as selfish mobile genetic elements (39-42), with REs themselves also implicated 
to play a role in genome evolution (43,44).  
1.1.2 Mobile genetic elements 
On an evolutionary timescale, the status of most genomes can be considered fluid and 
under selective pressure, a result of normal or aberrant cellular processes, spontaneous 
mutations, or the presence of mobile genetic elements (MGEs) (45-47). Initially thought 
to be mechanistically selfish and phenotypically neutral with respect to host biology 
(48,49), certain classes of MGEs can contribute to essential cellular functions including 
mating type switching in Saccharomyces cerevisiae or the maintenance of proper 
transcript splicing in bacteriophage T4 (50,51). MGEs often encode relatively small 
genes that act to initiate ‘self-mobility’ between host and recipient alleles (49,52), yet the 
cumulative presence of multiple MGEs is thought to comprise a significant proportion of 
many genomes (53-56). During the mobility process, MGEs have been shown to 
influence recipient genome dynamics by inducing genomic rearrangements (57-59), 
promoting the spread of antibiotic resistance genes (60-62), or fragmenting formerly 
intact genes (63-65).  
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Table 1.1: Properties of site-specific nucleases 
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Homing endonucleases (HEs) are one class of MGE that are often found encoded within 
introns, an arrangement that has been suggested as a mechanism to reduce the impact of 
the insertion of MGEs on host gene function (66-68). Within these introns, genes of HEs 
(or other classes of DNA endonucleases) can be found that initiate the mobility process 
(67,69-71) (Figure 1.1). The first step of intron propagation occurs when the intron-
encoded endonuclease is translated and generates a double-strand break within a naïve 
allele, followed by DNA repair processes within the recipient organism that utilize the 
MGE-containing donor allele as a template for repair (20,68). Other than HEs, a number 
of classes of endonuclease are known to initiate similar non-mendelian gene conversion 
events, including transposons, retrotransposons, and REs (44,71-74). Accordingly, the 
mechanisms by which various MGEs mobilize their encoding genes have been exploited 
for targeted genome editing applications (75-79).  
1.1.3 Strategies to hydrolyze DNA 
Site-specific endonucleases vary considerably in their oligomeric assembly on DNA, 
target site recognition, and method of DNA hydrolysis (Table 1.1) (18,80). Extensive 
studies have revealed an assortment of catalytic mechanisms utilized by REs and HEs to 
generate DSBs (Table 1.1, Figure 1.2). Many Type IIP REs, such as EcoRI, stably 
oligomerize on DNA to provide two active sites to hydrolyze each DNA strand (81). 
Alternatively, the Type IIP REs BcnI and MvaI bind DNA as monomers and ‘hop’ across 
the phosphate backbone between nicking reactions (82,83). Some Type IIS REs have also 
been shown to transiently dimerize or sequentially nick both strands via a conformational 
change mechanism (Figure 1.2, see also Chapter 1.2.5) (84,85). Yet another DNA 
hydrolysis mechanism has been proposed for the phospholipase D RE BfiI, where a 
single composite active site is formed at a dimer interface prior to hydrolysis through a 
covalent protein:DNA intermediate (86). A similar catalytic mechanism has been 
observed for the single active site Tn10 transposase, where successive phosphoryl 
transfer reactions contribute to DNA hydrolysis via an intra-strand DNA hairpin 
intermediate (87). The mechanisms by which HEs generate double-strand breaks to 
initiate their mobility have also been studied, and are discussed below. 
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Figure 1.1: Mobility pathway of selfish intron-encoded endonucleases 
The expression of an endonuclease gene embedded within an intron results in the lateral 
transfer of the intron sequence from the donor allele to an intronless recipient allele. 
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Figure 1.2: Mechanisms of DNA hydrolysis by site-specific endonucleases. 
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1.2 Homing and Type IIS restriction endonucleases 
Like other MGEs, HEs catalyze the ‘selfish’ propagation of their genes to naïve 
chromosomal sites through a process termed homing (Figure 1.1) (3,66). HEs were 
discovered when non-mendelian inheritance was observed for an intron in the 
mitochondrial large rRNA gene of Saccharomyces cerevisiae (88,89). It was later shown 
that the unidirectional gene conversion event was dependent on the intron-encoded open 
reading frame that expressed the ω factor, now known as the LAGLIDADG HE I-SceI 
(90,91). HEs share mechanistic and structural similarities with REs (Table 1.1), yet they 
differ by targeting extended recognition sites (14-36 base pairs) in a sequence tolerant 
manner (REs are generally intolerant to substitutions within their relatively short 3-8 base 
pair binding sites) (18,80). While Type IIS REs also bind short sequences, they are 
mechanistically similar to certain types of HEs by cleaving at a distance from their 
primary binding site, unlike canonical REs (Table 1.1) (92,93).  
Homing endonuclease genes have been identified in organisms within all kingdoms of 
life and constitute six different classes based on conserved structural and catalytic motifs 
(the LAGLIDADG, H-N-H, His-Cys, GIY-YIG, PD-(D/E)xK, and EDxHD families) 
(Figure 1.3) (94). The H-N-H and His-Cys box families contain highly similar active site 
structures (ββα-Me family), while the PD-(D/E)xK and EDxHD classes contain catalytic 
motifs analogous to those found within orthodox REs (79,95). The relatively small I-
Ssp6803I (150 amino acids) was the first identified HE gene that contains the PD-
(D/E)xK motif and is distinct from its RE counterparts as it binds a long 23 base pair 
target site in a tetrameric configuration (41,96). HEs are generally small proteins (<50 
kDa) that have mostly adopted two distinct strategies to target extended allelic sites: 
acquiring multiple DNA-binding elements to bind elongated asymmetric sites in a 
sequence tolerant manner, or dimeric assembly of comparatively globular folds to 
double-up their binding capacity on pseudo-palindromic sequences (Figure 1.3) (79,80). 
The structures and DNA hydrolysis mechanisms utilized by the three major families of 
HEs and Type IIS REs are further discussed below. 
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Figure 1.3: Structures of homing and restriction endonucleases 
Active site secondary structure elements are shown in orange, magnesium ions in red, 
and zinc ions in cyan. For simplicity, only the active site structures of the units directly 
involved in DNA hydrolysis for I-Ssp6803I are highlighted. HE, homing endonuclease; 
RE, restriction endonuclease; I-HmuI PDB:1U3E; I-TevI PDB:1MK0 & 1I3J; I-PpoI 
PDB:1A73; I-OnuI PDB:3QQY; I-Ssp6803I PDB:2OST; FokI PDB:1FOK. 
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1.2.1 GIY-YIG homing endonucleases 
Characterization of GIY-YIG HEs began when it was demonstrated that the mobility of 
the intron associated with the thymidylate synthase (td) gene of bacteriophage T4 was 
dependent on an encoded endonuclease (97). It was later discovered that the 
endonuclease, named I-TevI, comprised a two-domain structure with an N-terminal 
domain that contains a GIY-YIG nuclease motif and a C-terminal DNA-binding domain 
(Figure 1.4A) (3,98). The structural modularity of the endonuclease is also reflected in its 
target site, as cleavage and DNA-binding regions are present within I-TevI’s cognate 
substrate (99). Furthermore, mutagenesis and interference assays of the intronless td 
substrate revealed that I-TevI’s minor groove interactions with substrate are highly 
tolerant to nucleotide substitutions (100,101). Results from randomized cleavage motif 
selections and hydrolysis site mapping experiments revealed that I-TevI nicks the 
bottom- and top-strands of substrate within a CnnnG motif 25 and 23 base pairs upstream 
of the intron insertion site, respectively (Figure 1.4A) (101,102). Moreover, biochemical 
assays demonstrated that I-TevI binds DNA as a monomer and induced significant bends 
in its substrate near the cleavage site (103).  
Independent NMR and X-ray crystallography studies of the nuclease and DNA-binding 
domains of I-TevI provided high-resolution images of the enzyme’s modular structure 
(Figure 1.4C) (104-107). The catalytic domain structure revealed a tightly packed ~90 
amino acid core with a ββααβα fold, where the GIY and YIG motifs are encoded by the 
first two β-strands within a single active site (104,106,108). Additionally, the C-terminal 
domain/substrate co-crystal confirmed the sequence-tolerant minor groove interactions by 
I-TevI, and also identified NUMOD3 α-helix (nuclease associated modular) and helix-
turn-helix DNA-binding elements similar to those identified in ββα-Me HEs (Figure 
1.4A, see also Chapter 1.2.4) (105,109-111). Rather unexpectedly, the C-terminal 
structure of I-TevI revealed a non-canonical zinc-finger module that does not specifically 
contact DNA (105). It has been speculated that the I-TevI zinc-finger, along with the 
mostly-unstructured inter-domain linker, acts as a flexible distance determinant to 
position the GIY-YIG domain on substrate for cleavage (104,107,112,113). 
Unfortunately, the extraordinarily high specific activity of I-TevI leads to cytotoxicity  
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Figure 1.4: GIY-YIG homing endonucleases I-TevI and I-BmoI 
Schematic representations highlighting the protein and substrate modularity of (A) I-TevI 
and (B) I-BmoI. Both enzymes bind asymmetric sequences that span the intron-insertion 
site (IS) of their respective intronless thymidylate synthase alleles. Intron insertion 
renders the intron-containing alleles resistant to cleavage by altering critical base pairs at 
the cleavage site (shown in bold uppercase font). Bottom- and top-strand nicking sites are 
shown by filled and open triangles, respectively. (C) Composite structural representation 
of I-TevI displaying the independent N-terminal GIY-YIG domain and C-terminal DNA-
binding domain crystal structures. 
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when expressed in bacteria, precluding purification of the wild-type enzyme (114). 
Detailed biochemical studies to investigate the cleavage mechanism of I-TevI were 
therefore prohibited, though a conformational change model of cleavage was proposed 
where the monomeric nuclease domain sequentially nicks both DNA strands (Figure 1.2) 
(103).  
Fortuitously, an additional GIY-HE similar to I-TevI, named I-BmoI, is encoded within 
an intron that interrupts the thymidylate synthase gene (thyA) of Bacillus mojavensis 
(115). The thyA sequence that I-BmoI hydrolyzes is homologous to the td allele targeted 
by I-TevI, with I-BmoI preferring only a guanine nucleotide at its cleavage site in an 
analogous position to the G of the CnnnG motif observed for I-TevI (Figure 1.4B) 
(102,116). This preference renders the post-homing intron-containing allele immune to 
cleavage, as intron insertion disrupts the cognate I-BmoI cleavage site without affecting 
binding along the asymmetric recognition site (115). I-BmoI is also a modular enzyme 
where a flexible linker connects the N-terminal GIY-YIG domain to a DNA-binding 
domain that contains three predicted NUMOD3 α-helices and a helix-turn-helix domain 
(Figure 1.4B) (115,116). To generate a DSB, I-BmoI nicks the bottom-strand prior to the 
top strand (non-coding before coding) with multiple distinct DNA-distortions observed 
surrounding the cleavage site (117). As such, I-BmoI appears to operate via a comparable 
catalytic mechanism to I-TevI, where substantial protein and substrate conformational 
rearrangements facilitate cleavage by the GIY-YIG domain. Unlike I-TevI, however, I-
BmoI is easily overexpressed and purified from bacteria due to a ~750-fold reduced 
specific activity (116), allowing us to perform detailed biochemical examinations of 
protein:DNA interactions and specifically test DNA-hydrolysis models (Chapters 2-4). 
Additionally, because a major consideration of this thesis is the mechanism by which 
GIY-HEs hydrolyze DNA, the distribution, modularity, and mechanisms of other 
enzymes that contain the GIY-YIG motif are described below. 
1.2.2 Properties of other GIY-YIG family endonucleases 
First discovered within intron-encoded ORFs in bacteriophage and filamentous fungi 
(118), the GIY-YIG motif is distributed amongst nucleases with diverse structures and 
functions (104,119,120). Variations of the GIY-YIG consensus are found in HEs and REs 
13 
 
(GIY-REs) (40,97,115,121-126), non-LTR retrotransposons (127-129), non-specific 
nucleases (130), structure-specific nucleases involved in DNA-repair and recombination 
(131-136), and the recently described human and C. elegans LEM associated nucleases 
(137,138). Independent crystallographic studies revealed that the GIY-YIG domain is 
composed of a structurally conserved and tightly packed core that contains three β-
strands surrounded by at least two α-helices (Figure 1.5A) (106,139-143). The central 
GIY-YIG domain has a single active site and has acquired distinct context specific 
adaptations either within or surrounding the conserved fold to expand its functional 
diversity.  
Prior to studies that solved two separate GIY-RE:substrate co-crystals (142,143), 
functional roles of conserved tyrosine, histidine, arginine, and asparagine residues 
remained speculative, other than a metal binding role established for a conserved 
glutamate residue (E75 in α-helix 3 of I-TevI, residue numbering hereafter for I-TevI). 
The crystal structures subsequently suggested a concerted single-step cleavage reaction 
that utilizes a single magnesium ion for hydrolysis (143). The tyrosine residues of the 
GIY and YIG motifs (Y6 and Y17), found within β-strands 1 and 2, respectively, 
potentially act interchangeably as the primary general base to activate a water molecule 
(though Y6 is most likely). Additionally, the imidazole ring of H31 in α-helix 2 is within 
hydrogen bonding distance of both Y6 and Y17 and may assist in proton abstraction to 
initiate hydrolysis. The active site divalent metal ion, coordinated primarily by E75 in α-
helix 3 and to some extent by N90, is thought to simultaneously stabilize the reaction 
intermediate and 3’ leaving group. Interestingly, the role of R27 in α-helix 1 remains 
somewhat ambiguous, as it is found in different rotameric conformations between the 
dimer subunits in the structure of the GIY-RE Eco29kI structure (142). Roles have been 
proposed for the conserved arginine to contact the phosphate backbone, interact with the 
neighboring ribose, or to directly participate in catalysis (142,143). Furthermore, it is 
highly likely that additional contextually distinct functional residues within separate GIY-
YIG architectures are unidentifiably by conservation alone, and I present data in Chapter 
2 that identifies non-conserved yet functionally relevant residues of the I-BmoI catalytic 
domain (120). 
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Figure 1.5: GIY-YIG domain structures 
(A) Structures of six GIY-YIG nuclease domains. Secondary structure elements that 
contain the active site residues are shown in orange, and catalytic residues are shown in 
red for I-TevI. For the remaining five structures, only residues homologous to Y17 and 
R27 are shown. (B) DNA-bound structures of dimeric GIY-YIG REs Hpy188I and 
Eco29kI, with dimer half-units shown in cyan and green, and active site structures shown 
in orange. Views along the DNA axis or perpendicular to the plane of DNA are shown 
(left and right panels, respectively). Slx1 PDB:1ZG2; I-TevI PDB:1MK0; UvrC 
PDB:1YCZ; Hpy188I PDB:3OQG; T4 endo II PDB:2WSH; Eco29kI PDB:3NIC. 
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The conserved amino acids of GIY-YIG endonucleases are found within a structurally 
similar active site (Figure 1.5A), yet individual family members employ distinct 
architectures and function by a number of mechanisms (reviewed in reference 142). For 
example, GIY-REs have acquired supplementary protein folds that supply base-specific 
and backbone contacts necessary to bind 5 or 6 base pair target sites in a specific manner 
(142,143). The additional folds also assist in oligomerization as a mechanism for DSB 
formation, where Eco29kI and Hpy188I assemble as dimers (Figure 1.5B) and Cfr42I 
forms a tetramer upon DNA binding (126,143,144). Similarly, bacteriophage T4 
endonuclease II, which degrades host DNA during infection, forms a tetrameric structure 
that nicks both strands of a single substrate or synapses between multiple targets to nick 
one strand of each substrate (145). Alternatively, the bacterial nucleotide excision repair 
proteins UvrC and Cho employ single GIY-YIG domains as nickases to hydrolyze one 
DNA strand 3’ to DNA lesions of different sizes (132,133). These endonuclease also 
typically encode a secondary nuclease module to nick upstream of the damaged DNA 
base to fully excise the lesion (119). While it has been speculated that GIY-HEs 
hydrolyze DNA via a sequential nicking and conformational change mechanism 
(103,117,146), cleavage by I-TevI or I-BmoI has remained poorly understood. Both 
characterized GIY-HEs lack the supplementary catalytic domain folds necessary for 
dimerization and no additional putative nuclease motifs or active sites have been 
predicted. Therefore, I specifically test models for DNA hydrolysis by single active site 
enzymes in Chapters 4 and 5 (for I-BmoI and engineered I-TevI nucleases, respectively) 
towards understanding the GIY-HE cleavage mechanism. 
1.2.3 LAGLIDADG homing endonucleases 
LAGLIDADG homing endonucleases (LHEs) have a broad phylogenetic distribution and 
target sequences of moderate length from 16 to 26 base pairs (80,147). As described 
above for I-SceI, the discovery of LHEs provided a foundation from which we began to 
understand the mobility of selfish MGEs (52). With over 10 solved crystal structures to 
date, LHEs are well-characterized structurally and hydrolyze DNA within two active sites 
located at the base of the pseudo-dimeric enzyme interface (Figure 1.3) (80,148,149). 
Also termed dodecapeptide-nucleases, LHEs encode α-helices within each subunit that 
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contain the moderately conserved 10-residue motif and form the major interactions at the 
subunit interface. LHEs with a single copy of the motif function as homodimers and 
target near-palindromic sites (150,151), while single peptide chain LHEs with two copies 
of the motif and are monomers that can target asymmetric sequences (152,153). LHEs 
utilize four extended antiparallel β-sheets to bind DNA through the major groove where 
interactions from each half-unit span the cleavage site and induce a directed bend in the 
substrate (Figure 1.3) (150-154). Each half-unit of either the homodimeric or single chain 
enzymes hydrolyzes one strand of DNA, while for some LHEs it is suspected that a 
shared divalent metal ion across both active sites can contribute to DNA hydrolysis (80). 
As such, the DNA-binding mechanism and unique subunit interface has made LHEs 
intriguing candidates for genome editing applications (148,149,154,155). These prospects 
will be further discussed in Chapter 1.4.3, and we investigate the utility of a catalytically 
inactive LHE as a DNA-binding platform for engineered nucleases in Chapter 5. 
1.2.4 ββα-Me homing endonucleases 
His-Cys box and H-N-H family enzymes form structurally similar ββα-Me active site 
architectures and are found within a selection of endonucleases that perform various 
biological functions (80,156). Aside from HEs (109,157), the ββα-Me fold is found 
within REs (39,42,158), non-specific bacterial colicins and fungal nucleases (including 
the Serratia nuclease) (159-162), structure-specific holiday junction resolvases (163), and 
other DNA processing enzymes (164,165). The His-Cys motif is characterized by 
histidine and cysteine residues and is found within many HE genes (166-169). I-PpoI, the 
most well characterized His-Cys HE family member, dimerizes to bind and cleave a 
relatively short pseudo-palindromic 14 base pair recognition sequence (Figure 1.3) 
(111,170,171). Crystallographic studies revealed a tertiary structure rich in metal ions 
where multiple zinc ions are coordinated by histidine and cysteine residues to stabilize 
the protein core, and magnesium ions are coordinated within the ββα-Me active site to 
assist in hydrolysis by interacting with the scissile phosphate (157,172). A significant 
bend in DNA across the base pairs between the two active sites is observed, facilitated by 
NUMOD4 DNA-binding elements within each monomer (110,111). Interestingly, each 
subunit positions a hydrophobic leucine side-chain within the minor groove to widen the 
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distance between the phosphate backbones prior to hydrolysis, a mechanism that has been 
suggested to increase accessibility to the cleavage site prior to hydrolysis (173). 
While they share a ββα-Me fold, the H-N-H HEs are structurally dissimilar to I-PpoI as 
they target longer recognition sequences (24-40 base pairs) and do not bind DNA as 
symmetric dimers (52,79). The crystal structure of the H-N-H HE I-HmuI substrate-
bound complex revealed an extended monomeric configuration with N- and C-terminal 
DNA-binding domains flanking either side of the H-N-H active site (Figure 1.3) (109). 
Within the context of H-N-H HEs the catalytic motif inherently functions as a nickase, as 
I-HmuI and I-BasI bind DNA as monomers to nick only a single strand (174-176), and I-
TevIII forms an asymmetric dimer to induce a DSB by nicking both strands (177). It is 
possible that I-HmuI and related H-N-H HEs nick only a single strand of DNA as a result 
of their monomeric assembly on DNA combined with rotational restriction of the active 
site by surrounding DNA-binding elements. The I-HmuI N-terminal DNA binding 
domain displays high similarity to the NUMOD4 domains observed within I-PpoI, while 
the C-terminal domain contains NUMOD3 α-helices and a helix-turn-helix domain 
(similar to those observed for I-TevI), sandwiching the active site between elements with 
substantial affinity for DNA (109,110,175). Furthermore, the DNA-binding modules of I-
HmuI span the phosphate backbone twice to induce a 40° bend near the cleavage site, and 
like I-PpoI widen the minor groove (80,109). 
1.2.5 Type IIS restriction endonucleases 
Type IIS REs were the first identified Type II subclass due to their capacity to nick at 
least one strand of DNA at a precise distance anywhere from 0 to 21 base pairs from the 
primary 4-7 base pair binding site (32,92,93). Like GIY-HEs, many Type IIS REs are 
two-domain proteins connected by a flexible linker (178-180), with FokI being the most 
highly characterized of any Type IIS RE. A number of catalytic mechanisms have been 
described for the four subclasses of Type IIS REs, and FokI binds DNA as a globular 
monomeric protein to initiate hydrolysis (180,181). Upon DNA binding, the single active 
site nuclease domain of FokI is released from the globular structure allowing extension to 
the cleavage site where hydrolysis occurs non-specifically (84,182). Hydrolysis is most 
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efficient when dimerization with another substrate bound FokI molecule at a proximal 
secondary site occurs, another hallmark of many Type IIS REs (84,180,183). FokI nicks 
both DNA strands at 9/13 base pairs away from its primary binding site to generate a 
DSB, yet the composition of nucleotides surrounding the cleavage site does not affect 
hydrolysis (184,185). Thus, most Type IIS REs are said to non-specifically cleave DNA 
while retaining a distance preference for the location of hydrolysis (92,93). The 
modularity and non-specific nuclease activity of the FokI nuclease domain has garnered 
significant interest in the field of genome editing and has led to its adaptation within 
multiple engineered platforms (35,186). The architectures of FokI chimeric nucleases are 
discussed in Chapters 1.4.1 and 1.4.2, while the genome editing successes, limitations, 
and prospects are discussed in Chapters 1.5 and 6. 
1.3 Genome editing 
The ability to stably modify genomes has led to the elucidation of the functions of many 
genes in model systems and initiated the field of nuclease mediated gene therapy. In the 
late 1970’s, the first site-directed homologous gene targeting method demonstrated that 
synthetic genes could be stably integrated into Saccharomyces cerevsiae (187). The 
seminal study revealed that yeast could heritably acquire a metabolic gene from an 
exogenous source through homologous recombination (HR), when a stable leu2- strain 
was converted to a LEU2+ strain upon transformation with a bacterial plasmid encoding 
the corresponding leucine biosynthesis gene. This technique was subsequently adopted 
for many gene knock-in or knock-out studies in yeast (188-191), yet similar efficient 
gene conversion was not observed in mice or human cells (192-195). The finding that on 
average less than 0.01% of human cells were genetically modified was the due to the 
inherent biology of mammalian cells, where nonhomologous end joining (NHEJ) is the 
predominant DNA repair pathway at most cell stages versus HR in yeast, precluding the 
methodology from relevant human cell therapies (194,196,197). 
A shift in the paradigm of genome editing in mammalian cells occurred when traditional 
homologous gene replacement methods were coupled with a site-directed DSB (198,199). 
When a vector expressing the LHE I-SceI was cotransfected with a donor template for 
DNA repair via HR, greater than 100-fold increases in gene conversion events were 
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observed versus transfection of the HR template alone (200-202). By generating a 
sequence-specific break to initiate DNA repair in the presence of a donor template, the 
natural DSB-repair preference in mammalian cells was shifted from NHEJ to HR. The 
realization that genomes could be modified at defined locations was encouraging, as early 
efforts with high efficiency recombination based approaches using transposons or viral 
integrases remained relatively non-specific (203,204). Consequently, much effort has 
been devoted to developing site-specific endonuclease architectures for targeted genome 
modification, a subset of which are further discussed below. 
1.4 Genome editing with engineered nucleases 
At the beginning of this century, multiple clinical trials were initiated to treat two forms 
of severe combined immunodeficiency (X-SCID and ASA-SCID) using retroviral 
integrases (205-207). SCID is a genetic disorder of the adaptive immune system where 
the development of both T- and B-lymphocytes is impaired, making it an ideal disease 
model for therapy as corrected cells will selectively proliferate over a patient’s intrinsic 
population of deficient cells (208,209). Retroviral treatments were conducted on 
extracted hematopoietic stem cells to restore a functional immune system to recipients by 
stably integrating wild-type copies of their deficient genes (205,206,210). At early stages 
in their treatment regimens, patients appeared to recover from their SCID symptoms, 
however it was later discovered that in many cases their therapies had promoted the 
development of leukemia as a result of non-directed transgene integration adjacent to 
proto-oncogenes (209,211,212). Though these and other clinical trials prolonged the life 
of most patients, they reinforced the necessity for the development of highly targeted 
therapeutic technologies that could function in a site-specific manner.  
Around the same time, high frequency gene replacement in mammalian cells using site-
specific nucleases renewed optimism within the field of gene therapy (78,213-215). By 
mimicking the natural propagation mechanisms of ‘selfish’ genetic elements, engineered 
endonucleases were employed to disrupt or delete genes, correct deleterious single-
nucleotide polymorphisms (SNPs), or introduce exogenous corrective genetic cassettes 
(Figure 1.6) (216-218). Upon further refinement of engineered nuclease technologies, it 
has become possible to modulate the desired gene correction mechanism following a  
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Figure 1.6: Genome editing outcomes from targeted DNA breaks 
Site-specific endonucleases initiate DNA repair pathways at endogenous alleles leading 
to gene conversion events that differ depending on whether or not an exogenous donor 
template is provided. 
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DSB (NHEJ vs. HR, elaborated in Chapter 6) (219,220). Though some limitations 
associated with current platforms have led to the exploration of alternative nuclease 
technologies (221-223), the majority of engineered site-specific endonucleases utilize one 
of two architectures: customizable DNA-binding modules fused to the non-specific FokI 
nuclease domain, or LHEs whose binding specificities have been reengineered to target 
non-native sequences.  
1.4.1 Zinc-finger nucleases 
As described in Chapter 1.2.5, the Type IIS RE FokI is a bi-partite enzyme that 
transiently dimerizes through its catalytic domain to hydrolyze DNA. Accordingly, the 
modularity and catalytic mechanism of FokI has been exploited to generate chimeric REs 
by fusing the non-specific nuclease domain to targetable zinc-finger DNA-binding 
proteins, creating zinc-finger nucleases (ZFNs, Figure 1.7A, B) (34,35,224). The 
oligomeric nature of FokI requires a “head-to-head” design of ZFNs and necessitated 
optimization of the dimer interface and for efficient cleavage (Figure 1.7B) (225-227). To 
expand the genomic space targetable by ZFNs, the re-programmability of zinc-finger 
proteins as DNA-binding modules has been extensively explored (228-231). Each zinc-
finger unit contributes 3-4 base pairs of DNA-binding specificity, where engineered 
arrays of six zinc-fingers can theoretically bind an 18 base pair sequence (Figure 1.7B) 
(232). The combined optimization efforts have led to ZFN architecture refinements and 
the development of high-throughput assembly methods to construct active dimeric ZFN 
pairs (217,233-235). ZFNs have been notably successful tools for gene editing studies in 
model organisms and human cell lines (214,236-239), yet the limited targeting range, 
frequently ambiguous nucleotide recognition, and imperfect assembly of zinc-finger 
arrays has reduced the widespread technological potential of ZFNs (240,241). 
1.4.2 Transcription activator-like effector nucleases 
An alternative highly customizable DNA-binding platform has begun to supplant zinc-
finger arrays as the preferred targeting module in FokI chimeric nucleases (218,242). 
While characterizing the virulence of Xanthomonas strains as plant pathogens, it was  
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Figure 1.7: FokI nuclease derived ZFNs and TALENs 
(A) Structural representations of a zinc-finger array. Separate zinc-finger units that each 
target 3-4 base pairs are coloured in orange, green, and yellow, with zinc ions coloured in 
cyan. (B) Schematic of two 3-member ZFNs in a head-to-head orientation, each of which 
interacts with a 9 base pair target. (C) Structural representations of a 25-repeat TAL 
array, with repeats that each contact a single base pair coloured separately. (D) Schematic 
of two 12-repeat TALENs in a head-to-head orientation, each of which interacts with 12 
base pairs. 
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discovered that transcription activator-like (TAL) effector proteins recognize DNA 
through a highly repetitive structure (Figure 1.7C) (243). Uniquely, 2 amino acids within 
a repeated and otherwise almost absolutely conserved 33-35 amino acid structure dictate 
a single-base pair contact (termed the repeat-variable diresidue, or RVD) (244,245). 
Recent crystallographic studies confirmed the predicted 1:1 cipher that governs DNA 
recognition, where an array of sequential RVDs within the repeated TAL backbone can 
be assembled to bind defined sequences (Figure 1.7D) (246,247). It wasn’t long before 
studies emerged demonstrating that TALENs (TAL effector nucleases, where the FokI 
nuclease domain is fused to the TAL domain) efficiently target desired loci in yeast, 
plants, zebrafish, and mammalian systems (248-254). The early success of this 
architecture led to a much more rapid refinement of TALEN development and assembly 
compared to ZFNs, due in part to the pre-established knowledge of FokI biology. Within 
three years, numerous high-throughput assembly methodologies have been developed 
with considerable promise for widespread application of TALENs (249,255-258). 
Similarly to ZFNs, however, TALENs are subject to the limitations of the inherent 
biology and mechanism of the FokI nuclease domain and must therefore be constructed 
in a head-to-head design (4). 
1.4.3 Engineered LAGLIDADG nucleases 
As the initiators of modern genome engineering, LHEs have continued to drive 
innovation within the field. Their relatively small size and robust structural 
characterization have made them ideal candidates for application-oriented genome 
editing studies (149). Additionally, their natural pseudo-symmetric modularity, 
modifiable DNA-binding specificity, and growing number of identified family members 
have begun to translate to an almost unlimited targetable sequence space by engineered 
LHEs (148,149,154,259,260). Unlike the head-to-head design of FokI derived ZFNs and 
TALENs, engineered LHEs are single module enzymes that cleave within their respective 
binding sites. Initial studies to engineer the binding specificity of LHEs involved the 
generation of I-CreI/I-DmoI chimeras that target novel hybrid DNA sequences. The 
engineered ‘E-DreI’ chimeric LHE contained one I-CreI homodimeric subunit that 
functionally replaced one half of the single chain LHE I-DmoI (Figure 1.8A) (261,262).  
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Figure 1.8: Methods to engineer LAGLIDADG endonuclease specificity 
(A) Chimeras are created from left and right units derived from distinct parent enzymes 
and cleave a corresponding hybrid target site. (B) Directed evolution of amino acids that 
specify DNA interactions. Altered amino acid side chains are space filled in blue, while 
mutated base pairs are shown in red. Active site LAGLIDADG motifs are coloured in 
orange. 
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More recently, a study generated 30 different chimeric LHEs from the I-OnuI subfamily, 
14 of which displayed appreciable in vitro activity (155). Yet, the most powerful and 
successful directed evolution approaches have involved the semi-rational high-throughput 
re-engineering of the LHE DNA-binding interface (Figure 1.8B) (259,263-265). Using 
this method, LHEs have been re-targeted to engineer maize genes (266), generate 
populations of malaria resistant mosquitoes (267), and target numerous human alleles 
(154,268-270). Despite the successes associated with engineered LHEs, each directed 
evolution method must be coupled with concurrent (and sometimes challenging) re-
optimization of catalytic activity and protein stability, as LHEs are highly dynamic single 
module enzymes for which most intra-molecular interactions are not well understood 
(271-273).  
1.5 Scope of the thesis: can the cleavage mechanism of 
the GIY-YIG domain detoxify engineered nucleases? 
This thesis continues the story of GIY-HE characterization that began over 24 years ago 
when I-TevI was discovered (97). To date, studies with I-TevI have provided biochemical 
and structural insight into the roles of the nuclease, linker, and DNA-binding domains of 
GIY-HEs, yet were unable to specifically test models for DSB formation. Thus, the DNA 
hydrolysis mechanism utilized by GIY-HEs to mobilize their own genes has remained 
unknown. Using the related endonuclease I-BmoI, I have revisited this story to 
investigate catalytic domain interactions with substrate and specifically test DSB 
mechanisms. By understanding the biology of GIY-HE’s, I have been able to exploit the 
inherent properties of GIY-YIG nuclease domains to create chimeric enzymes fused to 
the three targetable DNA-binding platforms used in the field of genome editing.  
As described within this thesis, I propose a monomeric cleavage mechanism for GIY-
HEs that involves the repositioning of the single active site nuclease domain to perform 
sequential nicking reactions. The conformational change mechanism proceeds through 
multiple distinct DNA distortions, the first of which is dependent on an identified 
protein:DNA interaction that acts as a molecular tether to anchor the nuclease domain on 
substrate. Given that I-BmoI requires a GC base pair at its cleavage site for efficient 
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hydrolysis (Figure 1.4B), this added preference would imply that a di-nucleotide 
targeting rule exists for I-BmoI. Accordingly, an analogous protein:DNA tether for I-
TevI would lead to an expanded targeting preference from a CnnnG di-nucleotide to a tri-
nucleotide. This inference is plausible, as the functional similarity of the GIY-HE linkers 
has previously been demonstrated when chimeric TevBmo and BmoTev nucleases were 
shown to cleave corresponding hybrid target sites (113). This study also emphasized that 
the I-TevI and I-BmoI nuclease domains retained function in the context of a non-native 
DNA-binding platform, a significant result when considering either domain for genome 
editing applications.  
I envision the monomeric and site-specific cleavage mechanism of GIY-HEs as an 
advantageous property to ‘detoxify’ and improve existing genome editing reagents. 
Studies have revealed that the inherent non-specific nuclease activity and dimeric 
requirement of FokI-derived ZFNs and TALENs has led to high off-target cleavage rates 
by established ZFNs that are in clinical trials (274,275). While TALENs have performed 
slightly better than ZFNs in terms of genome modification activity at similar loci (276), 
the specificity of either platform has not been thoroughly examined and they remain 
susceptible to the same non-specific and toxic mechanisms inherent to the FokI nuclease 
domain (4). Conversely, the directed evolution of LHE DNA-binding specificity has not 
proceeded as readily as had been hoped. While the confinement of DNA-binding and 
cleavage properties within a single small architecture has advantages, subtle changes to 
the engineered LHE structure can have unforeseen consequences and often necessitates 
laborious re-optimization of catalytic activity. Consequently, the difficulties associated 
with these technologies have led to the exploration of alternative nuclease platforms that 
include chimeras of Type IIP REs to zinc-fingers and inactive LAGLIDADG HEs 
(221,277), and synthetic ‘guide’ RNAs that stimulate DNA hydrolysis by the 
CRISPR/Cas system (223,278,279). Unfortunately, the efficacy and specificity of either 
platform have not been robustly tested.  
The work presented within this thesis has directed the development of the first set of 
monomeric reprogrammable nucleases. By understanding the fundamental biology and 
cleavage mechanism of GIY-HE’s, I have been able to rationally design and test GIY-
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YIG engineered nucleases fused to the zinc-finger, LHE, and TAL DNA-binding 
platforms (GIY-ENs). It is possible that the inherent properties of GIY-ENs may 
circumvent the drawbacks associated with other technologies, as the requirements to 
cleave at a preferred motif and function as a monomer may abolish the promiscuous 
activity observed with FokI-derived nucleases. These potentially advantageous properties 
are elaborated in Chapter 6, along with future considerations and prospects for GIY-ENs. 
Overall, it has been important is to understand the inherent cleavage mechanism, 
nucleotide preference, and modularity of the GIY-HE family prior to generating chimeric 
and targetable enzymes. 
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Chapter 2  
2 A unified genetic, computational and experimental 
framework identifies functionally relevant residues of 
the homing endonuclease I-BmoI 
The work presented in this chapter is reproduced (with permission, Appendix S1) from: 
Kleinstiver, B.P., Fernandes, A.D., Gloor, G.B., Edgell, D.R. (2010) A unified genetic, 
computational and experimental framework identifies functionally relevant residues 
of the homing endonuclease I-BmoI. Nucleic Acids Research 38: 2411-2427 
2.1 Introduction 
The explosion of sequence and structural data has rapidly accelerated the pace of protein 
structure and function studies. Bioinformatic approaches that predict function based on 
amino acid conservation (1,2), homology modelling studies (3), and identification of co-
evolving residues (4,5) are among methods commonly used to address structure and 
function questions. There are, however, many protein families for which mechanistic 
insight is lacking. The GIY-YIG homing endonuclease family is one such example. 
Homing endonucleases are site-specific yet sequence-tolerant DNA endonucleases that 
are distinguishable from other DNA endonucleases in their ability to bind long target 
sequences and tolerate multiple substitutions within their binding site (6). They function 
primarily as mobile genetic elements, initiating the movement of their coding sequence 
and surrounding DNA by binding and cleaving a target site (the homing site) in genomes 
that lack the endonuclease (7). Homing endonucleases are phylogenetically widespread, 
and have traditionally been categorized into one of four large families based on 
conserved amino acid motifs, the LAGLIDADG, HNH, His-Cys box, and GIY-YIG 
families (6). The PE-(DE)-XK and Vsr-like enzymes are only recently described and 
have fewer family members (8,9). Much effort has been devoted towards re-engineering 
naturally occurring LAGLIDADG endonucleases to cleave novel target sequences with 
clinical relevance in the human genome (10-13). Similar studies could in principle be 
performed on any endonuclease family, necessitating a detailed understanding of 
mechanism. 
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Within the four largest endonuclease families, the GIY-YIG endonucleases are the least 
understood in terms of mechanism. The prototypical GIY-YIG family endonuclease is I-
TevI, encoded with the genome of Escherichia coli phage T4 (14). Studies on I-TevI 
revealed that the enzyme has a two-domain structure, composed of a N-terminal catalytic 
domain containing the class-defining GIY-YIG motif that is connected to a C-terminal 
DNA-binding domain by a flexible linker (15). Substantial experimental evidence 
suggests that the DNA-binding domain tethers the catalytic domain on its substrate to 
perform two sequential nicking reactions that generate a staggered 2-nt 3’ overhang (16). 
The catalytic domain has no measurable DNA-binding activity when expressed 
independently, and a critical function of the linker region in I-TevI, and its isoschizomer 
I-BmoI, is to correctly position the domain on substrate (17-19). Early bioinformatic 
studies revealed that the GIY-YIG domain is not exclusive to homing endonucleases 
(20), illustrated by the presence of the domain in the UvrC nucleotide excision repair 
protein (21), restriction enzymes (22,23), and retrotransposable elements (24). Structural, 
biochemical and bioinformatic studies have shown that the GIY-YIG domain is ~90 
amino acids with an α/β-fold composed of a central three-stranded antiparallel β-sheet 
flanked by three helices (21,25) (Figure 2.1). Four highly conserved residues in the GIY-
YIG domain, Y17, R27, E74, and N87 (numbered according to the I-BmoI sequence, 
Figure 1B) comprise a putative active site cleft (Figure 1C), with a single divalent metal 
ion coordinated by the glutamic acid residue in both the I-TevI and UvrC structures. 
Mutation of any of these residues abolishes DNA cleavage activity in a number of GIY-
YIG enzymes (20-22,26,27). 
In spite of a wealth of bioinformatic, biochemical, and structural data, the mechanism by 
which GIY-YIG homing endonucleases introduce a double-strand break in substrate is 
unknown (28). The mechanism must involve repositioning of a (presumably) single 
active site within the catalytic domain on substrate to perform two sequential nicking 
reactions, with the bottom (non-coding) strand nicked before the top (coding) strand 
(27,29). This mechanism is likely to be distinct from other enzymes that contain the GIY-
YIG domain, including the restriction enzyme Cfr42I that functions as a tetramer (30), 
Eco29kI that functions as a dimer (31), or the UvrC proteins that nick only a single-strand  
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Figure 2.1: I-BmoI is a modular GIY-YIG homing endonuclease 
(A) Schematic representation of I-BmoI interactions with intronless thyA substrate based 
on biochemical data (27,32). Top- and bottom-strand nicking sites are shown as open and 
filled triangles, respectively, and the critical -2 GC base pair is shown in enlarged, bold-
type font. The intron insertion site is indicated by a vertical line, with exon 1 sequence 
upstream (-) and exon 2 sequence downstream (+). (B) Homology model of the I-BmoI 
catalytic domain (residues 1-88). Highlighted are four highly conserved residues in GIY-
YIG alignments that are critical for function, and secondary structure elements of the 
domain. Subsequent illustrations of the catalytic domain will be shown from this view 
(front) or a 180-degree rotation (back). (C) Surface representation of a front view of the I-
BmoI homology model highlighting the putative catalytic cleft. The sidechains of Y17, 
R27, E74, and N87 are surface exposed, lie along the base of the cleft, and are situated in 
close proximity to one another. Patches of charge are shown in color, blue being positive, 
red being negative, and green being hydrophobic. 
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adjacent to a damaged base (21). In an effort to gain insight into the mechanism by which 
GIY-YIG homing endonucleases introduce a double-strand break, we have been studying 
I-BmoI (Figure 2.1), an isoschizomer of I-TevI (32). Like I-TevI, I-BmoI is a two-
domain endonuclease with an extended recognition sequence. Both enzymes cleave at the 
same positions within their respective intronless substrates, but I-BmoI requires only a 
critical G-C base pair at position -2 of intronless substrate for cleavage (33). As a model 
GIY-YIG homing endonuclease, I-BmoI has a number of advantages over I-TevI, 
including the fact that the wild-type (WT) enzyme can be overexpressed and purified in 
quantities that are difficult to obtain with I-TevI. Moreover, I-BmoI is ~750-fold less 
active than I-TevI, suggesting that early steps in the reaction pathway are more amenable 
to in vitro analysis (27,33).  
Here, we present a unified experimental framework that will provide a platform on which 
to base future structure and function studies of GIY-YIG homing endonucleases, and 
other GIY-YIG-containing enzymes. Our framework, which we term MUSE, synthesizes 
data from three distinct experimental approaches; mutual information analyses that 
identify co-evolving residues in the GIY-YIG domain, a unigenic evolution strategy that 
uses a functional genetic selection to identify hypo- and hyper-mutable residues, and 
interpretation of the data using paralog-specific sequence alignments and structural 
models of the GIY-YIG domain. While none of the approaches used in our study are 
individually novel, the synthesis of data from all three methods facilitated the 
identification of residues that are unlikely to have been identified as important for 
function using any one of the approaches in isolation. Mutational analyses of the 
positions revealed phenotypic differences relative to WT I-BmoI in functional assays, 
validating that MUSE can successfully identify previously unrecognized residues with 
the GIY-YIG domain as relevant for function.  
2.2 Materials and methods 
2.2.1 Strain and plasmid construction 
Strains and plasmids used in this study are listed in Supplementary Table S2.1, and 
oligonucleotides are listed in Supplementary Table S2.2. To construct strain 
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BW25141(λDE3) for use in unigenic evolution experiments, E.coli BW25141 was 
lysogenized using the λDE3 lysogenization kit (Novagen). The toxic plasmid backbone, 
p11-lacY-wtx1 (38), was used to construct pToxBmoHS and pToxBmoIn+ by inserting 
the corresponding intronless homing site (HS) and intron-containing target site (In+), 
respectively. To construct pToxBmoHS, oligonucleotides DE-395 and DE-396 were 
annealed and ligated into the XbaI and SphI sites of p11-lacY-wtx1. The 51bp intronless 
homing site corresponds to positions -10 to +41 of the exon1-exon2 junction relative to 
the intron insertion site (32). To construct pToxBmoIn+, oligonucleotides DE-429 and 
DE-430 were annealed and ligated into the XbaI and SphI sites of p11-lacY-wtx1. The 51 
bp intron-containing site corresponds to the final 10 bp of the 3’ end of the intron plus the 
first 41 bp of the 5’ end of exon 2 (32). pIBmoIE, which is a pUC57 derivative containing 
a codon optimized I-BmoI gene (IDT DNA), was used as a template for cloning the I-
BmoI gene (optimized I-BmoI sequence is presented in Supplementary Figure S2.1). 
Primers DE-331 and DE-384 were used to amplify and clone the codon optimized I-
BmoI into the NdeI and XhoI sites of pACYCDuet-1 to generate pACYCIBmoI. This 
plasmid was subsequently used as a template to generate pACYCR27A using the 
Quikchange XL site-directed mutagenesis kit (Stratagene) with primers DE-419 and its 
reverse complement, DE-420. All plasmid constructs were verified by sequencing. 
2.2.2 Genetic selection 
To generate strains harbouring the toxic plasmid for unigenic evolution, 
BW25141(λDE3) was transformed with one of the 3 toxic (reporter) plasmids (p11-lacY-
wtx1, pToxBmoHS, or pToxBmoIn+) and plated on LB plates containing 100 µg/ml 
ampicilin and 0.2% glucose. For each strain, a single colony was picked to inoculate 500 
ml LB plus 100 µg/ml ampicilin and 0.2% glucose to generate electrocompetent cells. 
Typically, 50 µl of electrocompetent cells were transformed with 100 ng of the 
expression plasmid (pACYCIBmoI or pACYCR27A). The transformations were allowed 
to recover in 500 µl of SOC media at 37oC for 5 minutes, then diluted into 2 ml 37oC 
SOC and shaken at 37oC for 75 minutes. We found that addition of IPTG was not 
necessary to induce I-BmoI expression, as an IPTG concentration of 0.1 mM led to toxic 
effects. After incubation, transformations were diluted 1000-fold in SOC, and 100-µl 
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aliquots were spread on plates containing LB plus 25 µg/ml chloramphenicol to estimate 
number of transformants, or plates containing LB plus 25 µg/ml chloramphenicol and 10 
mM arabinose to observe the number of colonies surviving the selection. Survival rate 
was calculated by dividing the number of colonies observed on chloramphenicol plus 
arabinose plates by colonies observed on chloramphenicol only plates.  
2.2.3 Construction of mutagenized I-BmoI libraries 
I-BmoI mutant libraries were generated by error-prone PCR from pACYCIBmoI using 
primers DE-490 and DE-491. The forward primer (DE-490) was designed such that only 
the ATG start codon was included in the primer, and the reverse primer (DE-491) was 
designed such that no part of the I-BmoI gene was present in the primer. Three mutagenic 
libraries were generated using identical PCR conditions in parallel 50-µl reactions 
containing 80 ng of pACYCIBmoI as template, 20 pmol of each primer (DE-490, DE-
491), 0.2 mM dATP, 0.2 mM dGTP, 1 mM dCTP, 1 mM dTTP, 0.5 mM MgCl2, 0.5 mM 
MnCl2, and 2.5 units of Taq polymerase (NEB) in the presence of 1x PCR buffer (10 mM 
KCl, 10 mM (NH4)2SO4, 20 mM Tris-HCl pH 8.8, 2 mM MgSO4, 0.1% Triton X-100).  
A total of 30 PCR cycles were run as follows: 94oC for 60s, 46.5oC for 60s, and 72oC for 
60s. Mutagenic PCR products were digested with NdeI and XhoI and ligated into 
pACYCR27A (used as a ligation target due to the fact that re-ligated singly cut R27A I-
BmoI would be non-functional in the selection). The ligated pools were independently 
transformed into DH5α, grown in 3 ml LB plus 25 µg/ml chloramphenicol for16 hours at 
37oC, and miniprepped (QIAGEN) to generate the mutant I-BmoI libraries.  
2.2.4 I-BmoI unigenic evolution and selection of variants 
The three mutagenic libraries were subjected to unigenic evolution to determine survival 
percentage and to obtain clones required for sequence analysis. We sequenced a total of 
167 selected clones picked from LB plus chloramphenicol and arabinose plates, of which 
87 independent clones (36, 34, and 17 clones from pools 1, 2, and 3 respectively) were 
identified (the rest discarded due to redundancy of DNA or amino acid sequence). These 
clones contained a total of 460 nucleotide substitutions corresponding to 271 amino acid 
substitutions. We also sequenced 62 unselected clones from LB plus chloramphenicol 
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only plates. The unselected clones harboured a total of 760 nucleotide substitutions, 577 
amino acid substitutions, and were used to establish baseline mutation frequencies.  The 
EoS value was calculated as described (40).  
2.2.5 Construction and purification of site-directed mutants 
We created a library of site-directed mutants using the Quikchange® XL Site-Directed 
Mutagenesis Kit (Stratagene) to generate point mutants in the pACYCIBmoI backbone. 
For purification purposes, a subset of these mutants were sub-cloned into the 
pTYB1vector and were expressed and purified as previously described with one change 
to the protocol (27). Once the clarified lysate has been loaded, the five column volume 
wash with buffer A now contains a final concentration of 1mM ATP (Bioshop Canada 
Inc.) to help remove bound chaperones. The concentrations of purified WT I-BmoI and I-
BmoI mutants were determined by a standard Bradford assay in duplicate using an 
Ultrospec 2100 pro (Biochrom Ltd). 
2.2.6 Characterization of I-BmoI variants 
A set of I-BmoI variants identified from the unigenic evolution study and the library of 
site-directed mutants were run through the genetic selection (as described above) to 
determine their survival versus WT. Cleavage assays were subsequently performed with 
I-BmoI mutants that were amenable to purification. The cleavage activities of WT and I-
BmoI mutants were determined using titrations with 10 nM pBmoHS and 2-fold serial 
dilutions of I-BmoI from 700 nM to 1.37 nM in 10-µl volumes for 5 min at 37oC in 50 
mM Tris pH 7.9, 50 mM NaCl, 2 mM MgCl2, and 1 mM DTT. Reactions were stopped 
by addition of 4 µl stop dye (100 mM EDTA pH 8.0, 25% glycerol, and 0.2% 
bromophenol blue) and heated at 90oC for 5 minutes. Stopped reaction were run on 1% 
agarose gels, stained with ethidium bromide (OmniPur) and analyzed on an 
AlphaImager™3400 (Alpha Innotech). Percent linear DNA is defined as the percentage 
of total DNA (circular, nicked, and linear) converted to linear product. Nicking assays 
were conducted as above, with a standard protein concentration of 175 nM and 10-µl 
aliquots of a reaction pool were stopped at 15 s, 30 s, 45 s, 1 min, 1min 30 s, 2 min, 3 
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min, and 5 min. The rate constants for the first strand (circular to nicked) and second 
strand (nicked to linear) steps were calculated as described in Supplementary Figure S2.3.  
2.2.7 Structure based alignment 
Sequences similar to the endonuclease domain of I-TevI (GI: 29345254) were identified 
by BLAST in the nonredundant protein database and in the metagenomic protein 
database at NCBI. All proteins with an E value less than 0.1 were aligned to the I-TevI 
catalytic domain structure (PDB ID: 1LN0) using the block align feature of Cn3D 
(http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml). The defaults of this feature 
were changed to not perform global alignments and to allow changes to the block 
structure of existing alignments. Long gaps were not allowed. One hundred and seventy-
four full-length sequences were identified. Partial sequences, sequences that required 
large gaps or that were missing the presumed catalytic residues (R27, E75, and N90, I-
TevI numbering) were excluded from the alignment. The alignment included the I-BmoI 
sequence (GI: 12958590). The alignment contained 4 bacteriophage sequences, 97 
sequences from the marine metagenome, 23 bacterial sequences and 50 eukaryotic 
sequences. The sequences were culled to remove the shorter member of a redundant pair 
with a threshold of 90% using JalView (49), leaving 146 sequences. To test the quality of 
the alignment and for contamination by paralogous GIY-YIG sequences, the UvrC 
sequence from Thermotoga maritima (GI: 8134799) was included in the initial alignment. 
Using the Cn3D block align method, the sequences were sorted by matches to the 
position sensitive scoring matrix. The T. maritima UvrC sequence was the third worst 
scoring protein by this measure, suggesting that UvrC proteins were effectively excluded 
from the alignment. Second, we examined the alignment for an excess of local 
covariation that can detect as little as 10% contamination of the alignment (35). This 
often results when paralogous gene families are incorporated into one alignment. No 
excess local covariation was identified, suggesting that contamination by UvrC or other 
parologous GIY-YIG type endonuclease domains was rare. Based on the alignment, we 
built a homology model of the I-BmoI GIY-YIG domain (residues 1-88) using 
MODELLER (50) and SWISS-MODEL (51) with the I-TevI structures (1MK0 and 
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1LN0) as templates. There was no significant difference between the two structural 
models.  
2.2.8 Co-variation analyses 
Three semi-independent methods, MIp (34), ∆Zp and ∆Zpx (35), were applied to the 
multiple sequence alignment to identify pairs or small groups of positions that showed 
non-independent evolution in the GIY-YIG domain, using scoring cutoffs of 4.5 (MIp), 
3.5 (∆Zpx) and 1.5 (∆Zp), respectively. Mutual information values were assigned to 
residues using the I-BmoI reference sequence. Distances were calculated using the closest 
non-hydrogen atom of co-evolving residues in the I-BmoI homology model. 
2.3 Results 
2.3.1 Improved alignment of the GIY-YIG domain 
Previous multiple sequence alignments of the GIY-YIG domain have included sequences 
of proteins with diverse functions, diluting the phylogenetic signal from GIY-YIG 
domains specific to homing endonucleases (20,23). To gain better insight into residues 
that are conserved amongst potential GIY-YIG homing endonucleases, we collected 
sequences by BLAST and aligned them to the I-TevI catalytic domain structure with 
Cn3D. BLAST searches were dominated by matches to the nucleotide excision repair 
protein UvrC, all of which were subsequently discarded. In addition, sequences that 
contained obvious insertions and deletions, or sequences that lacked residues equivalent 
to the functionally critical R27, E74 and N87 (I-BmoI numbering), were removed 
resulting in a final alignment of 146 sequences.  
The GIY-YIG domain has previously been separated into 5 conserved regions that are 
characterized by highly conserved residues, termed motifs A through E (20). In our new 
alignment (Figure 2.2A), the information content associated with the highly conserved 
residues has not changed significantly, with the exceptions of increases associated with 
the tyrosine residues of motif A (Y6 and Y17) and the phenylalanine residue of motif C 
(F57). There are, however, differences outside of the highly conserved residues that are 
apparent in our alignment. In particular, there are obvious increases in the information 
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Figure 2.2: Alignment of the GIY-YIG domain 
(A) Multiple sequence alignment of 146 sequences represented as a sequence logo (52). 
Positions are numbered according to the I-BmoI sequence that is shown below the 
alignment (conserved functionally critical residues are shown in green). Predicted 
secondary structure elements of the I-BmoI GIY-YIG domain are indicated on the 
sequence by shading, and motif assignments are identified on the alignment with shaded 
boxes. (B) Front (left) and rear (right) views of the homology model with the degree of 
conservation mapped onto the structure. Conserved positions are shown in dark green, 
with the side chains of highly conserved residues indicated. Variable positions are shown 
in white. 
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content of positions that intervene the GIY and YIG elements of motif A (I8, N10, and 
K15), and the stretch of residues (S48, K51, H52, G53) that precede the phenylalanine 
(F57) of motif C. In contrast, there is a decrease in the information content of the proline 
(P84) that precedes the conserved tyrosine (Y86) and asparagine (N87) residues of motif 
E (Figure 2.2A), attributable to the removal of UvrC sequences from the alignment that 
predominantly possess a proline at this position.  
To display sequence conservation within the GIY-YIG domain, the entropy for each 
position in the alignment was calculated and subsequently displayed on the I-BmoI 
homology model, with conserved positions (low entropy, high information content) 
coloured green and non-conserved positions (high entropy, little information content) 
coloured white (Figure 2.2B). As expected, the highly conserved residues that 
characterize the GIY-YIG domain (Y6, Y17, R27, E74, and N87) all surround the 
proposed catalytic surface. Of particular interest is H31 that displays high information 
content, and lies in close proximity to the essential R27 in α-helix1, with both residues 
stacked against each other and orientated towards the presumed catalytic surface (Figure 
2.2B). In general, the majority of conserved residues are similarly positioned, with the 
exception of a block of moderately conserved residues spanning positions 47-53 (located 
in α-helix 2, orientated away from the catalytic surface). Strikingly, many of the non-
conserved residues occupy positions distinct from the proposed catalytic surface, 
including residues in α-helix 1 and the loop connecting α-helix 1 and α-helix 2. 
Collectively, these data highlight the conservation of residues that surround the proposed 
catalytic surface of the GIY-YIG domain, whereas non-conserved residues tend to be on 
the periphery of the domain. 
2.3.2 Identification of co-evolving positions in the I-BmoI catalytic 
domain 
Additional insight into functionally important residues of the I-BmoI catalytic domain 
was obtained by applying mutual information analyses to detect amino acid positions that 
co-evolve, or co-vary, with each other. Such analyses can detect non-independent 
evolution of residues that co-vary with other residues because of functional constraints. 
Indeed, most residues that co-vary tend to be within contact distance of each other (4,34). 
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We applied three different methods to analyze co-variation in the GIY-YIG domain 
alignment, MIp, ∆Zpx, and ∆Zp (35), and found that the highest scoring amino acid pair 
by all methods was S20-I71 (Table 2.1). While S20 and I71 are not within predicted 
contact distance (6.3Å) in the homology model of the I-BmoI GIY-YIG domain, they 
occupy a surface of the domain that can be envisioned as a gateway to the catalytic cleft 
formed by the C-terminal end of β-sheet 2 and the N-terminal end of α-helix 3 (Figure 
2.3). In addition, we identified a set of four residues, L35-H40-N46-F49, that co-evolve 
with each other (Table 2.1). This set of residues was of interest because the H40Y 
mutation in I-TevI reduces catalytic activity relative to the WT protein (36), and the 
interaction between these residues may be required to position the H40 residue 
appropriately within the active site (Figure 2.3). Another intriguing residue identified by 
mutual information analyses was K7 that coevolves with three other residues, T9, F16 
and E60 (Table 2.1). All four residues lie in adjacently positioned β-sheets (Figure 2.3), 
suggesting that interaction between these residues is critical for folding of the GIY-YIG 
domain. Similarly, other sets of coevolving residues such as K51-H52, and H63-K73-
W76 (Table 2.1), are all within contact distance of each other and likely have roles in 
folding or stability of the domain.  
2.3.3 Unigenic evolution identifies mutable positions in I-BmoI 
The above results provided a phylogenetic and structural framework for the identification 
and analysis of potential functionally critical residues in the catalytic domain of I-BmoI. 
To gain experimental insight into residues that are functionally relevant across the full 
length of I-BmoI, we adapted the unigenic evolution method (37). In this method, a 
genetic selection is used to isolate functional variants of I-BmoI after random 
mutagenesis, facilitating identification of amino acid positions that were either tolerant 
(hypermutable) or intolerant (hypomutable) of substitutions. The selection utilizes a two-
plasmid system that relies on I-BmoI expression from one plasmid (pExp) to cleave a 
second, toxic plasmid (pTox) that contains the cognate I-BmoI homing site (38) (Figure 
2.4). Cells survive plating on selective media only if the toxic plasmid has been cleaved 
by a functional I-BmoI. As shown in Figure 2.4, we observed a survival ratio of 0.95 
when WT I-BmoI was expressed from pExp, and pTox contained the I-BmoI homing site 
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Table 2.1: Co-evolving residues in the I-BmoI GIY-YIG domain 
Pair MIp ΔZpx ΔZp Distance (Å) 
S20-I71 8 5.7 5.5 6.3 
H63-K73 4.8 3.8 3.5 3.1 
K51-H52 4.7 4.3 2 1.3 
K7-E60 4.1 3.6 2 3 
L35-N46 5.2 3.4 1.8 3.7 
K7-F16 3.9 3.7 1.8 4.2 
K73-W76 6 4.6 1.8 3.3 
K7-T9 3.2 3 1.8 3.8 
Q75-D79 3.8 4.1 1.8 3.1 
L35-F49 3.5 3.2 1.7 3.6 
N10-S48 4.6 3.9 1.6 3 
L35-H40 4.7 3.4 1.5 3.5 
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Figure 2.3: Co-evolving residues of the I-BmoI catalytic domain 
Position of four sets of co-evolving residues mapped onto the I-BmoI homology model, 
color-coded by co-evolving residues (yellow, L35, H40, N46, F49; red S20, I71; blue K7, 
T9, F16, E60; orange K51, H52). Front (left) and rear (right) views are shown, with 
functionally critical residues highlighted in light green. 
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Figure 2.4: The two-plasmid genetic selection 
(A) Schematic of the expression plasmid (pExp) and toxic (reporter) plasmid (pTox). (B) 
Verification of the genetic selection using variants of pExp and pTox. Survival rates are 
expressed as the ratio of colonies on chloramphenicol + arabinose plates to colonies on 
chloramphenicol only plates. WT I-BmoI, pExp expressing WT I-BmoI; R27A I-BmoI, 
pExp expressing an inactive R27A I-BmoI; randomized I-BmoI, library of I-BmoI 
variants; p11-lacY-wtx1, parental pTox without I-BmoI target site; ND, not determined.   
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(pToxBmoHS). In contrast, survival ratios of 0 were observed when WT I-BmoI was 
used with the pTox backbone (p11-lacY-wtx1) containing no homing site, and when a 
catalytically inactive I-BmoI variant, R27A, was used in combination with pToxBmoHS. 
Furthermore, the survival ratio was <0.0001 when pTox contained the intron-containing 
I-BmoI substrate (pToxBmoIn+), which I-BmoI cleaves poorly (33). These results 
validate the genetic selection system, showing that cells survive only when I-BmoI can 
cleave the toxic plasmid that contains the I-BmoI homing site.  
We used error-prone PCR to generate three independent libraries of I-BmoI variants in 
pExp, mutagenzied over the entire I-BmoI coding region. The libraries were transformed 
into the selection strain carrying pToxBmoHS, and survivors identified by plating on 
selective media with an average survival ratio of ~0.01 for the three pools. We identified 
and sequenced 87 independent I-BmoI variants that survived the selection, containing an 
average of 5.28 nucleotide substitutions (or 3.11 amino acid substitutions) per clone 
(Supplementary Figure S2.2). To determine the mutation frequencies inherent to the 
error-prone PCR, we sequenced 62 independent clones plated on non-selective media, 
which contained an average of 12.26 nucleotide substitutions per clone (Supplementary 
Figure S2.2). As expected, the average number of substitutions in the pool of unselected 
clones was much greater than the number in the selected pool, and the distribution of the 
number of changes between the selected and unselected clones differed. 
By mapping the mutable positions from the selected clones onto the I-BmoI sequence, we 
found that amino acid positions tolerant to substitutions were distributed throughout the 
length of the coding region (Figure 2.5). To gain further insight into tolerated mutations 
within the GIY-YIG catalytic domain, the mutable residues from positions 1-88 were 
mapped onto a homology-based 3D model of the I-BmoI catalytic domain (Figure 2.6). 
Interestingly, the majority of the mutations mapped to the periphery or the backside of 
the catalytic domain (opposite the proposed catalytic surface). Also, few mutations were 
observed near the proposed catalytic surface and no substitutions were observed in the 
four functionally critical residues (Y17, R27, E74, and N87). Some positions tolerated the 
same substitution more than once, as evidenced by the appearance of the same mutation 
in independent clones that contained an alternate set of accompanying mutations (Table  
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Figure 2.5: Unigenic evolution analysis of I-BmoI 
Shown is a summary of the mutations found in the 87 selected clones and the EoS value 
for each position. Non-synonymous substitutions found at each position are indicated 
beneath the corresponding I-BmoI sequence over the entire length of the protein (multiple 
independent occurrences of the same mutation are shown in subscript). Shown above 
each line of sequence is a graph of the evidence of selection (EoS) at each amino acid 
position of I-BmoI. Regions of modelled or predicted secondary structure are indicated 
by grey rectangles, and bold residues indicate the GIY and YIG motifs, functionally 
critical residues, or residues that are identical between I-BmoI and I-TevI in the linker 
domain. 
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Figure 2.6: Mapping positions that tolerate non-synonymous substitutions and EoS 
data onto the I-BmoI homology model 
 
For the left of each panel, amino acid positions that tolerate non-synonymous 
substitutions are shown in red and positions where no change was found are in white. On 
the right of each panel, the EoS score is shown as gradient. Positions with high EoS 
values are blue, and low EoS values are white. (A) Ribbon representations of a front view 
of the catalytic domain, with functionally critical residues identified by the present and 
previous studies indicated. (B) Surface representation of a front view of the I-BmoI 
catalytic domain, with the putative catalytic cleft bounded by white dashed lines. (C) 
Surface representation of a rear view of the catalytic domain. 
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S2.3). For example, residue N12 tolerated 10 amino acid substitutions (five to aspartate, 
four to threonine, and one to tyrosine) in different clones, indicating that the position is 
highly mutable. The significance of mutations in positions outside of the I-BmoI catalytic 
domain were difficult to interpret due to the absence of similarity between the DNA-
binding domain of I-BmoI and that of I-TevI, for which there is an available structure. 
However, the I-BmoI and I-TevI linker regions, encompassing residues 95-112 of I-
BmoI, show some degree of similarity (18). In particular, alanine-scanning mutants in 
this region of I-TevI functionally divided the linker into deletion intolerant and deletion 
tolerant regions (17,20). The equivalent deletion intolerant region of the I-BmoI linker 
appeared to contain few mutations among the selected clones (Figure 2.5), with some 
amino acid positions exhibiting high statistical confidence that the lack of mutation was 
not due to random chance (see below).  
2.3.4 Statistical analysis of unigenic evolution data reveals residues 
of potential functional importance 
More rigorous interpretation of the unigenic evolution data to identify hypo- and hyper-
mutable residues requires statistical analyses to determine the probability that any codon 
will undergo a synonymous or non-synonymous change, taking into account the expected 
substitution frequencies based on the bias of the mutagenic PCR and the base 
composition of individual codons. Previous methods utilized a statistic, H, varying 
between -1 and 1, to determine the mutability of an individual amino acid position 
(37,39). We found that H both over- and under-estimates the mutability of positions 
because it lacks the power to determine if a significant difference exists between the 
selected and unselected clones at each position (40). For instance, the number of 
hypomutable residues in a given protein was vastly overestimated by assigning a value of 
-1 for any residue that had no non-synonymous changes, whereas there will be many 
positions that do not contain sequence changes simply because the mutagenic method is 
not saturating.  
To take this, and other issues into consideration, we developed a new method for 
analyzing unigenic evolution data called EoS (Evidence of Selection) (40). The EoS 
value assesses whether the observed frequency of substitutions for any given codon in the 
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selected clones is statistically different from the expected frequency of mutations based 
on data for the same codon from the unselected pool of clones. Importantly, the EoS 
value explicitly represents both selection and the power to detect selection for each 
residue, and is plotted as the log2 ratio of the probability of non-random changes per 
codon versus the probability of random changes per codon. Thus, an EoS value of 8 
represents a 1 in 256 probability that the observed spectrum of mutations occurred at 
random. Moreover, the fact that some residues possess low EoS scores does not 
necessarily indicate that these residues are not of potential functional significance, only 
that the sample size is insufficient to determine their significance. 
For example, A/T rich codons are more likely to be mutated due to the bias of Taq 
polymerase, whereas G/C rich codons are less likely to be mutated. Under the EoS 
method, a lysine codon (AAA) for which there were no non-synonymous changes in the 
selected clones would be flagged as significant only if substitutions were observed at the 
same codon in the unselected clones. As an example, consider position K130. Six non-
synonymous substitutions were present in the unselected clones at this position, whereas 
no substitutions were observed in the selected clones at this position (Supplementary 
Table S2.3). Because the spectrum of observed substitutions in the selected clones was 
significantly different from the observed and expected spectrum of mutations in the 
unselected clones, K130 is assigned a high EoS value of 8.03, thus providing strong 
evidence that the position is intolerant to substitution. In contrast, K171 has a low EoS 
value of -0.65 because a similar spectrum of mutations was observed in the both the 
selected and unselected clones at this position (Supplementary Table S2.3).  
Using the EoS value as a guide, many positions throughout the length of I-BmoI appear 
to have potential functional importance (Figure 2.5). Of particular interest were residues 
in the catalytic domain that have a high EoS value. For example, K29, N42, N50, K51, 
F57, I67, I71, N80, and Y82 all have EoS values greater than 6. Apart from F57, none of 
these positions have been implicated by previous studies to be of potential functional 
importance. We mapped the EoS values of residues onto the I-BmoI homology model, 
and compared this representation to that of the mutable amino acid residues mapped onto 
the model (Figure 2.6). Residues that line the catalytic surface were refractory to 
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mutation in the selected clones (Figure 2.6A and 2.6B, and coloured white), whereas the 
EoS values indicate that the majority of these residues are predicted to be functionally 
critical (Figure 2.6A and 2.6B, and coloured blue). Many residues with high EoS scores 
were located away from the active site surface (Figure 2.6B and 2.6C), consistent with 
structural roles (for instance, K51, which strongly co-evolves H52; Table 2.1). Again, it 
is important to note that residues with a low EoS value (coloured white in Figure 2.6) do 
not imply that this position is not of potential significance, only that we lack the statistical 
power to draw such a conclusion given the observed spectrum of mutations (for example, 
R27). 
Inspection of EoS values for the remainder of the I-BmoI sequence revealed that many 
residues in the linker and C-terminal region appear to be of potential functional 
significance (Figure 2.5). For instance, two residues in the linker region that are identical 
between I-TevI and I-BmoI, K105 and K111, possesses EoS values >8. These residues in 
I-BmoI are excellent candidates for future mutagenic studies because they correspond to 
the deletion intolerant region of the I-TevI linker, where mutations drastically reduced or 
abolished cleavage activity (17,20). 
2.3.5 Genetic analysis of site-directed mutants 
The data generated by mutual information and unigenic evolution facilitated the 
identification of amino acids of potential functional importance that could be tested 
through mutational analyses. We focused on amino acids positions within the N-terminal 
catalytic domain, because these positions could be interpreted within the context of 
known and modelled GIY-YIG domain structures and previous mutagenic studies, and 
because mutations in the catalytic domain would not affect the DNA-binding activity of 
I-BmoI (15,32). Thus, we could be confident that any phenotype we observed for site-
directed mutants was due to a defect related to the function of the catalytic domain. We 
selected amino acid positions for mutagenesis based on one of the following criteria: (1) 
the position had a high EoS value, (2) the residue(s) was identified as co-evolving with 
another residue, or (3) the residue possessed high information content in the alignment 
and had not been previously analyzed by mutational studies. For instance, H31 was 
chosen for mutagenesis because it possessed high information content, had a moderate 
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EoS value of 3.52, and has not previously been targeted by mutagenesis studies of GIY-
YIG homing endonucleases. In contrast, position 71, an isoleucine in I-BmoI, displayed 
very low information content, yet had a high EoS value of 6.37. Furthermore, I71 co-
evolves with S20, thus both residues were chosen for further analyses. The rationale for 
choosing other amino acid positions for mutagenesis is provided in Supplementary Table 
S2.4. In addition to generating site-specific mutants, we chose two clones identified in the 
unigenic evolution study that contained single mutations within the catalytic domain 
(N12D and H52R) for further analyses. These clones are representative of amino acid 
positions within the catalytic domain that are tolerant to change.  
To determine if the identified residues were indeed critical for I-BmoI function, we 
individually analyzed the mutants using the genetic selection, allowing us to calculate a 
survival ratio that could be directly compared to that for WT I-BmoI. As shown in Table 
2.2, the mutants could be divided into four classes. Class I mutants, Y17F, Y17H, S20A, 
H31F, H31Y, N42D, and N42A, showed the most dramatic effect as none survived the 
selection. Class II mutants were severely compromised in their survival, with ratios 
<0.07, and included H31A, and I67N. Class III mutants, S20Q, H52R, I71N, and I71A, 
exhibited moderate survival ratios of between 0.14 and 0.43. The class IV mutants, 
N12D, S48A, K51L, H52Y, and Y86F all showed survival ratios essentially equivalent to 
WT I-BmoI, and thus were considered to have little effect on I-BmoI activity. We 
considered the possibility that a lack of survival in the selection could be due to the 
generation of a hyperactive mutant or an altered specificity mutant, resulting in a toxic 
endonuclease that would cause cell death. For all mutants, however, we observed no 
reduction in viable cells when cultures were plated on non-selective media during the 
selection protocol, suggesting that none of the mutants were toxic. Furthermore, we 
purified the H31A and N42D mutants and found by in vitro cleavage assays that both 
mutants were severely compromised for cleavage activity (see below and Figure 2.7), 
suggesting that the lack of survival in the genetic selection was due to loss of 
endonuclease activity. 
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Table 2.2 Survival ratios of I-BmoI variants with mutations in the catalytic domain 
Mutant Survival ratio relative to WT1 
Class I Y17F 0 
 Y17H 0 
 S20A 0 
 H31F 0 
 H31Y 0 
 N42A 0 
 N42D 0 
Class II H31A 0.003 +/- 0.002 
 I67N 0.06 +/- 0.04 
Class III S20Q 0.12 +/- 0.02 
 H52R2 0.43 +/- 0.04 
 I71A 0.22 +/- 0.03 
 I71N 0.20 +/- 0.03 
Class IV N12D2 1.06 +/- 0.03 
 S48A 1.02 +/- 0.03 
 K51L 0.86 +/- 0.10 
 H52Y 0.96 +/- 0.05 
  Y86F 0.99 +/- 0.04 
1 Values shown represent averages and standard deviation of at least three independent 
trials, normalized against the survival ratio for a WT I-BmoI selection performed in 
parallel. 
2 The H52R and N12D mutants were isolated from the pool of selected clones. 
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Figure 2.7: Cleavage activity of WT I-BmoI and site-directed mutants 
(A) Shown are representative cleavage assays using 2-fold serial dilutions of the WT and 
mutant I-BmoI proteins, from 700 nM on the right to 1 nM on the left. The first lane of 
each gel from the left is unreacted substrate. For the R27A, H31A and N42D mutants, 
only the three highest protein concentrations were tested. In the bottom panel, substrate 
linearized by EcoRI is shown in the leftmost panel. Circular (C), linear (L), and nicked 
(N) plasmid forms are indicated to the right of each gel. 
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2.3.6 Cleavage assays with key site-directed mutants 
To better understand the effect of individual mutations on endonuclease activity, we next 
purified key site-directed mutants (N12D, S20Q, H31A, N42D, I67N, and I71N) for use 
in in vitro cleavage assays (Figure 2.7 and Figure 2.8). The H31Y and I71A mutants were 
insoluble and not studied further, and apart from the N12D mutant, mutants with similar 
survival ratios to WT I-BmoI in the genetic assay were not purified for cleavage assays 
(Table 2.2). We first analyzed the activity of the mutant proteins relative to WT I-BmoI 
over a wide range of protein concentrations in cleavage assays using a circular substrate 
that contained a single I-BmoI site. As shown in Figure 2.7, the N12D, S20Q, I67N and 
I71N mutants exhibited a range of activities relative to WT I-BmoI. The N12D mutant 
was as active as WT I-BmoI, whereas I61N and I71N displayed intermediate cleavage 
activities. The S20Q mutant was the least active, and we estimate that this mutant 
retained ~30% cleavage activity of WT I-BmoI. In contrast, the H31A and N42D mutants 
were severely compromised for cleavage activity, with no linear product visible at the 
highest protein concentrations tested (Figure 2.7).  
To gain additional insight into the observed phenotypes, we performed time-course 
cleavage assays with WT and mutant proteins to detect the appearance of a nicked 
intermediate as well as the linear product (Figure 2.8). These assays were performed with 
limiting metal ion, as we have previously shown that this reaction condition can 
effectively distinguish the two sequential nicking reactions that generate a double-strand 
break (27). With circular plasmid substrates used in this assay, the first nicking reaction 
generates a nicked intermediate with slow mobility, and the subsequent nicking reaction 
generates a linear product. The profile of the nicking assays suggested that the I-BmoI 
cleavage reaction followed the reaction scheme shown in Equation (1):  
𝐶 !! 𝑁 !! 𝐿          (1) 
where C, N, and L are intact plasmid substrate, nicked intermediate, and linear product 
resulting from a double-strand break. The rate constant for the first nicking reaction is k1, 
and k2 is the rate constant for the second nicking reaction.  
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Figure 2.8: Nicking assays with WT and mutant proteins 
Shown are representative agarose gels of time-course assays, with time points in seconds 
indicated above the gels. The first lane of each gel contains unreacted substrate (-). 
Circular (C), linear (L), and nicked (N) plasmid forms are indicated to the right of each 
gel. Beside each gel image is a graphical representation of the disappearance of substrate 
and appearance of products formed over time. Data points from three independent 
experiments are plotted, with a continuous line drawn through the average. 
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As shown in Figure 2.8 and Table 2.3, the reaction profiles and rate constants of the WT 
protein and N12D mutant were very similar, with conversion of the nicked intermediate 
to linear product complete by ~120 seconds. The reaction profiles of the S20Q and I67N 
mutants were very different from WT and N12D, with k1 constants indicative of a slower 
first nicking reaction. Under conditions used in these assays, neither reaction was 
complete at the end of the time course, making it difficult to determine k2 for the S20Q 
and I67N mutants using Equation 1 (Supplementary methods S2). In contrast, Figure 8 
illustrates that the I71N mutant displayed a similar first nicking step to the WT and N12D 
proteins, but that the conversion to linear product was slower as indicated by kinetic 
analysis (Table 2.3), consistent with a nicked intermediate accumulating over an 
extended period of time relative to WT protein. Consequently, conversion to linear 
product was delayed, but still complete by the end of the time course. Collectively, these 
results clearly implicate residues identified by MUSE as functionally important, as 
mutation of these residues generates phenotypes that are distinct from the WT protein. 
2.4 Discussion 
Detailed insight into protein structure and function can be obtained by synthesizing data 
from multiple experimental, computational and structural approaches. Here, we elaborate 
an experimental framework to identify previously unknown functionally relevant residues 
of the GIY-YIG endonuclease I-BmoI that takes into account evidence other than strict 
conservation of residues in a multiple sequence alignment. Our goal was to use MUSE to 
identify key amino acids in I-BmoI for proof-of-principle experiments, highlighting the 
utility of the MUSE framework. We anticipate that our data will form a platform on 
which to pursue future structure and function studies of GIY-YIG homing endonucleases 
and other proteins containing the GIY-YIG domain, and that the MUSE approach will be 
generally applicable to a broad range of proteins.  
2.4.1 Application of MUSE to GIY-YIG homing endonucleases 
Past studies on GIY-YIG enzymes have utilized alignments and structural data to identify 
a set of absolutely conserved residues, subsequent mutation of which abolished cleavage 
activity. The residues were chosen for mutational analyses on the assumption that 
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Table 2.3: DNA cleavage by WT I-BmoI and variants identified by MUSE 
protein k1 (s-1)a k2 (s-1)b 
WT 0.080 ± 0.0033 0.034 ± 0.00069 
N12D 0.073 ± 0.0045 0.024 ± 0.00081 
I71N 0.045 ± 0.0028 0.015 ± 0.00051 
S20Q 0.012 ± 0.003 N.D. 
I67N 0.036 ± 0.0005 N.D. 
a k1 is the rate constant for the first nicking step that generates nicked intermediate from 
circular substrate. For S20Q and I67N, k1 is valid only at the initial time point 
(Supplementary Figure S2.4). 
b k2 is the rate constant for the second nicking step that generates a linear product 
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conserved residues are important for function, and likely are components of the enzyme’s 
active site. Such approaches, however, provided limited mechanistic insight and would 
miss residues that are not universally conserved amongst GIY-YIG enzymes, but 
nonetheless may be functionally critical. Furthermore, alignments of GIY-YIG 
containing proteins are dominated by the nucleotide excision repair protein, UvrC, which 
has a different set of functional constraints than GIY-YIG homing endonucleases. Thus, 
one aspect of the MUSE approach was to assemble an alignment of GIY-YIG proteins 
that closely resembled known homing endonucleases, with the goal of enhancing the 
information specific to GIY-YIG homing endonucleases. For instance, it is known that 
~140 well-aligned sequences will provide sufficient information for covariation analyses 
to detect co-evolving residues (4). As discussed below, the strongest co-evolving amino 
acid pair detected by covariation analyses was S20-I71. One of these residues, I71, has 
not previously been identified for mutational analyses because this position is highly 
variable in multiple sequence alignments, yet our data indicate that I71 is a functionally 
significant residue.  
That I-BmoI is a site-specific endonuclease was another critical factor in this study, 
facilitating the use of a genetic selection where survival in the assay was dependent on 
endonuclease function. Survival could also be influenced by the solubility or stability of 
I-BmoI variants. We found, however, that very low levels of I-BmoI expression were 
required for survival in the selection, suggesting that solubility was not likely a factor. 
Furthermore, use of a functional genetic selection allowed us to screen through a large 
population of I-BmoI variants mutagenized over the entire coding region, thus avoiding 
biases introduced by localized mutagenesis of specific residues or regions of the protein. 
Using the EoS method for analysis of unigenic evolution data, we obtained sufficient 
power to identify residues of potential functional significance for a protein the length of 
I-BmoI (266 residues) by sequencing a relatively small number of selected (87) and 
unselected (62) clones. In addition to identifying residues of potential importance, MUSE 
is also expected to identify positions that are tolerant to mutation (hypermutable). For 
instance, N12 was mutated 10 times in the selected clones as opposed to 7 times in the 
unselected clones, clearly implying a tolerance to mutation that is not expected to 
drastically affect I-BmoI function. Indeed, our in vitro analyses of the N12D mutant (the 
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most common mutation at that position) indicate essentially WT levels of activity, 
validating that the MUSE framework has the power to distinguish between residues in I-
BmoI the catalytic domain that are functionally important and those that are not.   
2.4.2 Residues within the GIY-YIG domain of I-BmoI that are 
important for function 
The proposed catalytic mechanism for the GIY-YIG domain is based on the predicted 
function of a set of conserved residues (Y17, R27, E74 N87), each with distinct roles 
(21,25). Y17 is thought to act as a general base to activate a nucleophilic water; R27 may 
stabilize the 5’ phosphate of the cleavage intermediate, or contact substrate; E74 
coordinates a divalent metal ion that likely functions as the Lewis acid; and N87 is 
thought mainly to have a structural role in maintaining the active site architecture. 
Mutation of any of these residues to alanine abolishes cleavage activity, an uninformative 
phenotype as limited mechanistic insight is gained from catalytically inactive mutants. 
Hence, many unanswered questions remain regarding the catalytic mechanism of the 
GIY-YIG domain. For instance, the path of substrate DNA has only been inferred from 
the position of the conserved residues in the catalytic domain. In this regard, it is worth 
noting that an I-BmoI R27A mutant displayed a loss of hypersensitivity in footprinting 
experiments compared to WT protein (27), suggesting that the R27A mutant possesses a 
DNA contact defect that would not be expected if R27 functioned as a catalytic residue. 
Thus, additional types of evidence other than structural data are needed to definitively 
assign functional roles to the presumed set of catalytic residues. Moreover, the 
significance of residues that lie very close to the proposed active site of I-TevI and UvrC 
are unknown, and have largely been ignored because they are not conserved in multiple 
sequence alignments. In the following sections, we discuss the potential structural and 
functional significance of residues identified by MUSE for which subsequent 
mutagenesis revealed effects on I-BmoI cleavage activity.  
2.4.3 S20 and I71 
The S20-I71 pair was chosen for further study because this pair was the highest scoring 
set of co-evolving residues (Table 2.1 and Supplementary Table S2.4). In the GIY-YIG 
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domain alignment, S20 and I71 are both poorly conserved positions (but are conserved 
between I-BmoI and I-TevI), and are most commonly varied to glutamine and asparagine 
residues, respectively. In the I-BmoI homology model and the I-TevI structure, the 
residues are located in the proposed catalytic surface (Figure 2.9). In the I-TevI structure, 
S20 lies within hydrogen-bonding distance of the metal-coordinating residue E75, and 
could potentially position E75 or stabilize the interaction of E75 with divalent metal ion. 
Intriguingly, I71 can be structurally aligned with L116 of the His-Cys box homing 
endonuclease I-PpoI, where the residue is inserted into the minor groove of its homing 
site substrate (41,42). Further evidence for significant roles of S20 and I71 stemmed from 
the unigenic evolution data, as S20 possessed an EoS score of 3.25 and I71 possessed a 
score of 6.37. Neither position was mutated in the selected clones, whereas both positions 
were mutated in the unselected clones (Supplementary Table S2.3). We made S20A and 
S20Q mutations and found that the S20A mutant did not survive the genetic selection, 
whereas S20Q had a survival ratio of 0.063. Cleavage assays with S20Q revealed that at 
high protein concentrations the enzyme retained ~30% activity of WT protein, and a 
similar reduction in cleavage activity was observed when the equivalent residue in UvrC 
(K32) was mutated (21).  
Both I71 mutants (I71A and I71N) survived the genetic selection, but with reduced ratios 
relative to WT I-BmoI. We purified the I71N mutant for further analysis, and found that 
it had slightly reduced activity relative to WT protein. Importantly, time-course cleavage 
assays revealed that the nicked plasmid intermediate persisted longer than for WT protein 
(Figure 2.8). Because I-BmoI generates a double-strand break by two independent and 
sequential nicking reactions (27), the phenotype of the I71N mutant implies a defect in 
the second nicking reaction. While the mechanistic basis of this defect will require future 
study, it is possible that I71 functions in substrate recognition, and that the I71N mutation 
greatly reduces substrate interactions that effect the second nicking reaction.  
One intriguing question regarding the S20 and I71 residues is why do they co-evolve? It 
is worth noting that the predicted distance separating the residues (~6Å) could reflect a 
limitation of the homology model of the I-BmoI catalytic domain, as these residues are 
~3.5Å apart in the I-TevI structure. In the 146 sequences used for mutual information 
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Figure 2.9: Summary of functionally relevant residues identified by MUSE 
Shown are ribbon (left) and surface (right) representations of the I-BmoI catalytic domain 
with the residues identified by MUSE (S20, H31, N42, I67, and I71) highlighted in green, 
and previously identified functionally critical residues (Y17, R27, E74 and N87) shown 
in black. The catalytic cleft is highlighted as in Figure 2.1C. 
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analyses, position 20 is most commonly a serine, and position 71 is most commonly an 
isoleucine. However, there are almost equal occurrences of Q20-N71, Q20-D71, and 
S20-L71 pairs among the sequences. We attempted to rescue the S20Q mutant by making 
a second site mutation in position I71, generating a S20Q/I71N double mutant, reasoning 
that this double mutant represented a tolerated amino acid pairing at positions 20 and 71. 
However, the S20Q/I71N double mutant did not survive the genetic selection, suggesting 
that this combination of residues is not tolerated in the I-BmoI background, and that 
changes at other positions would be required to restore activity. Both S20 and I71 are in 
close proximity to the proposed metal binding residue, E74 (E75 in I-TevI), implying that 
certain combinations of residues may be favoured for correct positioning of the metal-
binding residue within the active site (Figure 2.9).  
2.4.4 H31 
H31 was chosen for further analysis due to its high information content in the alignment, 
the observation that this position has a relatively high EoS score of 3.52, and a lack of 
mutations in the selected clones (but multiple mutations were present in the unselected 
clones; Supplementary Table S2.3). H31 is well conserved amongst GIY-YIG 
endonucleases, but is replaced by a tyrosine in the equivalent position in UvrC (Y43). In 
the homology model and I-TevI structure (Figure 2.9), H31 packs against the side chain 
of R27 and is within hydrogen bonding distance of both H40 and Y6, but no potential 
functional role was assigned to H31 based on the I-TevI structure. In the UvrC structure, 
Y43 was proposed to act as a general base to deprotonate a nucleophilic water molecule 
(21). To test the importance of H31 in I-BmoI, we made three mutations, H31A, H31F 
and H31Y, reasoning that the H31F would be structurally similar but chemically inert, 
while H31Y might retain limited function. Intriguingly, the H31F and H31Y mutants did 
not survive the genetic selection, while the H31A mutation had a very low survival ratio 
(Table 2.3). Unfortunately, the H31Y mutant proved to be insoluble and could not be 
studied in vitro, whereas no cleavage activity could be detected in vitro with the H31A 
mutant using plasmid-based cleavage assays. The H31A mutant may retain an extremely 
low level of activity that is difficult to detect using non-radioactive substrates, but that 
may be sufficient to permit very a low level of survival in the genetic selection. These 
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data provide the first evidence that H31 may play an important role in the active site of I-
BmoI and other GIY-YIG endonucleases, either functioning as a base, by stabilizing the 
active site architecture by forming a hydrogen bond network with Y6 and H40, or by 
contacting substrate.  
2.4.5 N42 
N42 was chosen for mutational studies because it possessed a high EoS score of 6.49 
(Figure 2.5 and Supplementary Table S2.4). In the GIY-YIG domain alignment, position 
42 has little information content, although there is a tendency for this position to be a 
polar residue. N42 is located in a loop connecting α-helix1 and α-helix2, and is 
orientated so that the side chain points towards the predicted active site surface (Figure 
2.9). Interestingly, the amino group of N42 is within hydrogen bonding distance of the 
hydroxyl group of the functionally critical Y17. We made two mutations that would 
disrupt this interaction, N42A and N42D, and found that both mutants did not survive the 
genetic selection, and that the N42D mutant displayed no cleavage activity in vitro. N42 
may be critical because it functions to correctly position Y17 within the active site of the 
enzyme.  
2.4.6 I67 
Like I71, I67 is not conserved amongst GIY-YIG endonucleases, with this position 
displaying no information content (Figure 2.2, Supplementary Table S2.4). In the 
homology model of the I-BmoI catalytic domain, I67 is positioned in a loop connecting 
α-helix 3 and β-sheet 3, with its side chain pointed towards the active site surface (Figure 
2.9). Mutation to asparagine reduced in vitro cleavage activity to approximately half that 
of WT I-BmoI, with defects in both the first and second nicking reactions (Figure 2.8). 
We envision that I67 may be involved in substrate interactions, similar to a role for I71. 
2.4.7 Residues outside of the catalytic domain predicted to be critical 
for function 
GIY-YIG homing endonucleases are modular proteins, with the N- and C-terminal 
domains connected by a flexible linker. Past studies on the I-TevI linker have revealed 
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that the linker is required to correctly position the N-terminal GIY-YIG domain on 
substrate for efficient cleavage (17,19,43). Remarkably, the linker can extend or retract to 
correctly position the catalytic domain on substrates that contain insertions or deletions 
that move the preferred cleavage sites from their WT position. This property of the linker 
has led to the proposal that I-TevI, and perhaps other GIY-YIG endonucleases, generates 
a DSB by a conformational change mechanism, whereby the linker is a critical 
component in repositioning the catalytic domain between the bottom- and top-strand 
nicking reactions. Interestingly, I-BmoI can also reposition the catalytic domain to cleave 
substrates with +5 and +10 insertions (18), suggesting that the I-BmoI linker functions 
analogously to the I-TevI linker in spite of limited amino acid similarity between the two 
proteins in the linker region. Intriguingly, our unigenic evolution data revealed that many 
residues within the I-BmoI linker region are predicted to be functionally significant. 
Notably, K105 and K111, conserved between I-TevI and I-BmoI, have EoS scores 
greater than 8. These residues correspond to the deletion intolerant region of the I-TevI 
linker, where 2- or 3-amino acid deletions abolish cleavage activity, although the 
functional basis for this phenotype is unknown (17,19). Furthermore, two additional sets 
of residues in the I-BmoI linker, centered on Y120 and K130, also have high EoS scores. 
Our data clearly implicate the I-BmoI linker as important for function, and identify a set 
of residues for future mutagenesis and functional studies. 
Apart from a repeated nuclease-associated modular DNA-binding domain motif 
(NUMOD3) (44), I-BmoI shares little amino acid similarity with I-TevI in the C-terminal 
DNA binding domain, even though the enzymes are isoschizomers and bind the same 
stretch of thymidylate synthase sequence in Bacillus mojavensis and phage T4, 
respectively (32). The NUMOD3 motif corresponds structurally to a minor-groove 
binding α-helix that was first identified in the co-crystal of the I-TevI DNA-binding 
domain with its homing site substrate (45), and later in the structure of an unrelated HNH 
endonuclease, I-HmuI (46). In the I-TevI structure, the α-helix is positioned along the 
minor groove of its DNA substrate, and only one residue in the α-helix (S191) makes a 
single hydrogen bond contact to the phosphate backbone. Immediately preceding the α-
helix, however, is H182 that makes two base-specific hydrogen bonds. Based on 
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sequence predictions, I-BmoI possesses three NUMOD3 motifs, with H147, H175 and 
H202 corresponding to the critical H182 of I-TevI. The EoS scores for the three histidine 
residues in I-BmoI are extremely low (Figure 2.5), and each position had multiple 
substitutions in the selected clones (Supplementary Table S2.3), suggesting that these 
residues perform different functions than the equivalent H182 of I-TevI. Similarly, 
residues that comprise the predicted I-BmoI helix-turn-helix (HTH) motif at the C-
terminal end of the DNA-binding all have low EoS scores (Figure 2.5). In I-TevI, the 
analogous HTH motif makes extensive hydrophobic contacts with thymine residues in 
the substrate, providing specificity to the I-TevI substrate interaction. The tolerance of the 
I-BmoI HTH to mutation implies that it may function differently than the analogous HTH 
motif of I-TevI, and a detailed study of the sequence requirements for DNA binding by 
both HTH motifs would provide an intriguing comparative study.  
2.4.8 Conclusion 
Using a unified experimental approach that synthesizes three distinct types of data, we 
have identified previously unknown functionally relevant residues in the GIY-YIG 
homing endonuclease I-BmoI. Our results will form a platform for future studies of I-
BmoI and other GIY-YIG-domain containing proteins because residues identified by 
MUSE, when mutated, generate distinct phenotypes that will provide mechanistic insight. 
Many of the positions identified by MUSE are non-conserved, and have escaped 
detection by traditional analyses such as strict conservation in multiple sequence 
alignments, providing a cautionary tale against using only a single methodology for 
structure and function studies. We anticipate that the MUSE framework will be generally 
applicable to a wide range of protein families, requiring ~140 well-aligned paralogous 
sequences, an enzymatic activity that forms the basis for a genetic selection and, although 
not essential, a structural model on which to interpret the MUSE data. For instance, the 
MUSE framework can be applied to any homing endonuclease or DNA endonuclease 
without difficulty, and would greatly aid in the re-design of endonucleases against novel 
target sequences. Unigenic evolution screens have been applied to eukaryotic proteins, 
including human Pin1 (a prolyl isomerase) and yeast TFIIB (47,48), and each of these 
proteins could be also analyzed within the MUSE framework. 
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Chapter 3  
3 Divalent metal ion differentially regulates the sequential 
nicking reactions of the GIY-YIG homing endonuclease 
I-BmoI 
The work presented in this chapter is reproduced (with permission, Appendix S1) from: 
Kleinstiver, B.P., Bérubé-Janzen, W., Fernandes, A.D., Edgell, D.R. (2011) Divalent 
metal ion differentially regulates the sequential nicking reactions of the GIY-YIG 
homing endonuclease I-BmoI. PLoS One 6(8):e23804. 
3.1 Introduction 
Homing endonucleases are DNA endonucleases that primarily function as mobile genetic 
elements by introducing double-strand breaks or nicks at specific homing sites in naïve 
genomes (1,2). DNA repair, recombination and replication pathways repair the double-
strand break (or nick) using the endonuclease-containing genome as a template, resulting 
in the mobilization of the homing endonuclease gene and surrounding DNA to the 
recipient genome (1). In model laboratory systems, the efficiency of endonuclease-
mediated homing is extraordinary, reaching 80-100% in some cases (3-5), implying that 
homing endonucleases can quickly spread through populations of naïve genomes. The 
rapid accumulation of genome sequence data has revealed an abundance of homing 
endonuclease genes in bacterial, archaeal, viral, and organellar genomes, including the 
mitochondrial and nuclear genomes of eukaryotes (6,7). Five distinct homing 
endonuclease families, defined by conserved amino acids, have been characterized to 
date. They are the LAGLIDADG, HNH, His-Cys box, GIY-YIG, and PD-(D/E)xK 
families (8,9).  
Homing endonucleases have attracted much interest as potential reagents for 
manipulating complex genomes, and substantial effort has been devoted to 
reprogramming the specificity of a select few LAGLIDADG endonucleases to cleave 
clinically relevant targets (10-14). Understanding the mechanism of DNA hydrolysis by 
homing endonucleases is critical for their utilization as reagents for targeted manipulation 
of complex genomes. From a mechanistic perspective, the least understood of the homing 
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endonuclease families are the GIY-YIG enzymes. GIY-YIG homing endonucleases are 
modular in nature and contain an N-terminal cleavage domain of ~100 amino acids that 
includes the class-defining GIY-YIG motif, and a C-terminal DNA-binding domain that 
is composed of distinct modules (Figure 3.1) (15,16). The N- and C-terminal domains are 
connected by a flexible linker that functions as a molecular ruler to position the catalytic 
domain at the correct distance on substrate from the DNA-binding domain (17-20). Two 
well-studied GIY-YIG endonucleases are the isocaudomers I-TevI and I-BmoI, encoded 
within group I introns interrupting the thymidylate synthase genes of bacteriophage T4 
and Bacillus mojavensis, respectively (21-23). I-TevI and I-BmoI introduce a staggered 
double-strand break by two independent and sequential nicking reactions at the same 
positions of their substrates, with the bottom (non-coding) strand of substrate nicked 
before the top (coding) strand (24,25). DNA bending assays and in-gel footprinting 
demonstrated that significant DNA distortions on the bottom strand occur independently 
of the first nicking reaction (24,25). Interestingly, studies with mutant DNA substrates 
revealed distinct sequence requirements for efficient double-strand break formation by 
each endonuclease. In particular, I-BmoI absolutely requires a GC base pair at position -2 
immediately 3’ to the top-strand nicking site (26), yet displays no sequence preference for 
bases flanking the bottom-strand nicking site, while I-TevI requires an additional CG 
base pair 5’ to the bottom-strand nicking site for cleavage activity (27). 
The GIY-YIG nuclease motif is not unique to homing endonucleases, as the domain is 
found in a variety of protein scaffolds (28), including DNA repair proteins (29), 
retrotransposable elements (30), and restriction endonucleases (31-33). Structural studies 
of diverse GIY-YIG domains have revealed a compact α/β-fold composed of a central 
three-stranded antiparallel β-sheet flanked by three α-helices (29,34-38). A set of 
conserved residues comprise the single active site that uses a one-metal ion mechanism to 
catalyze DNA hydrolysis (36,37). The function of the GIY-YIG nuclease domain varies 
in a scaffold-dependent manner, as the domain has acquired additional structural units 
that are interspersed within the GIY-YIG domain to direct oligomerization or DNA 
binding. For instance, the GIY-YIG restriction enzyme Eco29kI utilizes additional folds 
to function as a dimer (39), with each monomer nicking one strand of substrate. In the 
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Figure 3.1: Model of I-BmoI interactions with intronless and intron-containing 
substrates based on DNA footprinting experiments 
Shown is a schematic of the modular interaction of I-BmoI with the intronless thyA allele 
(upper), and the resultant changes to the target site upon intron insertion that generates 
the intron-containing allele (lower). Top- and bottom-strand nicking sites are indicated by 
open and filled triangles, respectively. The critical GC-2 base-pair is shown in enlarged 
bold-type font, and the intron insertion site (IS) is indicated by a vertical line with exon 2 
downstream and either exon 1 or the intron (red) upstream.  
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case of the UvrC nucleotide excision repair protein, the single GIY-YIG domain nicks 3’ 
to a lesion site to initiate a repair event (40). The homing endonucleases are distinct from 
other GIY-YIG family members, as they have an extended structure and bind DNA as 
monomers (25). They are believed to successively use the single active to generate a 
double-strand break (38), but how the active site is reorganized to accommodate different 
DNA strands for the sequential nicking reactions is unknown. 
Here, we investigate the contributions of divalent metal ion and DNA sequence to the 
sequential nicking reactions of I-BmoI. We show that cleavage by I-BmoI is sensitive to 
the identity and concentration of divalent metal ion, and that the second-strand nicking 
rate is affected to a greater extent by low metal ion concentrations than the rate of the 
first nicking reaction. DNA substrate mutations at key positions within the cleavage site 
of I-BmoI can differentially attenuate or completely abolish first- and second-strand 
nicking. Furthermore, we show that the GC-2 base pair is crucial for generating bottom 
strand minor-groove distortions that are a necessary prerequisite to cleavage.  
3.2 Materials and methods 
3.2.1 Bacterial strains and plasmids 
E.coli strains DH5α and ER2566 (New England Biolabs) were used for plasmid 
manipulations and protein expression, respectively. pTYBmoI was used to over-express a 
wild-type, codon-optimized version of I-BmoI for purification as previously described 
(41). pBmoHS is a pBS derivative that contains an insert corresponding to 49 bp of the 
intronless thyA substrate (26). A complete description of all plasmids used in this study is 
found in Supplementary Table S3.1.  
3.2.2 Oligonucleotides 
Oligonucleotides used in this study can be found in Supplementary Table S3.2. 
3.2.3 Cleavage assays on plasmid substrates 
Single time-point cleavage assays to examine metal dependence were performed in 10-µl 
volumes containing 20 mM Tris-HCl pH 8.0, 250 mM NaCl, 2.5% glycerol, 10 nM wild-
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type or G-2T pBmoHS, and various concentrations of MgCl2, CaCl2, CuCl2, MnCl2, 
NiCl2, and ZnCl2. Reactions were started by the addition of I-BmoI to final a 
concentration of 175 nM, allowed to proceed for 90 seconds at 37°C, and stopped by the 
addition of 4 µl stop dye (100 mM EDTA, 25% glycerol, 0.2% bromophenol blue). 
Stopped reactions were heated for 5 minutes at 95°C, cooled on ice for 5 minutes, 
electrophoresed on a 1% agarose gel, and stained in a 1xTAE solution containing 
ethidium bromide (Caledon) prior to analysis on an AlphaImager™3400 (Alpha 
Innotech). Time course cleavage reactions to determine Mg2+ dependence were 
performed on supercoiled pBmoHS in 115-µl volumes with conditions similar to those 
listed above, with either 0.5 mM, 1 mM, 2 mM, 5 mM, 7 mM, or 10 mM MgCl2. A 10-µl 
aliquot was removed prior to the addition of wild-type I-BmoI to final a concentration of 
175 nM, and subsequent 10-µl aliquots were removed at ten time points into 4 µl stop 
dye. Stopped reactions were visualized as indicated above. Reaction progress was 
determined by the relative amount of circular substrate, nicked intermediate, and linear 
product. At least 3 independent trials were conducted for each MgCl2 concentration. 
Time course cleavage reactions with mutant pBmoHS substrates were performed in 65-µl 
volumes with conditions similar to those listed above, with either 2 mM or 10 mM 
MgCl2. A 10-µl aliquot was removed prior to the addition of wild-type I-BmoI to final a 
concentration of 175 nM, and subsequent 10-µl aliquots were removed at 15, 30, 60, 120, 
and 180 seconds into 4 µl stop dye. Mutant substrates were classified as follows: class I 
substrates displayed a reaction progress similar to wild-type intronless substrate, class II 
substrates displayed defects for both bottom and top-strand nicking reactions at 2 mM 
MgCl2 and ‘rescue’ of cleavage to near WT levels after 180 seconds in 10 mM MgCl2, 
and class III substrates showed severe to complete defects in 2 mM MgCl2 and no 
appreciable rescue of activity in 10 mM MgCl2 after 180 seconds. Cleavage assays for 
class I, II, and a selection of class III substrates (G-2T, C-3G/C-5A, T-1G/C-3G/C-5A, C-
3G/C-4A/C-5A, and In+) were conducted as described above. For the remainder of class 
III substrates, only the accumulation of nicked intermediate or linear product above 
background levels was measured after a 180 second incubation with I-BmoI in 2 mM or 
10 mM MgCl2. Three independent reactions were performed for substrates that gave 
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measurable rate constants, and two independent trials were performed for class III 
substrates that displayed minimal or no cleavage. Rate constants for the reaction  𝐶 !! 𝑁 !! 𝐿  
were estimated for the two-constant irreversible kinetic model using Prism5 (GraphPad 
Software) or via the Bayesian bootstrap (61). The time-course data were fit to the three 
following equations  𝐶 = 𝐶! exp  (−𝑘!𝑡)        (equation 1) 𝑁 = 𝐶! !!!!!!! [− exp −𝑘!𝑡 + exp −𝑘!𝑡 ]    (equation 2) 𝐿 = 𝐶! [1+ !!!!!!(𝑘! exp −𝑘!𝑡 − 𝑘! exp −𝑘!𝑡 )]   (equation 3) 
where C0 is the initial concentration of circular substrate (in nM), N is the concentration 
of nicked DNA (in nM), L is the concentration of linear product (in nM), k1 is the first 
nicking rate constant (in s-1), k2 is the second nicking constant (in s-1), and t is time (in 
seconds). For each bootstrap replicate, parameters were optimized for minimal 
discrepancy with the data under the half-taxi metric (62). This procedure was found to be 
more robust than a standard least-squares estimation due to the constraint that the total 
amount of circular, nicked, and linear DNA is constant. Posterior parameter medians and 
95% confidence intervals are reported in Supplementary Table S3.3. The ratio of k1/k2 at 
various MgCl2 concentrations was reported as the value of the log10k1 – log10k2 to 
minimize over-weighting the end points if plotted on a linear scale.  
3.2.4 OP-Cu in-gel footprinting 
1,10-phenanthroline copper (OP-Cu) footprinting experiments were conducted as 
previously described (24). Substrates used included a 74-mer duplex oligonucleotide 
substrate corresponding to the intronless thyA target site (DE-116/DE-117), the intronless 
74-mer with G-2T (DE-446/DE-447), G-2A (DE-459/DE-460), or G-2C (DE-461/DE-
462) substitutions, the intron-containing 74-mer (DE-444/DE-445), and the intron-
containing 74-mer with A-2G substitution (DE-463/DE-464) (see Supplementary Table 
S3.2). Gel images were analyzed using ImageQuant 5.2 (GE Healthcare Life Sciences). 
To quantify hypersensitive sites observed in the OP-Cu footprint, two bands outside of 
the I-BmoI protection region were selected to normalize phosphorimager units (positions 
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+9 and +10 for intronless substrates, and +11 and +12 for intron-containing substrates, 
relative to the intron insertion site). Hypersensitivity to OP-Cu at positions -1 and -2 was 
calculated by expressing the ratio of normalized phosphorimager units at sites in the 
shifted footprint (UC, upper complex) to the units in the unbound substrate reaction 
(UNB, unbound) (24).  
3.2.5 Molecular modeling 
The I-BmoI GIY-YIG domain homology model was built as previously described (41), 
and alignments to annotated structures were performed using MacPyMOL v1.2r. 
Residues 6-10 of the homology model were aligned to residues 47-51 of the solution 
structure of E142Q Eco29kI (3MX1) (Figure 6A) (36). A subsequent alignment was 
performed with the I-BmoI homology model and a single subunit of the Y49F/L69K 
Eco29kI structure in complex with its 18 base pair substrate (3NIC) (36). For illustration 
purposes, only nucleotides (-4)-CCCGCGGGC-(+5) of the Eco29kI substrate were 
shown. Additional alignments were performed using structures of the I-TevI GIY-YIG 
domain (1KM0 and 1LN0) in place of the I-BmoI homology model (38), and of Hpy188I 
in complex with substrate (3OQG) in place of the Eco29kI structure (37), yielding nearly 
identical results. 
3.3 Results 
3.3.1 Magnesium is the preferred divalent metal ion for efficient and 
specific cleavage 
To determine the divalent metal ion preference for cleavage by I-BmoI, we tested various 
metals across a range of concentrations in assays with a supercoiled plasmid (pBmoHS) 
containing the I-BmoI intronless thyA target site (Figure 3.2). I-BmoI reaction progress 
can be visualized using supercoiled substrate, as the first nicking reaction generates a 
nicked plasmid intermediate and the second nicking reaction converts the nicked 
intermediate to linear product (41). Cleavage assays were performed under single 
turnover conditions (protein excess) with a range of MgCl2, CaCl2, CuCl2, MnCl2, NiCl2, 
and ZnCl2 concentrations (Figure 3.2). Reactions with CoCl2 did not yield any products.  
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Figure 3.2: Magnesium is the preferred divalent metal ion for efficient and specific 
cleavage by I-BmoI 
 
(A) Representative gel images of time-point cleavage assays with I-BmoI performed on 
supercoiled substrate containing the intronless thyA target site. Reactions contained 
increasing concentrations of MgCl2, CaCl2, CuCl2, MnCl2, NiCl2, and ZnCl2. Lanes that 
lack I-BmoI (-) have 10 mM metal (1 mM for ZnCl2), and nicked (N), linear (L), and 
circular (C) plasmid forms are indicated to the right of each gel image. (B) 
Representative gel images of I-BmoI cleavage assays performed on supercoiled substrate 
containing a mutation at the critical GC-2 basepair (G-2T). Reactions were performed in 
the presence of MgCl2 or MnCl2.	    
99 
 
The overall divalent metal ion preference of I-BmoI was Mn2+ > Mg2+ > Ni2+ > Ca2+ > 
Zn2+ >> Cu2+ = Co2+. In particular, cleavage was extremely efficient in the presence of 
MnCl2 for all concentrations tested, while reactions in MgCl2 displayed a second strand 
defect at 0.25 mM MgCl2, near complete conversion of nicked intermediate to linear 
product at 2 mM MgCl2, and complete conversion to product at 10 mM MgCl2 (Figure 
3.2A). NiCl2 appeared to be inhibitory at 10 mM, yet similar levels of cleavage were 
observed at 0.5 mM NiCl2 and MgCl2. Cleavage was observed in the presence of CaCl2 
(albeit greatly reduced versus MgCl2), whereas ZnCl2 and CuCl2 were inhibitory at most 
concentrations tested, with the exception that 0.05 mM ZnCl2 supported nicking only. 
These findings correlate well with the typical roles of divalent metal observed for the 
majority of site-specific DNA endonucleases, including the tetrameric GIY-YIG 
restriction enzyme Cfr42I, apart from the observation that cleavage by Cfr42I was most 
efficient in CoCl2-containing buffers (31,42-44).   
Site-specific endonucleases have been shown to exhibit increased activity in the presence 
of manganese, but at the cost of fidelity (45,46). To determine if I-BmoI displayed a 
similar loss of fidelity in the presence of MnCl2 relative to MgCl2, we performed 
cleavage assays on a plasmid substrate with a G-2T mutation, against which I-BmoI is 
known to retain only limited activity (Figure 3.2B) (26). We observed minimal nicking of 
the pBmoHS G-2T substrate by I-BmoI in the presence of 10 mM MgCl2, while 2 mM 
and 10 mM MnCl2 were condusive for cleavage (but reduced versus intronless thyA 
substrate). Collectively, these data suggested that the observed increase in efficiency in 
the presence of MnCl2 is partly due to decreased fidelity, allowing I-BmoI to cleave non-
cognate sites. Furthermore, based on these results we determined that of the divalent 
metal ions tested, a selection of magnesium concentrations would provide the optimal 
level of efficiency and specificity.  
3.3.2 Limiting divalent metal ion has a more pronounced regulation of 
second strand nicking 
To gain insight into the substrate conversion process by I-BmoI, we selected a range of 
MgCl2 concentrations to dissect reaction progress as previous data indicated that the 
sequential reactions have distinct metal requirements (24). We performed time-course 
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cleavage assays with the thyA supercoiled substrate and determined rate constants based 
on the following reaction scheme:   𝐶 !! 𝑁 !! 𝐿     
where k1 is the rate constant for conversion of supercoiled plasmid (C) to nicked 
intermediate (N), and k2 is the rate constant for conversion of nicked intermediate to 
linear product (L). Representative time course experiments in 0.5 mM and 10 mM MgCl2 
are shown in Figure 3.3, with k1 and k2 rate constants for all MgCl2 concentrations tested 
summarized in Table 3.1. We observed a 5.2-fold reduction in k1 when MgCl2 was 
reduced from 10 mM to 0.5 mM MgCl2, while a 12.2-fold decrease was observed for k2. 
The distinct metal requirements for each nicking reaction is represented in the log10k1 - 
log10k2 versus MgCl2 concentration plot, which shows a more pronounced decrease in k2 
as the concentration of MgCl2 is reduced (Figure 3.3C). These data suggest that divalent 
metal ion regulates the rate of both nicking reactions, but that the second strand nicking 
reaction has a more stringent requirement for divalent metal than the first nicking 
reaction. 
3.3.3 Assays with mutant substrates reveal three distinct cleavage 
phenotypes 
To further probe the contribution of divalent metal ion and DNA sequence to the 
sequential nicking reactions by I-BmoI, we performed time-course cleavage assays with 
various supercoiled mutant substrates at 2 mM and 10 mM MgCl2.  We took advantage of 
a series of previously constructed substrates (26), whereby positions -6 through -1 of 
intronless thyA substrate were individually and in combination changed to the 
corresponding intron-containing sequence (Figure 3.1 and Table 3.2), which I-BmoI does 
not cleave. End-point assays with these substrates highlighted the importance of the GC-2 
base pair in the generation of a DSB by I-BmoI (26). The previous assays, however, were 
incapable of distinguishing defects in each independent nicking reaction because they 
were performed on linearized plasmid substrates in 10 mM MgCl2. Time-course assays 
using mutant cleavage site plasmids revealed that the substrates segregated into three 
distinct classes (Figure 3.4 and Table 3.2). Class I mutants were defined as substrates that 
behaved essentially as intronless thyA substrate, showing slightly reduced nicking and 
slower conversion of nicked intermediate to linear product at 2 mM versus 10 mM MgCl2  
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Figure 3.3: Limiting divalent metal ion has a greater effect on second strand than 
first strand nicking 
	  
Shown are representative images of time-course cleavage assays with supercoiled 
substrate containing the intronless thyA target site and I-BmoI in (A) 0.5 mM MgCl2 and 
(B) 10 mM MgCl2, as well as progress curves for each condition. Circular substrate (C), 
nicked intermediate (N) and linear product (L) are indicated on the gel images. Individual 
data points from three independent replicates are shown in the progress curves, and the 
solid continuous lines are the best fit of the data to equations 1 and 2. (C) Plot of the 
log10k1 - log10k2 value for MgCl2 concentrations tested. 
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Table 3.1: Rate constants for first- and second-strand nicking reactions in different 
MgCl2 concentrations 
 
[MgCl2] (mM) k1 (s-1)a k2 (s-1) 
10 0.10 ± 0.007 0.078 ± 0.008 
7 0.10 ± 0.005 0.060 ± 0.003 
5 0.079 ± 0.004 0.050 ± 0.002 
2 0.056 ± 0.001 0.036 ± 0.001 
1 0.037 ± 0.0006 0.013 ± 0.0004 
0.5 0.019 ± 0.0002 0.0064 ± 0.0002 
a k1 and k2 rate constants are reported as the best fit value of three independent 
experiments with standard error. 
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Table 3.2: Summary of cleavage data for intronless and mutant substrates 
     
Rate constants (s-1) a 
  Substrate 2mM MgCl2 10mM MgCl2 
  -6 -5 -4 -3 -2 -1   k1 b k2c k1 k2 
(intronless) G C C C G T  0.057 0.026 0.11 0.074 
Class I     A         0.05 0.028 0.1 0.057 
(like wild-type) T       0.057 0.024 0.087 0.058 
Class II           G   0.031 0.0095 0.065 0.025 
(rescue)    G    0.01 0.0084 0.025 0.025 
  A      0.0095 0.016 0.031 0.042 
   A G    0.0082 0.0091 0.024 0.022 
  A A     0.0044 0.015 0.014 0.043 
 T A      0.011 0.017 0.028 0.048 
 T A A     0.0045 0.015 0.014 0.047 
Class III         T     0.00027 n.d.d 0.00061 n.d. 
(no rescue)     T G  n.d. n.d. n.d. n.d. 
    G T   n.d. n.d. n.d. n.d. 
   A  T   n.d. n.d. n.d. n.d. 
  A   T   n.d. n.d. n.d. n.d. 
  A  G    0.00037 0.00053 0.0013 0.014 
    G T G  n.d. n.d. n.d. n.d. 
  A  G  G  0.00016 n.d. 0.00035 0.0026 
   A G T   n.d. n.d. n.d. n.d. 
 T  A  T   n.d. n.d. n.d. n.d. 
  A A G    0.0002 0.0017 0.00052 0.0091 
  A A G T   n.d. n.d. n.d. n.d. 
(intron-containing) T A A G T G   n.d. n.d. n.d. n.d. 
 
a Rate constants were determined from three independent experimental trials for all substrates. 
b k1, the rate constant for the first nicking reaction that generates nicked intermediate from 
circular substrate (expressed as the median of a 95% confidence interval, see Supplementary 
Table S3.3) 
c k2, the rate constant for the second nicking reaction that generates the linear product (expressed 
as the median of a 95% confidence interval, see Supplementary Table S3.3) 
d n.d. not determined. 
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Figure 3.4: Magnesium concentrations reveal three distinct classes of substitutions 
 
Cleavage assays with I-BmoI were conducted on supercoiled plasmid substrates 
containing substitutions at positions -6 to -1 in the presence of 2 mM or 10 mM MgCl2 
(see also Table 2). Mutant substrates were arranged into three classes. (A) Substrates that 
showed a phenotype similar to wild-type intronless thyA substrate (class I); (B) substrates 
that demonstrated poor cleavage in 2 mM MgCl2 and rescued cleavage in 10 mM MgCl2 
(class II); (C) substrates with significantly reduced or no cleavage (class III). Shown are 
representative gel images of time-course cleavage assays, where the second lane from the 
left contains unreacted plasmid substrate (-). Nicked (N), linear (L), and circular (C) 
plasmid forms indicated to the right. Beneath each gel image is a graphical representation 
of reaction progress over time in 2 mM and 10 mM MgCl2 using dashed and solid lines, 
respectively. Data points representing three independent experiments for class I and II, 
and two experiments for class III are shown. 
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(Figure 3.4A). The substrates were those with substitutions C-4A or G-6T, and the rate 
constants for the first and second strand nicking reactions in low and high MgCl2 were 
very similar to those obtained for intronless thyA substrate (Table 3.2 and  Supplementary 
Table S3.3).   
Class II mutants were defined as substrates that exhibited a greater impairment of first 
and second strand nicking in low versus high MgCl2 conditions. This class included the 
singly mutated substrates T-1G, C-3G, and C-5A, as well as the multiply substituted C-
3G/C-4A, C-4A/C-5A, C-5A/G-6T and C-4A/C-5A/G-6T substrates (Table 3.2). The 
general characteristics of substrates in this class were the accumulation and persistence of 
the nicked intermediate in 2 mM MgCl2 (which resulted in impaired double-strand break 
formation), and the rescue of cleavage in 10 mM MgCl2 resulting in the near complete 
conversion to linear product by 180 seconds (Figure 3.4B and Table 3.2). Rate constant 
analysis indicated a further segregation of substrates within class II by differential base-
specific effects on first and second strand nicking reactions (Table 3.2). The T-1G 
substitution decreased the first (k1) and second (k2) strand rates by roughly 2- and 3-fold 
versus intronless thyA substrate in the presence of 2 mM and 10 mM MgCl2, respectively, 
suggesting a more profound modulation of second-strand nicking. The C-3G substitution, 
which displayed similar defects in the presence or absence of a C-4A substitution, 
generated approximately 5- and 3- fold reductions in k1 and k2 versus intronless substrate, 
regardless of MgCl2 concentration. Interestingly, the C-5A substitution, alone or in the 
context of a G-6T substitution, decreased k1 by roughly 6- and 3-fold in the presence of 2 
mM and 10 mM MgCl2, respectively. The addition of a C-4A substitution to the C-5A 
template exacerbated the k1 defect to 12- and 9-fold in the presence of 2mM and 10 mM 
MgCl2. Surprisingly, the C-5A substitution showed less of an influence on the second-
strand nicking rate (k2), evidenced by a 1.5-fold rate reduction in both MgCl2 
concentrations. This result was observed with the C-5A substitution alone or in the 
context of the double mutation with C-4A.  
Class III mutants were defined as substrates with drastically reduced reaction rates that 
displayed little or no cleavage in either low- or high-metal ion conditions (Figure 3.4C 
and Table 3.2). All substrates with mutations at the -2 position fell into this category, in 
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addition to substrates with mutations at both the -5 and -3 positions. Interestingly, we 
observed that the G-2T substitution alone, and in combination with substitutions at 
positions -1 or -4 and -6, demonstrated limited accumulation of nicked intermediate at 
180s in high metal. First strand nicking rates (k1) for class III substrates were 84- to 314-
fold reduced as compared to intronless thyA substrate, indicating a substantial first strand 
defect. Additionally, we observed that the substrates containing a combination of C-3G 
and C-5A mutations retained low levels of double-strand break formation after 180s in 10 
mM MgCl2, and that the addition of a T-1G or C-4A mutation did not abolish the low 
amount of cleavage. Importantly, the intron-containing substrate showed no evidence of 
nicking or cleavage after 180 seconds under either condition tested (Table 3.2).  
Collectively, the cleavage assays indicated that substrates with individual mutations at 
positions -4 or -6 had little effect on first- or second-strand nicking in either low or high 
metal ion conditions. Additionally, substrates with single mutations at positions -1, -3 or -
5 exhibited defects in both first- and second-strand nicking in low metal conditions and 
an observable rescue of cleavage by high divalent metal ion. Substrates with mutations at 
both the -3 and -5 positions were not significantly rescued by high metal ion, and those 
with mutations at position -2 were defective for cleavage under all conditions tested.  
3.3.4 In-gel footprinting reveals multiple minor groove distortions 
dependent on GC-2 
The cleavage data suggested that divalent metal ion and the GC-2 base pair are required 
for efficient double-strand break formation. To gain further insight into the role of the 
GC-2 base pair in the cleavage pathway, we performed in-gel footprinting with the minor 
groove-specific reagent 1,10-copper phenanthroline (OP-Cu). I previously used in-gel 
footprinting to show that significant OP-Cu hypersensitive sites were localized to 
positions -2 and -1 of the bottom strand of the I-BmoI-thyA complex (24), consistent with 
protein-induced DNA distortions that make the minor groove more accessible to OP-Cu. 
The distortions were also present in I-BmoI-substrate complexes formed with the 
catalytic mutants R27A and E74A, implying that the distortions precede first-strand 
nicking and do not require the presence of a metal ion bound by E74 (24). Previous 
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footprinting studies, however, did not explore the requirement of the GC-2 base pair in 
formation of OP-Cu hypersensitive sites. 
We performed in-gel footprinting with a 74-mer duplex oligonucleotide substrate 
corresponding to the intron-containing substrate (In+), which contains an alternative 
sequence upstream of the insertion site relative to the intronless substrate and notably has 
a G-2T substitution (Figure 3.5). As shown in Figures 3.5B and 3.5C, the OP-Cu 
hypersensitive sites at positions -2 and -1 on the bottom strand were significantly reduced 
in the UC consisting of I-BmoI-In+ substrate as compared to UC formed with intronless 
thyA substrate. We next mutated the GC-2 base pair within the context of the intronless 
substrate to TA-2, AT-2 or CG-2, and measured the extent of the OP-Cu hypersensitive 
sites at positions -2 and -1 on the bottom strand. These three mutations reduced the OP-
Cu hypersensitive sites to the same extent as was observed with intron-containing 
substrate (Figure 3.5B and 3.5C), indicating the GC-2 base pair is critical for inducing 
DNA distortions that result in enhanced OP-Cu sensitivity. To provide further evidence 
for this model, we tested a T-2G substitution within the context of the intron-containing 
substrate (Figure 3.5A), reasoning that this mutation should restore the OP-Cu 
hypersensitivity if contacts to the GC-2 base pair are required for minor-groove 
distortions. Indeed, footprinting reactions on the T-2G intron-containing substrate 
revealed a restoration of OP-Cu hypersensitivity at positions -2 and -1 to approximately 
half of those observed on thyA intronless substrate. Products seen at the -4 position are 
indicative of bottom-strand nicks observed when I-BmoI-thyA complexes were formed 
in-gel in the absence of exogenously added metal (24), as Cu2+ is not a productive 
divalent metal ion for cleavage (Figure 3.2A).   
3.3.5 Modeling of an I-BmoI-substrate complex 
To gain insight into the role of divalent metal ion and substrate contacts in the I-BmoI 
reaction pathway, we used the recently solved co-crystals of the GIY-YIG restriction 
enzymes Eco29kI and Hpy188I with their respective substrates to model an I-BmoI-
substrate complex (36,37). Eco29kI and Hpy188I function as dimers to cleave 
palindromic sites, with each GIY-YIG monomer nicking one strand of the 
substrate(37,39). We first generated a homology model of residues 1-92 of I-BmoI based  
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Figure 3.5: The GC-2 base pair is required for minor-groove distortions near the 
bottom-strand nick site 
 
(A) Illustration of base pairs -6 to +7 of the intronless (In-), intron-containing (In+), and 
mutant 74-mer substrates used for in-gel 1,10-phenanthroline copper (OP-Cu) 
footprinting reactions. First- and second-strand nicking sites are indicated by open and 
filled triangles, respectively. (B) Representative denaturing gel image of OP-Cu 
footprinting reactions on bottom-strand labeled In-, In+, and mutant substrates. Nicked 
products at -4 and minor groove distortions at positions -2 and -1 are indicated using 
filled triangles, asterisks, and greater-than symbols, respectively. Sequence upstream of 
the intron insertion site (IS) varies whether the intronless or intron-containing substrate 
was used as a template. (C) Graphical representation of the minor groove sensitivity to 
OP-Cu at positions -2 (asterisk, blue) and -1 (greater than symbol, purple) for In-, In+, 
and mutant substrates, expressed as the ratio of normalized phosphorimager units of the 
upper complex (UC) and unbound substrate (UNB). 
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on the closely related I-TevI GIY-YIG domain structure (38). Next, we superimposed the 
I-BmoI model on a monomer of the dimeric Eco29kI and Hpy188I structures by aligning 
residues 6-10 of I-BmoI with the structurally analogous amino acids of Eco29kI (residues 
47-51) and Hyp188I (residues 61-65) (which included key structural resides of the β-
sheet 1). We observed that the position of the I-BmoI active site residues (Y6, Y17, R27, 
H31, E74 and N87) aligned well with the homologous residues in both restriction 
enzymes (Figure 3.6A and data not shown), as was observed in two other structure 
superposition studies (36,37). To model the position of the substrate in the I-BmoI active 
site, we included the substrate DNA from the Eco29kI structure, and similar results were 
obtained using the DNA from the Hpy188I structure. As shown in Figure 3.6, the path of 
the DNA follows a previously hypothesized catalytic cleft that is lined by the active site 
residues of I-BmoI (41), with the metal ion coordinated by E74 positioned in close 
proximity to the bottom-strand scissile phosphate at position -4. Of particular interest are 
the OP-Cu hypersensitive sites at positions -2 and -1 of the bottom strand that result from 
a widening of the minor groove. These distortions could place the base edge of the 
bottom strand C of the critical GC-2 base pair within hydrogen bonding distance of a 
number of side chains, highlighting the importance of this base pair in the cleavage 
pathway.  The model also reinforces the notion that the role of divalent metal ion in 
promoting second-strand nicking must be in repositioning of the substrate-DNA complex 
rather than by directly participating in DNA hydrolysis. 
3.4 Discussion 
Enzymes that function as DNA endonucleases almost always require the presence of 
active site divalent metal ions (8,42,44). In general, the preferred ion is magnesium, 
which acts to catalyze reaction progress by stabilizing negative phosphoanion transition 
states, or by acting as Lewis acids to modulate the pKa of coordinated water molecules 
(42,44). Metal-activated water molecules can function as catalytic agents by adopting the 
roles of nucleophiles and general bases, or by protonating leaving groups (44,47). 
Families of site-specific DNA endonucleases have distinct metal ion requirements, and 
generally function by either a one- or two-metal ion mechanism (44,47). The metal ion 
requirements for homing endonucleases are best understood for the LAGLIDADG family  
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Figure 3.6: Model of I-BmoI GIY-YIG domain interactions with substrate 
(A) Cartoon representation of the I-BmoI GIY-YIG domain homology model (gray) (41) 
aligned with the solution structure of related GIY-YIG restriction enzyme Eco29kI 
(3MX1, blue) (36). The side chains of the conserved and catalytically relevant residues 
Y6, Y17, R27, H31, E74, and N87 of I-BmoI are shown in black, and equivalent Eco29kI 
residues in orange (Y49, Y76, R104, H108, E142, and N154). The position of divalent 
metal coordinated by Eco29kI is represented by the red sphere. (B) Cartoon 
representation of the I-BmoI homology model aligned with a segment of the DNA from 
the substrate-bound Eco29kI structure (3N1C, -4C to +5C). The top strand of the 
Eco29kI substrate is labeled according to the nucleotides of the I-BmoI intronless allele (-
8G to +1A). The phosphate of the bottom strand nick site is highlighted in blue, the 
bottom strand distortions at positions -2 and -1 are shown in green, and the -2GC base 
pair is shown as a stick model in red. (C) Surface representation of the GIY-YIG domain 
for the model shown in panel (B). (D) Similar to panel (C), with a 90° rotation of the 
model on the horizontal axis, and a 180° rotation around the vertical axis. 
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that have an active-site preference for magnesium, and can uniquely function by a two-
metal mechanism where a third divalent metal ion is shared between two active sites 
(8,48,49). The H-N-H homing endonuclease I-HmuI, which generates single-stranded 
nicks in DNA substrates, functions optimally at 1 mM MgCl2 or MnCl2 and nicks via a 
one-metal ion mechanism (43). Studies of the related H-N-H colicin E9 revealed different 
divalent metal ion requirements for cleavage of distinct nucleic acid substrates, with 
magnesium promoting cleavage of dsDNA and zinc being more effective for nicking of 
ssDNA (50). I-PpoI, a His-Cys box homing endonuclease, functions by a one-metal ion 
mechanism and requires zinc and magnesium for folding and cleavage, respectively 
(8,51). The focus of this paper, the GIY-YIG homing endonucleases, have traditionally 
been studied in the presence of magnesium that structural studies indicate is coordinated 
by a conserved active site glutamate (E74 in I-BmoI) (38). GIY-YIG enzymes likely use 
a single-metal ion to promote DNA hydrolysis (36,37), and our data agrees with studies 
of the tetrameric GIY-YIG restriction enzyme Cfr42I that revealed a broad tolerance to 
divalent-metal ion (31).   
Among the GIY-YIG family of enzymes, there is tremendous diversity in how the GIY-
YIG nuclease domain is utilized to hydrolyze DNA. For instance, the restriction enzymes 
Eco29kI and Hpy188I function as dimers (37,39), with each GIY-YIG monomer nicking 
one strand, whereas the UvrC nucleotide excision repair protein uses a single GIY-YIG 
domain to nick 3’ to a mutagenic lesion (40). In this respect, GIY-YIG homing 
endonucleases differ from characterized GIY-YIG enzymes that make a DSB in that a 
single catalytic domain is used in two ordered and sequential nicking reactions to 
generate a DSB (24,25). How the single active site of the GIY-YIG nuclease domain is 
reorganized on substrate between nicking reactions is unknown, but previous studies 
suggested an involvement of divalent metal ion in this process (24). Our current study 
more accurately defines the roles of divalent metal ion and DNA substrate bases in this 
process as evidenced by reaction conditions that differentially affect k1 or k2. Not 
surprisingly, substrates that contained a mutation in the critical GC-2 base pair displayed 
drastically impaired rate constants, indicating a severe defect in first-strand nicking and 
an inability to form a DSB. Interestingly, bases surrounding the bottom-strand nicking 
site at positions -4 and -5 also resulted in reduced nicking rates when mutated. This 
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observation was somewhat surprising as previous studies had not revealed a critical role 
of these positions for cleavage by I-BmoI (26), likely because past studies examined only 
linear product formation under high metal conditions rather than employing reactions 
conditions that could temporally dissect base-specific nicking effects. The I-BmoI-
substrate model predicts that multiple amino acid side chains within the catalytic cleft 
project into the major groove near positions -4 and -5, implying that base pair 
substitutions result in altered contacts that consequently reduce k1. The observation that 
k1 defects associated with these substrates were significantly rescued in the presence of 
10 mM MgCl2 suggests that magnesium can compensate for lost I-BmoI-substrate 
interactions by promoting alternative conformations of protein or substrate within the 
catalytic cleft that facilitate cleavage. Additionally, substitutions near the bottom strand-
nicking site had a comparatively insignificant effect on the top strand-nicking rate (k2), 
which is in agreement with the bottom strand contacts being necessary only for k1. 
A crucial aspect of the I-BmoI cleavage pathway is the introduction of a significant minor 
groove distortion in thyA substrate (24); similar DNA-bending was also observed in I-
TevI-td substrate complexes (25). These protein-dependent DNA distortions are observed 
in the absence of exogenous magnesium, and the precise role of these distortions in the 
cleavage pathway is unknown. Parallels can be drawn with other site-specific 
endonucleases, as large DNA distortions have been shown to bring opposite strand 
scissile phosphates into close proximity (52). Conversely, the natural curvature of nucleic 
acids is highly sequence dependent and can be influenced by the presence of divalent 
metal ions (53-55). Interestingly, magnesium ions have been shown to induce much 
greater changes in the curvature of GC- versus AT-rich DNA (53). In this respect, it is 
noteworthy that the DNA distortions introduced by I-BmoI and I-TevI occur in stretches 
of GC-rich DNA (24,25), suggestive of distinct metal dependent and protein induced 
distortions that promote substrate conformational changes between nicking reactions. It is 
possible that aside from directly participating in catalysis, magnesium may induce a 
secondary substrate conformation that is distinct from the distortion resulting from 
contacts to the GC-2 base pair. Reduced rate constants observed for I-BmoI on mutant 
substrates can therefore be rationalized by lack of base-specific contacts to the GC-2 pair 
and to other positions, as well as the sequence-dependence of DNA distortions induced 
113 
 
by magnesium. Decreased fidelity of I-BmoI on the G-2T substrate in the presence of 
manganese can alternatively be explained by different protein-DNA conformations 
promoted by manganese ions relative to magnesium, as they have differential effects on 
natural DNA curvature (56). 
Similar roles for metal ions in promoting protein-DNA interactions and conformational 
changes required for efficient catalysis have been dissected in other enzyme systems 
where a single active site is used sequentially to perform multiple reactions (57). Notably, 
sub-optimal magnesium concentrations can uncouple excision and strand transfer events, 
and manganese can reduce target site specificity of the Tn10 transposase (57). However, 
the modular structure of I-BmoI and other GIY-YIG homing endonucleases resembles 
that of Type IIs restriction enzymes, including the well-characterized FokI that is a 
monomer in solution but transiently dimerizes to generate a DSB (58,59). The FokI 
cleavage mechanism has been suggested as a solution to how the single active site of 
GIY-YIG homing endonucleases is used to affect a double-strand break (38). 
Interestingly, divalent metal ion has been shown to stabilize the FokI dimer/substrate 
complex (59), and it is possible that a reduction in the k2 rate constant we observe in low 
magnesium conditions reflects a defect in transient dimerization between I-BmoI 
monomers. No obvious dimer interface was evident in the structure of the I-TevI catalytic 
domain (38), which shares high identity with that of I-BmoI, but it is possible that 
dimerization determinants lie outside of the catalytic domain. Interestingly, the type IIs 
enzyme Eco31I also has a modular structure but binds and cleaves DNA as a monomer 
(60), suggestive of mechanistic similarities to I-BmoI and I-TevI.  
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Chapter 4  
4 The monomeric GIY-YIG homing endonuclease I-BmoI 
uses a molecular anchor and a flexible tether to 
sequentially nick DNA 
The work presented in this chapter is reproduced from (with permission, Appendix 1) the 
accepted version of: 
Kleinstiver, B.P., Wolfs, J. W., Edgell, D.R. (2013) The monomeric GIY-YIG homing 
endonuclease I-BmoI uses a molecular anchor and a flexible tether to sequentially 
nick DNA. Nucleic Acids Research, doi: 10.1093/nar/gkt186 
4.1 Introduction 
Site-specific DNA nucleases are central to many cellular processes, including DNA 
recombination and repair, restriction defense systems, and the mobility of selfish genetic 
elements (1,2). A number of nuclease active sites have evolved that are characterized by 
conserved amino acid motifs and operate via distinct catalytic mechanisms to generate 
nicks or double-strand breaks (DSBs) in DNA (1-3). There is often little correlation 
between the identity of the nuclease active site motif and cellular function, as conserved 
catalytic cores from individual nuclease families are found within diverse protein 
scaffolds (1,4). As such, a fundamental understanding of the mechanisms by which each 
nuclease family generates a DSB is required, as several families have been exploited for 
genome engineering purposes (5-9).   
One such nuclease family contains the GIY-YIG catalytic motif, consisting of a compact 
domain of ~100 amino acids that is characterized by at least two α-helices that surround a 
three-stranded β-sheet (10-14). The catalytic core includes a number of conserved amino 
acids that are essential for DNA-hydrolysis via a one-metal ion mechanism (14). The 
minimal GIY-YIG nuclease domain is often found associated with protein scaffolds that 
function to anchor the GIY-YIG domain in close proximity to DNA, implying that the 
GIY-YIG domain itself has weak DNA-binding activity (15-20). Included in this 
category is the nucleotide excision repair protein UvrC that has acquired distinct binding 
domains and uses a single GIY-YIG domain to nick 3’ to DNA lesions (11). 
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Alternatively, the restriction enzymes Eco29kI and Hpy188I have acquired 
supplementary units of structure that are intertwined within the conserved GIY-YIG 
domain to promote oligomerization and assembly on DNA, with each GIY-YIG 
monomer nicking one strand (13,14,19,21). The GIY-YIG nuclease domain is also found 
within homing endonucleases (GIY-HEs) as an N-terminal fusion to sequence-tolerant 
DNA-binding domains that target extended asymmetric binding sites (22,23).  
GIY-HEs function as mobile genetic elements by introducing DSBs at a defined site 
within naïve genomes to promote mobility of their own genes (2,24,25). I-TevI and I-
BmoI, encoded within introns interrupting the td and thyA thymidylate synthase (TS) 
genes of bacteriophage T4 and Bacillus mojavensis, remain the best-characterized GIY-
HEs to date, however sequencing efforts have identified additional putative GIY-HEs 
(26-28). I-BmoI and I-TevI bind a homologous target site in their respective TS genes 
and consist of N-terminal GIY-YIG domains connected by linkers to C-terminal domains 
that contact 30-35 base pairs of substrate (Figure 4.1A) (15,23,29). Studies of I-TevI 
indicate that the inter-domain linker is flexible (29,30), supported by its ability to position 
the catalytic domain on substrate. The modularity of GIY-HEs is also evidenced in their 
cognate target sites, as the asymmetric target sequences contain distinct motifs for DNA 
binding and cleavage (15). The I-BmoI and I-TevI target sites share 48% identity and 
previous in vitro substrate selections identified a conserved G-C base pair that flanks the 
I-BmoI and I-TevI cleavage sites as critical for cleavage (Figure 4.1A) (31,32). Contacts 
to the G-C base pair are essential for both GIY-HEs to perform the sequential and 
independent nicking reactions to generate a DSB with a 2-nt 3’ overhang (23,33,34). 
Previous studies with I-TevI showed that the two-domain enzyme bound DNA as a 
monomer and induced significant substrate bending near the cleavage site (35), while 
chimeric enzymes with the I-TevI nuclease domain fused to the ryA zinc-finger generated 
a DSB in a non-cooperative manner (9).  Kinetic analyses of the two-step nicking 
reaction using I-BmoI showed that the first-strand nicking reaction proceeds 
approximately 2-fold faster than the second nicking reaction (28). Moreover, divalent 
metal ion and DNA sequence at the cleavage site influences I-BmoI activity, likely by 
modulating local DNA structure and promoting sequential protein interactions with bases 
in the cleavage site region (36). However, the central question of how the single active  
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Figure 4.1: I-BmoI interactions with substrate and monomeric cleavage models 
 (A) Schematic of the modular structure of I-BmoI interacting with intronless thyA 
substrate. Bottom- and top-strand nicking sites are indicated by filled and open triangles, 
respectively. IS, intron-insertion site. NUMOD; nuclease-associated modular DNA-
binding domains. (B) Models for double-strand break formation by monomeric nucleases 
with single active sites. For transient dimerization, the secondary enzyme molecule can 
dimerize with the primary DNA-bound molecule from solution or via synapsis as a 
substrate-bound molecule at an additional target site. 
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site of GIY-HEs is utilized to successively nick each DNA strand has not been rigorously 
addressed. Based largely on studies with I-TevI, a conformational change model was 
proposed whereby the GIY-YIG nuclease domain and substrate undergo substantial re-
arrangements between nicking reactions to reposition the active site (Figure 4.1B) (35). 
However, the extreme cytotoxicity of I-TevI precluded detailed kinetic studies that could 
rule out alternative mechanisms of DSB formation by monomeric nucleases, including 
transient dimerization between catalytic domains, synapsis of two enzymes bound to 
separate target sites, or cleavage through sequential transesterification reactions (Figure 
4.1B) (37-39).  
Here I capitalize on the ability to purify wild-type I-BmoI to explicitly test models of 
DSB formation. Significantly, we show that I-BmoI functions as a monomer at all stages 
of the reaction pathway and does not use a hairpin mechanism for DNA cleavage. The 
data are consistent with a model where the monomeric GIY-YIG domain rotates between 
nicking sites to generate a DSB, with the I-BmoI DNA-binding domain functioning to 
anchor the linker and nuclease domain to substrate. I envision that a better understanding 
of the catalytic mechanism will provide insight into the ability of GIY-HEs to invade a 
diverse range of biological alleles, as well as enhance ongoing efforts to utilize the GIY-
YIG nuclease domain as a genome-editing tool. 
4.2 Materials and methods 
4.2.1 Strain and plasmid construction 
A complete description of strains and plasmids used in this study are found in 
Supplementary Table S4.1. E.coli strains DH5α, ER2566, and BW25141(λDE3) were 
used for plasmid manipulations, expression studies, and genetic selections, respectively. 
Sequences and details of oligonucleotides are in Supplementary Table S4.2. Full-length I-
BmoI, R27A I-BmoI, and N- and C-terminal truncations were expressed and purified as 
previously described (28). Codon optimized N- and C-terminal I-BmoI domain 
truncations were cloned by PCR using Phusion (N.E.B.) into the NdeI and KpnI sites of 
pTYB1. To construct plasmid pLBmo, the PvuII fragment of pBmoHS was subcloned 
into the PvuII site of LITMUS28i (N.E.B.). A duplex 49mer oligonucleotide containing 
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the I-BmoI thyA target site (DE-906/907) was ligated into the SwaI site of pLBmo in the 
opposite or same orientation as the primary I-BmoI target site to generate the 2-site 
plasmids pLBmo2a and pLBmo2b, respectively. Quikchange (Stratagene) reactions were 
performed on pLBmo to generate pLBmoNa and pLBmoNb by introducing Nt.BbvCI 
sites 1082 or 60 base pairs from the I-BmoI top-strand nick site, respectively. Both 
Nt.BbvCI sites were introduced into pLBmo to generate pLBmo2N.  
To create the pTox plasmid, Quikchange was performed (DE-1171/1172) to remove the 
EcoRI site from p11-lacY-wtx1 (40) and an oligo cassette containing an EcoRI site (DE-
1173/1174) was ligated into XbaI/SphI. The kanamycin-resistant pKox plasmid was 
generated by cloning the kanamycin resistance gene into the ScaI site of pTox. The 
vectors pKoxBmoHS and pKoxBmoIn+ were similarly generated from their respective 
pTox precursors (28). pTox and LITMUS28i plasmids containing variant I-BmoI homing 
sites with G+7A, G+7C, or G+7T mutations were generated by ligating the appropriate 
duplex oligos into XbaI/EcoRI of either vector. Plasmid constructs with nucleotide 
insertions in the I-BmoI homing site were generated by ligating the appropriate oligos 
into XbaI/EcoRI of LITMUS28i. All plasmid constructs were verified by sequencing.  
4.2.2 Identification of I-BmoI domains 
Limited proteolysis trials were conducted in reactions containing 1X binding buffer (50 
mM Tris-HCl pH 8.0, 50 mM NaCl, 1mM DTT), 5 µM I-BmoI, and 5.5 µM intronless 
thyA (DE-116/117), intron-containing (DE-444/445), non-specific (DE-144/144GC), or 
mutant (see below) 74-mer duplex oligonucleotide substrates. Reactions were incubated 
at room temperature for 5 minutes and an aliquot (‘0’ time-point) was extracted prior to 
the addition of either 50 ng trypsin, 100 ng chymotrypsin, 5 ng substilisin A, or 1 µg 
elastase in 1X protease dilution buffer (20 mM Tris-HCl pH 7.9, 50 mM KCl, 10 mM 
MgSO4). Aliquots were removed from the digest, added to stop buffer (100 mM EDTA 
pH 8.0, 150 mM Tris-HCl pH 6.8, 4.8 % SDS, 24% glycerol), and boiled at 95oC prior to 
electrophoresis on 15% SDS-PAGE gels. Coomassie stained bands of stable domains 
were excised prior to in-gel trypsin digestion at the London Regional Proteomics Facility. 
Recovered peptides were subjected to MALDI-TOF mass spectrometry and the results 
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analyzed using the UCSF MS-Bridge webpage. To delineate the boundary of the trypsin- 
and elastase-stable catalytic domain, LC mass spectrometry was performed on a 3Q mass 
spectrometer (Micromass) equipped with a Z-spray source and run in positive ion 
nanospray mode. Results were analyzed using MassLynx 4.0.  
4.2.3 Biophysical characterization of I-BmoI 
Differential scanning calorimetry was performed using a VP-DSC MicroCalorimeter 
(MicroCal) equilibrated with buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 5% 
glycerol) in a 500 µl cell at the Biomolecular Interactions and Conformations Facility at 
the University of Western Ontario. Trials consisted of 5.2 µM I-BmoI in the presence or 
absence of 5.9 µM thyA 74-mer duplex oligonucleotide substrate, with a heating rate of 
1°C/minute from 10-100°C. Data were analyzed with MicroCal Origin 7 software 
(including corrections for buffer baseline and protein concentration) using a two-state 
model that assumes a single independent unfolding transition (41). 
4.2.4 DNA-binding affinity of I-BmoI domains 
Binding reactions contained 250 mM NaCl, 50 mM tris pH 8.0, 2.5 mM EDTA, 1 mM 
DTT, 5 ng/µl poly dIdC, 5% glycerol, and 0.25 nM of intronless thyA, intron-containing, 
or randomized 74-mer substrates radio labeled on the top strand with γ-32P. Serial 
dilutions of the I-BmoI domain truncations were added to the reaction mixture prior to 
incubation at room temperature for 15 minutes and the addition of loading buffer. 
Reaction were loaded on 10% native polyacrylamide (19:1) and visualized using a 
Phosphorimager (GE Healthcare). Data were fit to the equation !"! !"!#$ =    [!]! !!!. 
4.2.5 Gel filtration chromatography 
I-BmoI and I-BmoI:thyA complexes (DE-130/131) were incubated at room temperature 
for 10 minutes, spun for 10 minutes at 9300x g, applied to a Superose 12 10/300 GL 
column (Amersham Biosciences) pre-equilibrated with dialysis buffer (25mM Tris-HCl 
pH 8.0, 500mM NaCl and 5% glycerol), run at 4°C at a flow rate of 0.5 ml/min. Fractions 
of 0.25 ml were collected and run on a 12% SDS-PAGE gel (29:1 (w/w) acrylamide to 
bis-acrylamide) and a 1% agarose gel.  Protein standards used to calibrate the column: 
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carbonic anhydrase, 29 kDa; albumin, 66 kDa; β-amylase, 200 kDa; and apoferritin, 443 
kDa.  The calibration curve was used to calculate the molecular masses of I-BmoI, thyA 
substrate, and the I-BmoI:thyA complex by interpolating elution volumes onto the curve. 
4.2.6 Cleavage assays with plasmid substrate 
The dependence of the initial reaction velocity on protein concentration was determined 
by cleavage reactions containing 20 mM Tris-HCl pH 8.0, 250 mM NaCl, 2 mM MgCl2, 
2.5% glycerol,10 nM pBmoHS, and I-BmoI (5.5 nM to 175 nM). Aliquots were removed 
at time points into stop dye (100 mM EDTA, 25% glycerol, 0.2% bromophenol blue), 
heated for 5 minutes at 95°C, electrophoresed on a 1% agarose gel, and stained in 
ethidium bromide (Caledon) solution prior to analysis on an AlphaImagerTM3400 (Alpha 
Innotech). Rate constants were calculated as best fit value of at least three experiments, as 
previously described (9). Initial reaction velocities were determined by calculating the 
slope of the line for the early time points of product formation. All subsequent plasmid 
cleavage assays were conducted as described above with exceptions indicated below. 
Two-site plasmid cleavage assays were performed on the single-site pLBmo plasmid and 
two-site pLBmo2a and pLBmo2b plasmids. Reactions were supplemented with either 2 
mM or 10 mM MgCl2, and I-BmoI was added to a final concentration of 22.1 nM, 54.3 
nM, or 87.5 nM. Domain addition assays were performed on pBmoHS with 10 mM 
MgCl2. I-BmoI was added to 11 nM or 22 nM in reactions containing 11 µM N111 I-
BmoI, N130 I-BmoI, or BSA (1000- or 500-fold excess domain, respectively). Assays on 
plasmids with nucleotide insertions or G+7 substitutions were performed on pLBmo, 
pLBmo+5T, pLBmo+5C pLBmo+3Ta, pLBmo+3Tb, pLBmo+3Ca, pLBmo+3Cb, 
pLBmoG+7A, pLBmoG+7C, and pLBmoG+7T. Reactions were supplemented with 0.5 
mM, 2 mM, or 10 mM MgCl2, and 87.5 nM I-BmoI.  
4.2.7 Gel-mobility shift assays with pre-nicked substrates 
Binding reactions were assembled in the presence of 10 mM EDTA or 10 mM MgCl2 and 
run as previously described (34). To generate the 3 substrates required, the top strand 
74mer (DE-116) was 5’ labeled with γ-32P prior to annealing with the complement full-
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length bottom-strand oligo (DE-117) to generate the thyA substrate (WT). The substrate 
with the 3’-OH -5/-4 bottom strand nick was generated with a 3’-23mer (DE-125) and 5’-
51mer (DE-123) (-4 nick). To create the -5/-4 bottom strand nick substrate with a 3’-H (-
4 ddGTP), the 3’-23mer (DE-125) and 5’-50mer (DE-124) that had been extended with 
ddGTP by terminal transferase (N.E.B.) were used. To ensure addition of a single ddGTP 
nucleotide to DE-124, we analyzed the product of the terminal transferase reaction by 
denaturing electrophoresis that revealed only a single nucleotide addition as compared to 
an unreacted DE-124 oligonucleotide.  
4.2.8 thyA cleavage site and spacer selection 
The 4 bp upstream and 9 bp downstream of G-2 in the thyA substrate were randomized to 
generate the pKoxRCS library (DE-1228, GCGGAATTCGANNNNGNNNNNNNNNCATGGCCTTGGG-
AAATCCCTTCAATGTATTCCGGCATG). A 5’-phosphorylated primer (DE-1229) complimentary 
to the underlined sequence was annealed to leave a 4-nt 3’ SphI overhang. The library 
was made double stranded by extension with 3’5’ exo- Klenow Fragment (N.E.B.), 
digested with EcoRI, and ligated into EcoRI/SphI cut pKox. The potential complexity of 
the library was estimated to be approximately 1.6 x 104 based on the number of 
independent transformants. 
To screen pKoxRCS for cleavable target sites, 60 µl of BW25141(λDE3) cells harboring 
pACYCIBmoI were transformed with 200 ng of pKoxRCS. Transformations were 
allowed to recover in 500 µl SOC at 37°C prior to plating on non-selective media (LB 
plus 25 µg/ml chloramphenicol, 50 µg/ml kanamycin, and 0.2% glucose). 2400 
transformant colonies, representing ~15% of the library, were replica-gridded on non-
selective and selective media (LB plus 25 µg/ml chloramphenicol and 10 mM L-(+)-
arabinose). Colonies containing cleavable substrates survived on both media, whereas 
those with non-cleavable substrates survived only on non-selective media. 86 colonies 
were verified as cleavable by replica-gridding in triplicate, and 96 clones were verified as 
non-survivors. The survivors and non-survivors were grown in separate 96-well plates in 
1 ml LB + 50 µg/ml kanamycin and 0.2% glucose, and 200 µl from each well was pooled 
prior to DNA extraction to generate survivor and non-survivor plasmid libraries. 
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Samples were prepared for Ion Torrent sequencing at the London Regional Genomics 
Centre by PCR amplifying the survivor, non-survivor, and pKoxRCS libraries with PWO 
(Roche) for 25 cycles with barcoded PCR primers. Custom Perl scripts were used to 
interpret the sequencing results, revealing 9982 unique sequences in the input library with 
an approximately equal distribution of all four nucleotides at each position. Sequences 
that occurred greater than 10 times in the survivor and non-survivor pools were retained 
for further analyses only if the sequences were also present in the input library. 
Nucleotide proportions at each position in the input and survivor datasets were used to 
calculate a Position-Specific Scoring Matrix (PSSM), and used to display relative 
enrichment by calculating the differences in proportions for each nucleotide at each 
position between the datasets.  
4.2.9 in vivo survival assays 
Two plasmid in vivo substrate activity assays were performed as previously described 
(28), with toxic (reporter) plasmids containing the wild-type thyA I-BmoI target site or 
variants with G+7 mutations.  Briefly, the in vivo I-BmoI cleavage efficiency for each 
substrate was calculated by dividing the number of colonies observed on selective plates 
(LB plus 25 µg/ml chloramphenicol and 10 mM L-(+)-arabinose) by those on non-
selective plates (LB plus 25 µg/ml chloramphenicol).  
4.2.10 OP-Cu in-gel footprinting  
1,10-phenanthroline copper (OP-Cu) footprinting experiments were performed using 10 
pmol of the catalytically inactive R27A variant of I-BmoI, as previously described (34). 
Duplex 74-mer substrates (0.1 pmol) used include: thyA, or thyA with G+7A (DE-
1356/1357), G+7C (DE-1358/1359), or G+7T (DE-1360/1361) substitutions. Hypo- and 
hyper-sensitivity to OP-Cu was calculated as the pixel density ratio between bands in the 
protein:DNA complex (UC) and unbound substrate lanes. Traces were normalized using 
bands outside of the footprinting region (C-12 and A-11). 
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4.3 Results 
4.3.1 I-BmoI is partially disordered in the absence of substrate 
Previous bioinformatic and experimental studies have suggested that I-BmoI is a modular 
protein composed of distinct N- and C-terminal domains connected by a linker 
(23,42,43). To investigate domain structure changes in the presence of substrate, we 
performed limited proteolysis experiments with I-BmoI or I-BmoI in complex with its 
cognate thyA substrate, derived from the intronless version of the B. mojavensis thyA 
gene (22). Trypsin, elastase, and chymotrypsin digests of I-BmoI revealed a pattern of 
proteolysis converging on a single stable domain of ~10 kDa (Figure 4.2A, 
Supplementary Figure S4.1A). Solution mass-spectrometry, as well as in-gel trypsin 
digest followed by mass spectrometry identified the stable domain as the N-terminal 
GIY-YIG domain consisting of residues 1-92. Strikingly, protease digests of I-BmoI in 
complex with its cognate 74-mer thyA substrate under identical conditions revealed a 
different pattern of protease sensitivity. For all three proteases, substrate-bound I-BmoI 
was far more resistant to proteolysis (Figure 4.2A, Supplementary Figure S4.1A). 
Additional stable domains of ~18-20 kDa were also observed and subsequently identified 
by in-gel trypsin digestion followed by mass spectrometry as peptides that mapped C-
terminal to residue 130. Western blot analyses using an antibody raised against residues 
1-111 of I-BmoI (N111) confirmed the identities of both stable domains (Supplementary 
Figure S4.1B). Digests of I-BmoI with all 3 proteases in the presence of a non-cognate 
oligonucleotide substrate revealed a pattern of protease sensitivity similar to that 
observed for I-BmoI without substrate (data not shown). No change in protease 
sensitivity was observed under cleavage conditions with 10 mM MgCl2. The protease 
digestion patterns of the I-BmoI:thyA complex revealed a stable two-domain structure 
resulting from specific DNA binding where the inter-domain linker remains moderately 
accessible to proteases. 
An exception was observed when digests were performed with intron-containing thyA 
substrate. I-BmoI binds the intron-containing substrate with similar affinity to the cognate 
intronless allele, however nucleotide differences upstream of the intron insertion site 
within the intron-containing target abolish the I-BmoI cleavage site (23). Trypsin digests 
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Figure 4.2: Identification of stable I-BmoI domains 
(A) Images of coomassie stained SDS-gels of trypsin limited proteolysis time-course 
experiments performed on I-BmoI and I-BmoI pre-incubated with intronless thyA 
substrate. Aliquots were removed at the indicated time points. In-gel trypsin digest 
followed by mass spectrometry was performed to identify the peptide products indicated 
with an asterisk (*). M, protein marker (sizes in kDa indicated to the left). (B) (top panel) 
Coomassie stained SDS-gel of trypsin limited proteolysis time-course experiments of I-
BmoI in complex with intronless or intron-containing substrates. (bottom panel) Plot of 
the fraction of full length I-BmoI remaining or increase of the catalytic domain peptide 
over time. Fraction of total protein is calculated after normalization to the untreated lane, 
with error bars representing the standard deviation of two replicates. (C) Enthalpy of 
transition curves for differential scanning calorimetry of I-BmoI or I-BmoI pre-incubated 
with substrate. 
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of the I-BmoI:intron-containing substrate complex showed a loss of protection of full-
length protein, revealing a ~25% greater degradation after 20 minutes into N- and C-
terminal domains (Figure 4.2B). A ~4 fold increase in the presence of the catalytic 
domain fragment was also observed, suggesting that nucleotide changes at the cleavage 
site disengage the catalytic domain from substrate resulting in increased protease 
sensitivity of the I-BmoI linker. These results are consistent with previous results where 
I-BmoI was unable to distort the intron-containing substrate as a prerequisite to bottom 
strand nicking, suggesting a loss of catalytic domain contacts at the cleavage site (36). 
Additional insight into the stability of I-BmoI was gained through differential scanning 
calorimetry analyses that revealed a broad denaturation profile with an observed Tm of 
45.1 °C.  In the presence of thyA substrate, we observed a ~5-fold increase in the 
enthalpy of transition versus that observed for I-BmoI in solution, consistent with an 
increase in protein stability (Figure 4.2C) (44). Collectively, these data suggest that only 
the N-terminal catalytic domain of I-BmoI is stable in the absence of substrate and that 
the C-terminal domain becomes structured upon DNA binding.  
4.3.2 N-terminal domains have weak but specific DNA-binding affinity 
To investigate the solubility and DNA-binding activity of the N- and C-terminal domains 
of I-BmoI, we expressed and purified a number of truncations. N-terminal constructs that 
contained the GIY-YIG nuclease domain were soluble and expressed very well (N92, 
N111, N130, and N154), while C-terminal constructs were generally insoluble, with the 
exception of 130C (Figure 4.3A). Binding assays with full-length I-BmoI and soluble 
domain truncations showed stable complex formation with thyA substrate 
(Supplementary Figure S4.2A), and quantitative DNA-binding assays were performed to 
determine dissociation constants of each of the N-terminal domain truncations for thyA 
intronless substrate. Binding reactions with intron-containing substrate were also 
performed to determine whether the N-terminal truncations possessed affinity for the 
cleavage site region of thyA substrate. The dissociation constants for the N92, N111, and 
N130 truncations were in the 10 µM range, while the N154 truncation had a KD of ~500 
nM for both intronless and intron-containing substrates indicating that the cleavage site 
region is not a major determinant for DNA binding (Figure 4.3B, Supplementary Figure 
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Figure 4.3: I-BmoI domains have distinct affinities for DNA 
(A) Schematic of I-BmoI truncations and image of a coomassie stained SDS-page gel 
containing 1.5 µg of each soluble construct (left and right panels, respectively). FL, full 
length I-BmoI; N92, residues 1-92 of I-BmoI; N111, 1-111; N130, 1-130; N154, 1-154; 
92C, 92-266; 106C, 1- 266; 130C, 130-266. (B). Images of native gel-shift experiments 
for N154 binding reactions performed on labeled intronless, intron-containing, and non-
specific substrate. The left lane contains substrate only, and lanes 1 through 16 contain 
serial dilutions of N154 from 52.3 µM to 1.60 nM. (C) Graph of the binding curves of 
N154 I-BmoI on intronless thyA or intron-containing substrate, with data from three 
replicates plotted (see also Supplementary Table S4.3). 
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S4.2B, and Supplementary Table S4.3). Discrete complex formation with the N-terminal 
truncations in the presence of a non-specific substrate was not observed under our 
binding conditions, apart from N154 which aggregated at a concentration that increased 
the KD by over 100-fold (Supplementary Table S4.3, Supplementary Figure S4.2B). The 
dissociation constants for the full-length protein and 130C DNA-binding domain were 
~10 nM for both intronless and intron-containing thyA substrates, consistent with 
previous data (23,31). Collectively these data show that I-BmoI possesses two functional 
domains connected by a protease-sensitive linker, where the N-terminal catalytic domain 
has weak affinity for DNA and the C-terminal domain contributes the majority of the 
DNA-binding energy.  
4.3.3 I-BmoI binds DNA as a monomer  
One model that has been proposed for DNA cleavage by GIY-YIG homing 
endonucleases requires the formation of a transient or stable dimer, with each monomer 
nicking one DNA strand (36). The ability to purify wild-type I-BmoI allowed us to 
determine the oligomeric status of I-BmoI and I-BmoI:substrate complexes in solution 
using gel filtration analyses (Figure 4.4). The elution profile of I-BmoI alone (35 kDa) 
matched very well with the calculated mass of an I-BmoI monomer (32 kDa), indicating 
that in solution I-BmoI is monomeric. The 46-mer thyA DNA substrate eluted at an 
observed mass of 99 kDa, well above that of its calculated mass of 29 kDa, due to 
aberrant migration of cylindrical DNA through the gel-filtration column. The observed I-
BmoI:thyA complex, assembled at a 5:1 protein:DNA ratio, eluted with a size (133 kDa) 
consistent with an monomeric I-BmoI:DNA substrate complex. Changing the protein to 
DNA ratio to 1:2 did not change the elution profile of the I-BmoI:thyA complexes, 
suggesting that I-BmoI does not synapse between two DNA molecules. The gel-filtration 
results were confirmed by protein cross-linking experiments using two different reagents 
with I-BmoI and I-BmoI:thyA complexes (Supplementary Figure S4.3). No cross-linked 
products were observed under binding or cleavage conditions (without exogenous metal 
or with 10 mM MgCl2, respectively) by gel electrophoresis or Western blot analyses, 
even at µM concentrations of protein. Thus, I-BmoI is monomeric and does not form 
stable higher order complexes in solution or when in complex with substrate. 
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Figure 4.4: I-BmoI is a monomer in solution and in complex with thyA substrate 
Graph of gel filtration elution profile of I-BmoI, 46-mer thyA substrate, or I-
BmoI:substrate complex, with observed molecular weights indicated. Standards used to 
generate the elution volume standard curve are shown. Gel filtration analyses were 
performed in duplicate. Ve, elution volume; Vo, void volume. 
 
  
134 
 
4.3.4 The oligomeric status of I-BmoI does not change during 
cleavage 
To specifically test whether the oligomeric status of I-BmoI changes during cleavage, we 
performed in vitro kinetic assays to 1) examine the dependence of initial reaction velocity 
on protein concentration, 2) determine whether synapsis by two endonuclease monomers 
in a two target site plasmid can enhance cleavage rate, and 3) investigate whether adding 
excess catalytic domain can stimulate cleavage (37,38). Prior to performing the in vitro 
kinetic assays, we sought to examine whether DNA topology influenced the rate of 
substrate cleavage by I-BmoI. To accomplish this, we used a plasmid containing a thyA 
target site into which we introduced restriction sites for the Nt.BbvCI nickase at two 
positions. The same plasmid could therefore be used as a supercoiled, relaxed, or linear 
substrate depending on whether the plasmid was relaxed with Nt.BbvCI or linearized 
with SwaI. As shown, no significant difference was observed for the rate of product 
formation on supercoiled, relaxed plasmid, or linear substrates at 0.5 mM, 2 mM, or 10 
mM MgCl2 (Supplementary Figure S4.4), and no difference in rate was observed on 
relaxed plasmids that were nicked at either or both Nt.BbvCI sites (data not shown). 
Subsequent in vitro cleavage assays were performed on supercoiled plasmid substrate 
unless otherwise indicated, as this allowed us to observe and determine rate constants for 
all steps of the reaction.  
Insight into the oligomeric status of I-BmoI during cleavage was obtained by establishing 
the relationship between enzyme concentration and initial reaction velocity. Single-
turnover cleavage reactions with eight concentrations of I-BmoI were performed on 
plasmid substrates containing a single thyA target-site where product formation was 
measured by the appearance of linear DNA (Figure 4.5A). The initial rate of product 
appearance for each I-BmoI concentration was calculated and plotted against I-BmoI 
concentration, yielding a linear dependence (Figure 4.5B). These data suggest that I-
BmoI-catalyzed DNA hydrolysis is first order with respect to protein concentration, 
indicative of non-cooperative cleavage.  
Additional cleavage assays were performed on substrates containing two target sites to 
address whether the cleavage rate could be enhanced by synapsis of two I-BmoI 
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Figure 4.5: I-BmoI functions as a monomer 
(A) Graph of initial reaction progress for cleavage assays with eight I-BmoI 
concentrations expressed as percent linear product. (B) Plot of initial reaction velocity 
versus I-BmoI concentration. (C) Graph of reaction progress for cleavage assays with I-
BmoI and 1- or 2-site substrate plasmids (left and right panels, respectively). L1+L2, 
linear products from 2-site plasmid cleavage. (D) Domain addition experiments. Graph of 
linear product formation for cleavage assays with 22 nM I-BmoI and 10 nM plasmid. 
Reactions were supplemented with 500-fold molar excess of N111, N130, or BSA. All 
cleavage assays were performed in triplicate. BSA, bovine serum albumin. 
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monomers bound to distinct target sites within a single plasmid. Reaction progress was 
examined on plasmids that contained a primary target site alone, or those that contained 
an additional secondary target site in the opposite or same orientation relative to the 
primary site (Figure 4.5C and Supplementary Figure S4.5). No rate enhancement was 
observed for either nicking reaction by I-BmoI on plasmids containing secondary target 
sites relative to plasmids with a single site, suggesting that synapsis is not required for 
cleavage. To further address a cooperative or synaptic cleavage mechanism, biotin-
tagged/radiolabeled oligonucleotides were immobilized on streptavidin-coated magnetic 
beads prior to the addition of I-BmoI (Supplementary Figure S4.6A). After the beads 
were stringently washed to remove unbound I-BmoI, cleavage was induced by the 
addition of magnesium and product liberation was measured by quantification of 
radiolabel released into solution. Cleavage levels were similar regardless of whether or 
not excess I-BmoI was added to the pre-formed I-BmoI:substrate complexes during the 
magnesium cleavage step (Supplementary Figure S4.6B).  
Next, we tested whether transient interactions between catalytic domains could stimulate 
cleavage by performing cleavage assays with I-BmoI in the presence of excess N-
terminal domain truncations. Cleavage assays with I-BmoI and 500-fold molar excess 
N111 or N130 did not stimulate cleavage rate relative to the addition of BSA (Figure 
4.5D). Assays with a 500-fold molar excess of N154 led to non-specific cleavage, as the 
concentration of the domain added approached the KD of non-specific binding for N154 
(Supplementary Table S4.3). A similar pattern of non-specific substrate degradation was 
observed for reactions containing the same concentration of N154 alone (data not 
shown). Given that I-BmoI exists as a stable monomer in solution and in complex with 
substrate, these data demonstrate that I-BmoI acts as a monomer at all stages of the 
cleavage pathway and rules out transient dimerization through the catalytic domain as a 
potential cleavage mechanism. 
4.3.5 I-BmoI does not function via a substrate hairpin mechanism  
As a monomeric nuclease, I-BmoI could employ a substrate ‘hairpin’ mechanism to 
hydrolyze DNA, where the liberated 3’-OH from the primary nick in DNA acts as the 
nucleophile to attack the scissile phosphate bond of the opposite strand. The intra-strand 
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transesterification mechanism has been demonstrated for the Tn10 transposase, the 
retroviral HIV-1 DNA intergrase, and V(D)J recombinases(45-47). Alternatively, I-BmoI 
could form a covalent protein-DNA intermediate, as is the case with the phospholipase D 
superfamily enzyme BfiI (48). We tested this hypothesis by generating substrates that 
contained pre-nicked bottom strands with either a 3’-OH or 3’-H at the bottom strand 
nick site. If I-BmoI uses an intra-strand transesterification reaction, the second nicking 
reaction of the top strand should be greatly reduced with the 3’-H substrate. Both pre-
nicked substrates were bound and cleaved equivalently to the intact thyA substrate, 
demonstrating that the primary 3’-OH product is not required for resolution of the DSB 
and that I-BmoI does not function via an intra-strand substrate hairpin mechanism (Figure 
4.6).  
4.3.6 The I-BmoI target site is modular 
Since I-BmoI acts as a monomer throughout all steps of the cleavage pathway, a potential 
mechanism for DSB formation involves dynamic conformational changes within the 
enzyme:substrate complex leading to the reorientation of the single I-BmoI active site. 
This model implies that the thyA substrate should also be modular and contributes to the 
DNA distortions observed during cleavage (34). Previous results indicated that the G-2 
base is critical for cleavage and that other bases surrounding the cleavage site can 
modulate cleavage efficiency (31,36). Additionally, nucleotide insertions downstream 
from the intron insertion site between positions A+8/C+9 alter cleavage by I-BmoI (42). 
To delineate functional regions of the thyA substrate and examine the effect of nucleotide 
insertions on the first- and second-strand nicking rates, we generated a series of plasmid 
substrates that contained target sites with 3-nucleotide insertions between A+4/A+5 or 
A+8/C+9, and substrates with 5-nucleotide insertions between A+8/C+9 (Figure 4.7A). 
Substrates containing TTT and CCC insertions between A+4/A+5 attenuated cleavage by 
~5-fold under standard conditions with 10 mM MgCl2, leading to second-strand rate 
constants (k2) of 0.0084 ± 0.0006 s-1 and 0.0051 ± 0.0003 s-1, respectively (Figure 4.7B). 
Also evident from the reaction progress curves is the lack of accumulation of a nicked 
intermediate, consistent with first-strand nicking being rate limiting (k1 < k2). Assays 
performed on the same substrates with 2 mM or 0.5 mM MgCl2 showed low levels of 
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Figure 4.6: I-BmoI does not function via an intra-strand hairpin mechanism 
Image of I-BmoI binding reactions performed with dual labeled thyA substrate (WT), 
bottom-strand pre-nicked substrate between -5/-4 (-4 nick), and bottom strand pre-nicked 
substrate lacking the 3’-OH at the nick site (-4 ddGTP). Reactions were performed with 
10 mM EDTA or 10 mM MgCl2. Schematic and naming of complexes are as previously 
described (34). Reactions were performed in duplicate showing similar results. 
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Figure 4.7: Insertions in the I-BmoI substrate spacer reduce or abolish cleavage  
(A) Schematic of the wild-type thyA I-BmoI substrate and the substrates generated 
containing 3- or 5-nucleotide insertions. Filled and open triangles represent the bottom- 
and top-strand nicking sites, respectively. (B) Progress curves for cleavage reactions on 
thyA, Ins1, and Ins2 substrates in 10 mM MgCl2. Curves are generated from reactions 
performed in triplicate. The x-axis has been manipulated so that reaction progress for all 
substrates can be visualized. 
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cleavage (Supplementary Figure S4.7). Cleavage assays on the four substrates with target 
sites containing 3 or 5 nucleotide insertions between A+8/C+9 showed only minimal 
nicking activity after prolonged incubations under standard reaction conditions with 10 
mM MgCl2 (data not shown). These substrates allowed us to identify the sequence 
upstream of A+5 as tolerant to insertions and the sequence downstream of A+8 as 
intolerant to insertions. One interpretation of this data is that specific bases in the 
A+5/A+8 region may act as anchor points to position the I-BmoI linker or DNA-binding 
domain on substrate.  
To determine if individual bases in the G-6 to A+8 region of thyA substrate were 
important for function in vivo, we adapted an in vitro substrate selection that previously 
identified G-2 to be critical for cleavage by I-BmoI (31). We generated a target site with 
randomized nucleotides between G-6 and A+8, while maintaining G-2 fixed, to create a 
library of target site toxic reporter plasmids (pKoxRCS) to be screened in vivo (Figure 
4.8A). The pKoxRCS library was transformed into cells harboring the I-BmoI expression 
plasmid (pACYCIBmoI) and transformants were replica-gridded in triplicate onto 
selective and non-selective plates (Figure 4.8B), where control toxic plasmids containing 
the thyA intronless target site survived on selective media and plasmids encoding the 
intron-containing target did not. We identified 86 robustly cleaved reporter plasmids and 
sequenced their target site regions, as well as the input library of randomized sites using 
barcoded PCR products on an Ion Torrent platform. A plot of the relative change in 
nucleotide proportions at each position between the survivor sequences and input pool, as 
well as a position-specific scoring matrix (PSSM), identified the wild-type guanine 
nucleotide as highly preferred at position +7 (Figure 4.8C, Supplementary Figure S4.8A). 
Consistent with previous results, positions within the G-6 to T-1 cleavage motif did not 
show strong nucleotide preference (31,36). Positions that displayed slight nucleotide 
preference identified the wild-type nucleotide as preferred at that position. A plot of the 
relative change in nucleotide proportion between the survivor sequences and a pool of 
non-cleavable (‘dead’) clones showed similar results, identifying +7 as the only position 
with a strong preference for any nucleotide (Supplementary Figure S4.8B). 
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Figure 4.8: An in vivo screen identifies I-BmoI nucleotide preference at G+7 
(A) (top) Schematic representation of the randomized cleavage site from -6 to +8 with G-
2 fixed (in bold enlarged font). (bottom) The pKoxRCS library and I-BmoI expression 
plasmids. Filled and open triangles represent the bottom- and top-strand nicking sites, 
respectively. IS, intron-insertion site. (B) Work flow to select for cleavable target sites. 
(C) Sequencing results from cleavable targets represented as the difference in nucleotide 
proportion from the clones in the survivor pool versus the input library. 
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4.3.7 Contacts to G+7 facilitate cleavage by I-BmoI 
To better understand the preference for guanine at position +7, we designed plasmid 
substrates that contained G+7A, G+7C, and G+7T target site substitutions for in vitro and 
in vivo assays. Cleavage assays on the G+7T substrate with 0.5 mM MgCl2 showed a 
~2.5 fold decrease in both k1 and k2 versus the wild-type G+7 substrate (Figure 4.9A, 
Table 4.1). The G+7A substrate displayed kinetics similar to the wild-type target site, 
while G+7C showed a slight first-strand nicking defect (Table 4.1). Metal-dependent 
rescue of cleavage defects on mutant substrates in vitro was observed in reactions with 2 
mM or 10 mM MgCl2, consistent with previous results (36).  
The observed cleavage defects on the G+7 substitution substrates were exaggerated when 
the same target sites were examined by the in vivo two-plasmid survival assay, possibly 
due to low levels of in vivo protein expression versus excess protein to DNA ratios in 
vitro (28,40). Briefly, the cleavage efficiency of I-BmoI on non-cognate substrates can be 
assessed by the degree to which a target site embedded within a toxic reporter plasmid is 
cleaved and survival percentage is reported as the ratio of colonies on selective versus 
non-selective plates (28). We observed ~90% survival by I-BmoI on the wild-type thyA 
target site and decreasing survival on G+7A > G+7C > G+7T substrates (Figure 4.9B). 
The correlation of reduced in vitro cleavage and poor in vivo survival for transversion 
substitutions at G+7 suggests that a purine at position +7 acts as a critical anchor point 
for I-BmoI on thyA substrate.  
To establish a physical basis for the observed defect associated with substitutions at G+7, 
we performed in-gel footprinting with the minor groove specific reagent 1,10-
phenanthroline copper (OP-Cu) on oligonucleotide substrates containing G+7 mutations. 
OP-Cu was selected as a footprinting reagent because minor groove distortions of 
substrate are identified as hypersensitivity to OP-Cu (49), and because it has previously 
been used to identify DNA distortions surrounding the I-BmoI cleavage site that are 
dependent on contacts to G-2 (34,36). Reactions were performed using the catalytically 
inactive R27A variant of I-BmoI, as bottom-strand nicked products would otherwise 
occlude distortions surrounding the bottom-strand nicking site (34). We found no 
difference in the binding affinity of I-BmoI for the three mutant substrates relative to the 
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Figure 4.9: Mutations at G+7 affect I-BmoI activity 
(A) Plot of reaction progress with I-BmoI and G+7 (WT) or G+7T plasmid substrates in 
0.5 mM MgCl2. Curves are plotted as a fit to the mean of three replicates with standard 
deviation shown. (B) In vivo survival of I-BmoI on thyA, G+7A, G+7C, and G+T toxic 
reporter plasmid substrates, with four replicates plotted (C) Denaturing gel image of in-
gel OP-Cu footprinting reactions with R27A I-BmoI on bottom-strand labeled G+7 
(WT), G+7A, G+7C, and G+7T substrates (Unb, unbound substrate; UC, full-length I-
BmoI bound to substrate). Sites that are hypersensitive to the footprinting reagent are 
highlighted with an asterisk, and filled triangles indicate the bottom strand nick site. To 
the right of the gel image is a graph of the normalized pixel density ratio for bands in the 
UC lane vs. the Unb lane. (D) Coomassie stained SDS-gel of trypsin limited proteolysis 
time-course experiments of I-BmoI in the presence of G+7 (WT), G+7A, G+7C, and 
G+7T substrates. (E) Plot of the fraction of full length I-BmoI remaining over time for 
reactions shown in panel (D), calculated as the fraction remaining after normalization to 
the untreated lane (error bars represent the standard deviation of two replicates). 
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Table 4.1: Rate constants for first- and second-strand nicking reactions on G+7 
mutant substrates 
 
substrate k1 (s-1) k2 (s-1) 
G+7 (WT) 0.0441 ± 0.0021 0.0198 ± 0.0015 
G+7A 0.0478 ± 0.0010 0.0303 ± 0.0007 
G+7C 0.0313 ± 0.0014 0.0320 ± 0.0009 
G+7T 0.0172 ± 0.0009 0.0082 ± 0.0005 
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wild-type G+7 substrate. Footprinting reactions revealed drastic reductions in 
hypersensitivity to OP-Cu versus the wild-type substrate at positions surrounding the 
bottom-strand nicking site on the G+7C and G+7T substrates (G-5/G-4/G-3), while 
modest reductions were observed on the G+7A substrate (Figure 4.9C). All three mutant 
substrates did not exhibit sensitivity to OP-Cu on the bottom strand at position T+4 that 
was previously observed for the R27A footprint on wild-type thyA substrate (34). 
Additionally, a dramatic increase in sensitivity to OP-Cu was observed at A+11 on the 
bottom strand on all 3 mutant substrates. A similar increase in OP-Cu sensitivity at A+11 
was previously observed within the lower-complex footprint of I-BmoI (34). The lower-
complex consists of I-BmoI:thyA complexes that are unable to form DNA-contacts via 
the catalytic domain, or proteolyzed I-BmoI fragments that retain DNA-binding activity 
but presumably lack the catalytic domain entirely (23). The footprinting data in Figure 
4.9C suggests that mutations at G+7 reduce I-BmoI catalytic domain and linker contacts 
that are essential for inducing distortions adjacent to the bottom-strand nicking site, with 
hypersensitivity at +11 resulting from the catalytic domain and linker of I-BmoI being 
disengaged from substrate. 
To provide further evidence that I-BmoI catalytic domain contacts are disturbed by G+7 
substitutions, we performed protease-mapping experiments on I-BmoI:G+7A, G+7C, and 
G+7T substrate complexes. Loss of catalytic domain or linker contacts to substrate would 
be observed as an increase in protease sensitivity within the I-BmoI linker, and time 
course reactions with trypsin revealed a reduction in the protection of full-length I-BmoI 
from protease digestion (Figure 4.9D, 4.9E). An increase in abundance of the catalytic 
and DNA-binding domain peptides was observed, indicating greater protease sensitivity 
within the I-BmoI linker in the presence of G+7 mutant substrates versus I-BmoI:thyA 
complexes. An increase in protease sensitivity was also observed for the 130C I-BmoI 
DNA-binding domain construct in complex with the G+7T substrate. Trypsin digests 
revealed a significantly greater rate of proteolytic degradation versus 130C I-BmoI:thyA 
complexes, indicating that I-BmoI contacts to the G+7 base pair are C-terminal to I-BmoI 
residue 130 (Supplementary Figure S4.9). 
146 
 
The results from the physical assays probing G+7 interactions are consistent with a model 
whereby G+7 mutations lead to 1) a reduction in I-BmoI catalytic domain or linker 
contacts to DNA surrounding the cleavage site that are necessary to induce bottom strand 
distortions near the bottom strand nicking site, 2) loss in sensitivity at +4 that is 
indicative of changes in protein-DNA interactions downstream of the cleavage site, and 
3) a disengagement of the catalytic domain from substrate that leads to new DNA 
distortions at +11 as well as increased protease sensitivity within the linker and across the 
DNA binding domain (Figure 4.10). 
4.4 Discussion 
Early efforts with I-TevI to address the mechanistic question of how the single active site 
of GIY-HEs is utilized to make a DSB revealed that the two-domain protein bound DNA 
as a monomer, that the linker connecting the functional domains was flexible, and that the 
N-terminal GIY-YIG nuclease domain possessed a single active site (10,15,30,35). These 
data all pointed towards GIY-HEs functioning as monomers, with significant domain 
rearrangements postulated to reposition the nuclease domain between strand-specific 
nicking reactions to generate a DSB. However, the extreme cytotoxicity of I-TevI 
precluded necessary kinetic studies to determine whether the enzyme functioned as a 
monomer in all stages of the reaction pathway, and prohibited the exclusion of alternative 
cleavage mechanisms. A number of mechanisms have been described for monomeric 
nucleases that make DSBs, and we discuss the relevance of these mechanisms in light of 
our current data supporting a monomeric mode of action by I-BmoI whereby the C-
terminal domain acts as a molecular anchor to tether the N-terminal nuclease domain to 
sequentially nick both DNA strands. 
As structurally bipartite enzymes, GIY-HEs closely resemble the type IIS restriction 
enzymes FokI and MboII that bind DNA through N-terminal domains and cleave at a 
distance via C-terminal single-active site catalytic domains (50,51). FokI can form a DSB 
by a cooperative transient dimerization mechanism where a substrate bound FokI can 
dimerize with additional solution monomers, or synapse with the catalytic domain of 
another FokI molecule bound to a secondary target site (37,38). We did not find evidence 
for I-BmoI functioning via a transient dimerization mechanism, as the rate of cleavage is 
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Figure 4.10: The domains of I-BmoI form distinct DNA-contacts to distort DNA 
prior to cleavage 
 
(A) Schematic of I-BmoI domains and substrate modularity. The protease resistant 
domains of I-BmoI and substrate bases required for efficient cleavage are highlighted. 
Bottom- and top-strand nicking sites are indicated by filled and open triangles, 
respectively. (B) Model of I-BmoI bending DNA to induce substrate distortions near the 
bottom-strand nick site (indicated by yellow and orange filled stars that represent OP-Cu 
hypersensitivity for R27A and WT I-BmoI footprinting reactions, respectively). Rotation 
of the enzyme:substrate complex after bottom-strand nicking to reposition the nuclease 
domain for top-strand nicking is indicated by a dashed arrow around a vertical axis. 
Interactions at G-2 and G+7 may form a hinge necessary to distort DNA. (C) Schematic 
of nucleotide substitutions and insertions that affect I-BmoI catalytic activity. 
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linear with respect to protein concentration, addition of excess catalytic domain cleavage 
does not stimulate product formation, and two-site plasmids are cleaved at the same rate 
as a single site plasmid. Furthermore, the structure of the I-TevI catalytic domain and 
homology model of the I-BmoI catalytic domain did not reveal an obvious dimer 
interface (10,28,36). Interestingly, the type IIS enzyme Eco31I is also a two-domain 
protein with a single HNH active site that cleaves close to its binding site (52,53). Unlike 
FokI, Eco31I does not transiently dimerize to generate a DSB, meaning that the single 
HNH active site sequentially nicks each strand. The reaction pathway of Eco31I proceeds 
with roughly equal rate constants for both nicking reactions and therefore parallels that of 
I-BmoI, where the single GIY-YIG active site sequentially nicks the bottom- and top-
strands with only a ~2-fold difference in rates.   
The two-domain structure of I-BmoI is also similar to I-HmuI, an HNH family homing 
endonuclease that binds an extended target site (54). I-HmuI consists of an N-terminal 
HNH catalytic domain, and a C-terminal DNA-binding domain composed of minor-
groove binding α-helix (NUMOD3) and helix-turn-helix modules that are very similar to 
those found within the I-TevI DNA-binding domain (43,54,55). I-HmuI, however, nicks 
only one strand of its substrate, presumably because DNA-binding elements found on 
either side of the HNH nuclease motif prevent release of the catalytic domain after 
nicking. Our data suggest that the I-BmoI catalytic domain is released from substrate 
between nicking reactions, as the minimal I-BmoI N-terminal domain (N92) possesses 
weak DNA affinity (KD > 23 µM), and limited-protease digestions of full-length I-BmoI 
on intron-containing and G+7 mutant substrates revealed that the catalytic domain was 
disengaged from substrate. Moreover, the homology model of the I-BmoI catalytic 
domain does not possess additional units of protein structure that bind DNA, consistent 
with the evolutionary acquisition of distinct DNA-binding modules by GIY-YIG family 
enzymes due to the inherently weak DNA affinity of the nuclease domain. 
DNA cleavage mechanisms that require conformational changes and rearrangements of 
single active sites have been proposed for the phospholipase D superfamily restriction 
enzyme BfiI and the type IIP restriction enzymes BcnI and MvaI (56-58). BfiI exists as a 
dimer yet forms only a single active site at the dimer interface that rotates and switches 
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orientation between sequential nicking reactions (56). I-BmoI is unlike BfiI as there 
remains no evidence for the formation of an I-BmoI dimer, and the proposed catalytic 
mechanism for BfiI involves a covalent DNA intermediate. Based on active site 
similarity to other GIY-YIG nucleases (10-14,36), it is unlikely that GIY-HEs form 
covalent protein:DNA intermediates, and we have shown that I-BmoI does not function 
via an intra-strand transesterification mechanism. Conversely, a mechanism has been 
demonstrated for BcnI where the enzyme acts as a monomer to nick one strand prior to 
‘hopping’ to the opposite strand where it interacts in the reverse orientation to generate 
the second nick (57). The affinity of the I-BmoI DNA-binding domain for substrate and 
the fact that I-BmoI remains bound to the cleavage product would preclude the full-
length enzyme from hopping to the opposite strand and nicking in an alternate 
orientation. It is possible, however, that the I-BmoI catalytic domain dissociates and 
rearranges between nicking reactions due to its inherently weak DNA affinity and the 
flexible nature of the linker. 
We envision a monomeric cleavage mechanism by I-BmoI where the DNA-binding 
domain acts as a molecular tether to allow the GIY-YIG catalytic domain to diffuse and 
reposition to effect the sequential nicking reactions. Conformational changes in the I-
BmoI:substrate complex that precede bottom-strand nicking are dependent on contacts to 
the G-2 and G+7 base pairs, as mutation of either position abolishes DNA distortions by 
I-BmoI that precede nicking (36).  The function of the G+7 anchor point to position the I-
BmoI catalytic domain and linker is supported by +4/+5 and +8/+9 insertions in thyA 
substrate that drastically reduce k1 or abolish activity, respectively. Insertions at +4/+5 
extend the spacing that intervenes the cleavage site and G+7 anchor to a distance where 
bottom-strand nicking is constrained, while insertions at +8/+9 destroy I-BmoI 
interactions with G+7 leading to undetectable levels of cleavage. I-BmoI contains three 
predicted NUMOD3 minor-groove DNA-binding repeats similar to those that are found 
in I-TevI and I-HmuI, with the most N-terminal NUMOD3 of the I-BmoI DNA-binding 
domain encompasses residues G144-S156 (28). We found a ~100-fold difference in the 
KD values of N130 and N154 I-BmoI for thyA substrate, and protease mapping of 130C I-
BmoI performed on the G+7T mutant substrate led to a higher level of proteolytic 
digestion than was observed on the wild-type thyA substrate. It is therefore possible that 
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the N-terminal I-BmoI NUMOD3 repeat interacts with thyA substrate at G+7 to anchor 
the linker to substrate to facilitate positioning of the nuclease domain.  
Given that I-BmoI generates a DSB by sequentially nicking the bottom- and top-strands, 
the GIY-YIG domain must reposition to the opposite DNA strand after first-strand 
nicking to hydrolyze the phosphodiester bond that lies in the reverse orientation. The 
observation that the two nicking reactions differ by only an ~2-fold rate difference 
suggests that conformational changes during cleavage are not limiting for second-strand 
nicking. Following first-strand hydrolysis, the nicked DNA intermediate could rotate 
around the top-strand backbone, reducing the spatial reorientation required to move the 
top-strand scissile phosphate bond into the active site of the catalytic domain. This model 
is consistent with the fact that I-BmoI can cleave substrates where the bottom- or top-
strands have been resected to leave a single-stranded target on the non-resected strand 
(34). 
Homing endonucleases often target functionally critical regions of conserved genes as a 
strategy to ensure that their target site will be present in naïve genomes (59). For 
instance, the critical G-C base pair at position -2 of the I-BmoI target corresponds to the 
second nucleotide position of a conserved arginine codon that is present in all TS genes 
(31,32). Likewise, the G-C base pair at position +7 that acts as an I-BmoI anchor point 
corresponds to the first nucleotide position of an aspartate codon that is also highly 
conserved. The same G-C base pair and aspartate codon is also present in the I-TevI td 
target site, falling within a hypomutable region of the td DNA substrate (22). 
Additionally, ethylation and methylation interference assays of I-TevI:td complexes 
suggested that I-TevI contacts the G of the G-C base pair and phosphate backbone at this 
position (22). It is therefore possible that mutations at this position would also impact I-
TevI cleavage efficiency; however this nucleotide position has not previously been the 
target of mutagenesis studies.   
In summary, we show that I-BmoI generates a DSB via a mechanism that is distinct from 
other GIY-YIG domain containing enzymes that oligomerize. The I-BmoI GIY-YIG 
domain is fused to a C-terminal DNA-binding domain to overcome the inherently weak 
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affinity of the nuclease domain for DNA.  The linker that connects the I-BmoI N- and C-
terminal domains functions as both an anchor to position the catalytic domain and a 
flexible tether to permit conformational rotation between the sequential nicking reactions. 
It is interesting to note that the I-BmoI and I-TevI linkers share significant amino acid 
similarity, suggesting that the enzymes function via similar cleavage mechanisms. 
Moreover, the fact that both the I-BmoI and I-TevI substrates share the G+7 nucleotide in 
their native substrates becomes an important consideration when targeting chimeric GIY-
YIG nucleases for genome-editing applications.. In particular, investigating whether I-
TevI cleavage efficiency is also influenced by the analogous G+7 position will help 
determine if the proximity of the anchor point to the cleavage site can influence catalytic 
activity of chimeric GIY-YIG nucleases. 
4.5 References 
1.  Yang,W. (2011) Nucleases: Diversity of structure, function and mechanism. Q. 
Rev. Biophys., 44, 1-93. 
2.  Stoddard,B.L. (2005) Homing endonuclease structure and function. Q Rev 
Biophys, 38, 49-95. 
3.  Galburt,E.A. and Stoddard,B.L. (2002) Catalytic mechanisms of restriction and 
homing endonucleases. Biochemistry, 41, 13851-60. 
4.  Taylor,G.K. and Stoddard,B.L. (2012) Structural, functional and evolutionary 
relationships between homing endonucleases and proteins from their host 
organisms. Nucleic Acids Res., 40, 5189-5200. 
5.  Kim,Y.G., Cha,J. and Chandrasegaran,S. (1996) Hybrid restriction enzymes: Zinc 
finger fusions to fok I cleavage domain. Proc. Natl. Acad. Sci. U. S. A., 93, 1156-
1160. 
6.  Ashworth,J., Havranek,J.J., Duarte,C.M., Sussman,D., J.,M.R.,Jr, Stoddard,B.L. 
and Baker,D. (2006) Computational redesign of endonuclease DNA binding and 
cleavage specificity. Nature, 441, 656-9. 
7.  Chan,S.H., Stoddard,B.L. and Xu,S.Y. (2011) Natural and engineered nicking 
endonucleases--from cleavage mechanism to engineering of strand-specificity. 
Nucleic Acids Research, 39, 1-18. 
8.  Fonfara,I., Curth,U., Pingoud,A. and Wende,W. (2012) Creating highly specific 
nucleases by fusion of active restriction endonucleases and catalytically inactive 
homing endonucleases. Nucleic Acids Res., 40, 847-860. 
152 
 
9.  Kleinstiver,B.P., Wolfs,J.M., Kolaczyk,T., Roberts,A.K., Hu,S.X. and 
Edgell,D.R. (2012) Monomeric site-specific nucleases for genome editing. Proc. 
Natl. Acad. Sci. U. S. A., 109, 8061-8066. 
10.  Van Roey,P., Meehan,L., Kowalski,J.C., Belfort,M. and Derbyshire,V. (2002) 
Catalytic domain structure and hypothesis for function of GIY-YIG intron 
endonuclease I-TevI. Nat Struct Biol, 9, 806-11. 
11.  Truglio,J.J., Rhau,B., Croteau,D.L., Wang,L., Skorvaga,M., Karakas,E., 
Dellavecchia,M.J., Wang,H., Van Houten,B. and Kisker,C. (2005) Structural 
insights into the first incision reaction during nucleotide excision repair. EMBO J, 
24, 885-94. 
12.  Andersson,C.E., Lagerback,P. and Carlson,K. (2010) Structure of bacteriophage 
T4 endonuclease II mutant E118A, a tetrameric GIY-YIG enzyme. Journal of 
Molecular Biology, 397, 1003-16. 
13.  Mak,A.N., Lambert,A.R. and Stoddard,B.L. (2010) Folding, DNA recognition, 
and function of GIY-YIG endonucleases: Crystal structures of R.Eco29kI. 
Structure, 18, 1321-31. 
14.  Sokolowska,M., Czapinska,H. and Bochtler,M. (2010) Hpy188I-DNA pre- and 
post-cleavage complexes--snapshots of the GIY-YIG nuclease mediated catalysis. 
Nucleic Acids Research, 39, 1554-64. 
15.  Derbyshire,V., Kowalski,J.C., Dansereau,J.T., Hauer,C.R. and Belfort,M. (1997) 
Two-domain structure of the td intron-encoded endonuclease I-TevI correlates 
with the two-domain configuration of the homing site. J Mol Biol, 265, 494-506. 
16.  Pyatkov,K.I., Arkhipova,I.R., Malkova,N.V., Finnegan,D.J. and Evgen'ev,M.B. 
(2004) Reverse transcriptase and endonuclease activities encoded by penelope-
like retroelements. Proc Natl Acad Sci U S A, 101, 14719-24. 
17.  Dunin-Horkawicz,S., Feder,M. and Bujnicki,J.M. (2006) Phylogenomic analysis 
of the GIY-YIG nuclease superfamily. BMC Genomics, 7:98. 
18.  Lagerback,P., Andersson,E., Malmberg,C. and Carlson,K. (2009) Bacteriophage 
T4 endonuclease II, a promiscuous GIY-YIG nuclease, binds as a tetramer to two 
DNA substrates. Nucleic Acids Research, 37, 6174-83. 
19.  Ibryashkina,E.M., Sasnauskas,G., Solonin,A.S., Zakharova,M.V. and Siksnys,V. 
(2009) Oligomeric structure diversity within the GIY-YIG nuclease family. 
Journal of Molecular Biology, 387, 10-16. 
20.  Brachner,A., Braun,J., Ghodgaonkar,M., Castor,D., Zlopasa,L., Ehrlich,V., 
Jiricny,J., Gotzmann,J., Knasmueller,S. and Foisner,R. (2012) The endonuclease 
Ankle1 requires its LEM and GIY-YIG motifs for DNA cleavage in vivo. J. Cell. 
Sci., 125, 1048-57. 
153 
 
21.  Kaminska,K.H., Kawai,M., Boniecki,M., Kobayashi,I. and Bujnicki,J.M. (2008) 
Type II restriction endonuclease R.Hpy188I belongs to the GIY-YIG nuclease 
superfamily, but exhibits an unusual active site. BMC Structural Biology, 8:48. 
22.  Bryk,M., Quirk,S.M., Mueller,J.E., Loizos,N., Lawrence,C. and Belfort,M. (1993) 
The td intron endonuclease I-TevI makes extensive sequence-tolerant contacts 
across the minor groove of its DNA target. EMBO J, 12, 2141-9. 
23.  Edgell,D.R. and Shub,D.A. (2001) Related homing endonucleases I-BmoI and I-
TevI use different strategies to cleave homologous recognition sites. Proc Natl 
Acad Sci U S A, 98, 7898-903. 
24.  Quirk,S.M., Bell-Pedersen,D. and Belfort,M. (1989) Intron mobility in the T-even 
phages: High frequency inheritance of group I introns promoted by intron open 
reading frames. Cell, 56, 455-65. 
25.  Edgell,D.R. (2009) Selfish DNA: Homing endonucleases find a home. Current 
Biology, 19, 115-17. 
26.  Sandegren,L. and Sjoberg,B.M. (2004) Distribution, sequence homology, and 
homing of group I introns among T-even-like bacteriophages - evidence for recent 
transfer of old introns. J. Biol. Chem., 279, 22218-27. 
27.  Nord,D. and Sjöberg,B.-. (2008) Unconventional GIY-YIG homing endonuclease 
encoded in group I introns in closely related strains of the bacillus cereus group. 
Nucleic Acids Res, 36, 300-10. 
28.  Kleinstiver,B.P., Fernandes,A.D., Gloor,G.B. and Edgell,D.R. (2010) A unified 
genetic, computational and experimental framework identifies functionally 
relevant residues of the homing endonuclease I-BmoI. Nucleic Acids Research, 
38, 2411-27. 
29.  Liu,Q., Dansereau,J.T., Puttamadappa,S.S., Shekhtman,A., Derbyshire,V. and 
Belfort,M. (2008) Role of the interdomain linker in distance determination for 
remote cleavage by homing endonuclease I-TevI. J Mol Biol, 379, 1094-106. 
30.  Dean,A.B., Stanger,M.J., Dansereau,J.T., Van Roey,P., Derbyshire,V. and 
Belfort,M. (2002) Zinc finger as distance determinant in the flexible linker of 
intron endonuclease I-TevI. Proc Natl Acad Sci U S A, 99, 8554-61. 
31.  Edgell,D.R., Stanger,M.J. and Belfort,M. (2003) Importance of a single base pair 
for discrimination between intron-containing and intronless alleles by 
endonuclease I-BmoI. Curr Biol, 13, 973-8. 
32.  Edgell,D.R., Stanger,M.J. and Belfort,M. (2004) Coincidence of cleavage sites of 
intron endonuclease I-TevI and critical sequences of the host thymidylate synthase 
gene. J Mol Biol, 343, 1231-1241. 
154 
 
33.  Bell-Pedersen,D., Quirk,S.M., Bryk,M. and Belfort,M. (1991) I-TevI, the 
endonuclease encoded by the mobiletdintron, recognizes binding and cleavage 
domains on its DNA target. Proc Natl Acad Sci U S A, 88, 7719-23. 
34.  Carter,J.M., Friedrich,N.C., Kleinstiver,B. and Edgell,D.R. (2007) Strand-specific 
contacts and divalent metal ion regulate double-strand break formation by the 
GIY-YIG homing endonuclease I-BmoI. J Mol Biol, 374, 306-21. 
35.  Mueller,J.E., Smith,D., Bryk,M. and Belfort,M. (1995) Intron-encoded 
endonuclease I-TevI binds as a monomer to effect sequential cleavage via 
conformational changes in thetdhoming site. EMBO J, 14, 5724-35. 
36.  Kleinstiver,B.P., Berube-Janzen,W., Fernandes,A.D. and Edgell,D.R. (2011) 
Divalent metal ion differentially regulates the sequential nicking reactions of the 
GIY-YIG homing endonuclease I-BmoI. Plos One, 6, e23804. 
37.  Bitinaite,J., Wah,D.A., Aggarwal,A.K. and Schildkraut,I. (1998) FokI 
dimerization is required for DNA cleavage. Proc Natl Acad Sci U S A, 95, 10570-
5. 
38.  Vanamee,E.S., Santagata,S. and Aggarwal,A.K. (2001) FokI requires two specific 
DNA sites for cleavage. J. Mol. Biol., 309, 69-78. 
39.  Sasnauskas,G., Connolly,B.A., Halford,S.E. and Siksnys,V. (2007) Site-specific 
DNA transesterification catalyzed by a restriction enzyme. Proc Natl Acad Sci U 
S A, 104, 2115-20. 
40.  Chen,Z. and Zhao,H. (2005) A highly sensitive selection method for directed 
evolution of homing endonucleases. Nucleic Acids Res, 33, e154. 
41.  Spink,C.H. (2008) Differential scanning calorimetry. Biophysical Tools for 
Biologists: Vol 1 in Vitro Techniques, 84, 115-41. 
42.  Liu,Q., Derbyshire,V., Belfort,M. and Edgell,D.R. (2006) Distance determination 
by GIY-YIG intron endonucleases: Discrimination between repression and 
cleavage functions. Nucleic Acids Res, 34, 1755-64. 
43.  Sitbon,E. and Pietrokovski,S. (2003) New types of conserved sequence domains 
in DNA-binding regions of homing endonucleases. Trends Biochem Sci, 28, 473-
7. 
44.  Johnson,C.M. (2012) Differential scanning calorimetry as a tool for protein 
folding and stability. Arch. Biochem. Biophys., doi: 10.1016/j.abb.2012.09.008. 
[Epub ahead of print] 
45.  Kennedy,A.K., Guhathakurta,A., Kleckner,N. and Haniford,D.B. (1998) Tn10 
transposition via a DNA hairpin intermediate. Cell, 95, 125-34. 
155 
 
46.  Engelman,A., Mizuuchi,K. and Craigie,R. (1991) Hiv-1 dna integration - 
mechanism of viral-dna cleavage and dna strand transfer. Cell, 67, 1211-21. 
47.  Mcblane,J.F., Vangent,D.C., Ramsden,D.A., Romeo,C., Cuomo,C.A., Gellert,M. 
and Oettinger,M.A. (1995) Cleavage at a V(d)j recombination signal requires only 
Rag1 and Rag2 proteins and occurs in 2 steps. Cell, 83, 387-95. 
48.  Sasnauskas,G., Halford,S.E. and Siksnys,V. (2003) How the BfiI restriction 
enzyme uses one active site to cut two DNA strands. Proc Natl Acad Sci U S A, 
100, 6410-5. 
49.  Spassky,A. and Sigman,D.S. (1985) Nuclease activity of 1,10-phenanthroline-
copper ion. conformational analysis and footprinting of the lac operon. 
Biochemistry, 24, 8050-6. 
50.  Li,L., Wu,L.P. and Chandrasegaran,S. (1992) Functional domains in fok I 
restriction endonuclease. Proc. Natl. Acad. Sci. U. S. A., 89, 4275-4279. 
51.  Soundararajan,M., Chang,Z.Y., Morgan,R.D., Heslop,P. and Connolly,B.A. 
(2002) DNA binding and recognition by the IIs restriction endonuclease MboII. J. 
Biol. Chem., 277, 887-95. 
52.  Jakubauskas,A., Giedriene,J., Bujnicki,J.M. and Janulaitis,A. (2007) Identification 
of a single HNH active site in type IIS restriction endonuclease Eco31I. J. Mol. 
Biol., 370, 157-69. 
53.  Jakubauskas,A., Sasnauskas,G., Giedriene,J. and Janulaitis,A. (2008) Domain 
organization and functional analysis of type IIS restriction endonuclease Eco31I. 
Biochemistry (N. Y. ), 47, 8546-56. 
54.  Shen,B.W., Landthaler,M., Shub,D.A. and Stoddard,B.L. (2004) DNA binding 
and cleavage by the HNH homing endonuclease I-HmuI. J Mol Biol, 342, 43-56. 
55.  Van Roey,P., Waddling,C.A., Fox,K.M., Belfort,M. and Derbyshire,V. (2001) 
Intertwined structure of the DNA-binding domain of intron endonuclease I-TevI 
with its substrate. EMBO J, 20, 3631-7. 
56.  Sasnauskas,G., Zakrys,L., Zaremba,M., Cosstick,R., Gaynor,J.W., Halford,S.E. 
and Siksnys,V. (2010) A novel mechanism for the scission of double-stranded 
DNA: BfiI cuts both 3'-5' and 5'-3' strands by rotating a single active site. Nucleic 
Acids Res., 38, 2399-410. 
57.  Sasnauskas,G., Kostiuk,G., Tamulaitis,G. and Siksnys,V. (2011) Target site 
cleavage by the monomeric restriction enzyme BcnI requires translocation to a 
random DNA sequence and a switch in enzyme orientation. Nucleic Acids Res., 
39, 8844-56. 
156 
 
58.  Kaus-Drobek,M., Czapinska,H., Sokolowska,M., Tamulaitis,G., 
Szczepanowski,R.H., Urbanke,C., Siksnys,V. and Bochtler,M. (2007) Restriction 
endonuclease MvaI is a monomer that recognizes its target sequence 
asymmetrically. Nucleic Acids Res, 35, 2035-46. 
59.  Edgell,D.R., Belfort,M. and Shub,D.A. (2000) Barriers to intron promiscuity in 
bacteria. J Bacteriol, 182, 5281-9. 
60.  Crona,M., Moffatt,C., Friedrich,N.C., Hofer,A., Sjoberg,B. and Edgell,D.R. 
(2011) Assembly of a fragmented ribonucleotide reductase by protein interaction 
domains derived from a mobile genetic element. Nucleic Acids Res., 39, 1381-89. 
 
 
 
 
157 
 
Chapter 5  
5 Monomeric site-specific nucleases for genome editing 
The work presented in this chapter is reproduced (with permission, Appendix S1) from: 
Kleinstiver, B.P., Wolfs, J.M., Kolaczyk, T., Roberts, A.K., Hu, S.X., Edgell, D.R. 
(2012) Monomeric site-specific nucleases for genome editing. Proceedings of the 
National Academy of Sciences USA 109(21):8061-6 
The reproduced text has been modified from the published version by the addition of 
sections 5.3.5 and 5.3.6 to include data that was not available at the time of publication. 
Other sections have also been modified accordingly.  
5.1 Introduction 
Precise genome editing often requires the introduction of a double-strand break (DSB) at 
defined positions (1-3), and two distinct site-specific DNA endonuclease architectures 
have been developed towards this goal. One of these architectures relies on 
reprogramming the DNA-binding specificity of naturally occurring LAGLIDADG 
homing endonucleases (LHEs) to target desired sequences (4,5). The other architecture 
utilizes the reprogrammable DNA-binding specificity of zinc-finger proteins or TAL-
effector domains that are fused to the non-specific nuclease domain of the type IIS 
restriction enzyme FokI to create chimeric zinc-finger nucleases (ZFNs) or TAL effector 
nucleases (TALENs) (6-8). Regardless of the architecture, the underlying biology of the 
component proteins imposes design challenges and the relative merits of the LHE and the 
ZFN/TALEN architectures are the subject of much debate in the literature (6,9). One 
notable constraint imposed by the FokI nuclease domain is the requirement to function as 
a dimer to efficiently cleave DNA (10,11). For any given DNA target, this necessitates 
the design of two distinct ZFNs (or two TALENs), such that each pair of zinc finger or 
TAL effector domains is oriented for FokI dimerization and DNA cleavage (12).  
Expanding the repertoire of DNA nuclease domains with distinctive properties is 
necessary to facilitate the development of new genome editing reagents. Indeed, a 
number of recent studies have explored the potential of the PvuII restriction enzyme as an 
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alternative site-specific nuclease domain for genome editing applications (13,14). The 
PvuII chimeras, however, share similar design constraints as ZFNs and TALENs, 
requiring two nuclease fusions for precise targeting. In considering alternative nuclease 
domains for genome editing, we were intrigued by the properties of the GIY-YIG 
nuclease domain that is associated with a variety of proteins of diverse cellular functions 
(15). The small (~100 aa) globular GIY-YIG domain is characterized by a structurally 
conserved central three-stranded antiparallel β sheet, with catalytic residues positioned to 
utilize a single metal ion to promote DNA hydrolysis (16-18). Intriguingly, the GIY-YIG 
homing endonucleases, typified by the isoschizomers I-TevI and I-BmoI (19), bind DNA 
as monomers (20), and generate a DSB with 2-nt, 3’ overhangs. It is unknown, however, 
if GIY-YIG homing endonucleases function as monomers in all steps of the reaction, as 
the oligomeric status during cleavage has yet to be studied. Notably, GIY-YIG homing 
endonucleases prefer a specific DNA sequence to generate a DSB (21,22). For I-TevI, the 
bottom (↑) and top (↓) strand nicking sites lie within a 5‘-CN↑NN↓G-3’ motif (CNNNG), 
with the critical G optimally positioned ~28 bp from where the helix-turn-helix (H-T-H) 
module of the I-TevI DNA-binding domain interacts with substrate (21,22). From an 
engineering perspective, the modularity and sequence specificity of the GIY-YIG 
nuclease domain is appealing to create new chimeric endonucleases. Indeed, swapping of 
the I-BmoI and I-TevI catalytic and DNA-binding domains suggested that the GIY-YIG 
nuclease domain could be fused to unrelated DNA-targeting platforms (23). 
To highlight the genome engineering potential of the GIY-YIG nuclease domain, we 
fused the domain to 3-member zinc fingers to construct GIY-YIG zinc finger 
endonucleases (GIY-ZFEs). The GIY-ZFEs are active in bacterial and yeast cells, and in 
vitro data show that they function catalytically as monomers and retain the cleavage 
specificity associated with the parental GIY-YIG nuclease domain. The GIY-YIG 
nuclease domain is also portable to the LHE platform, as we constructed monomeric 
GIY-LHEs that are active in vivo and possess ~18-bp binding specificity. We selected 
LHEs as a DNA targeting domain because of the greater sequence specificity compared 
to 3-member zinc fingers, the ability to reprogram LHE DNA-binding specificity (24-26), 
and recent success in generating PuvII-LHE fusions (13). Finally, we demonstrate the 
flexibility and applicability of the I-TevI nuclease domain by fusing it the TAL platform 
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(2), revealing that GIY-TALs are functional in yeast and can cleave substrates that 
contain nucleotide mutations near the cleavage site. Collectively, our data highlight the 
unique biochemical properties of the GIY-YIG nuclease domain as an alternative to the 
FokI nuclease domain for genome editing applications. 
5.2 Materials and methods 
See detailed S5 Supplementary materials and methods. Briefly, Tev-ZFE, Tev-LHE, and 
Tev-TAL fusions and hybrid target sites were modeled in PyMOL using the I-TevI 130C 
(PDB 1I3J), Zif268 (PDB 1AAY), I-OnuI (PDB 3QQY), and PthXo1 (PDB 3UGM) co-
crystal structures (25,27,28,38). The in vivo activity of fusions was determined using a 
two-plasmid bacterial selection (31) or yeast-based reporter assay (that was used to 
calibrate activity of Tev-ZFEs and Tev-TALs) against a characterized ZFN (35). 
TevN201-ryA was purified using nickel affinity chromatography to determine the in vitro 
biochemical properties of Tev-ZFEs. Cleavage assays were performed as described (43). 
A custom Perl script was created to determine CNNNG occurrences relative to 8,829 
predicted ZFN sites on zebrafish chromosome 1 (40). 
5.3 Results 
5.3.1 Construction and validation of GIY-zinc finger endonucleases 
To create novel chimeric enzymes, we modeled GIY-zinc finger endonucleases (GIY-
ZFEs) using existing crystal structures of the I-TevI 130C DNA binding domain and the 
Zif268 zinc finger (27,28). One notable feature of our constructs is the polarity, as the I-
TevI nuclease domain is fused to the N-terminal end of the 3-finger ryA zinc-finger 
protein to mimic it’s native orientation, unlike FokI constructs that are fused to the C-
terminal end of zinc-finger proteins. We modeled the Zif268 zinc finger in place of the 
H-T-H module at the C-terminus of I-TevI, providing the rationale to subsequently fuse 
various lengths of the I-TevI N-terminal region to the ryA zinc finger that targets a 
sequence in the Drosophila rosy gene to create Tev-ryA zinc finger endonucleases (Tev-
ZFEs, Figure 5.1A) (29). The Tev-zinc finger DNA substrates (TZ) consisted of 30 to 38 
bps of the I-TevI td homing site joined to the 9-bp ryA target site. The TZ substrates 
differ in the distance of the CNNNG cleavage motif relative to the ryA-binding site  
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Figure 5.1: Design and functionality of Tev-ZFEs 
(A) Modeling of a Tev-zinc finger fusion with DNA substrate (light green) using 
structures of the I-TevI catalytic domain in green (PDB 1MK0), the I-TevI DNA-binding 
domain co-crystal in blue (PDB 1I3J), and the Zif268 co-crystal in red (PDB 1AAY) (B) 
The TZ-ryA substrate is colored according to the structural model. Shown is the top 
strand of the I-TevI td homing site substrate fused to the 5’ end of the ryA-binding site 
for all wild-type substrates tested. The substrate is numbered from the first base of the td 
homing site sequence (the numbering scheme is reverse of that used for the native td 
homing site). The substrates tested differ by insertion or deletion of td sequence at the 
junction of the td/ryA sites. (C) Percent survival of three representative Tev-ryA ZFEs in 
the bacterial two-plasmid selection. All Tev-ryA ZFEs were tested against plasmids 
containing various length substrates (TZ1.30-1.38), plasmids lacking a target site 
(p11lacY), and TZ1.33 plasmids with single or double mutations in the CNNNG motif 
(G5A and C1A/G5A) (Supplementary Table S5.1). (D) Percent survival of TevN201-ryA 
and TevN201-ryB ZFEs on their cognate and reciprocal target sites. Data are plotted with 
standard deviation for n ≥ 3.  
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(Figure 5.1B). Each TZ substrate possesses a single zinc finger targeting sequence, rather 
than two head-to-head zinc finger sites necessary for efficient ZFN cleavage. A similar 
set of I-BmoI-ryA fusions (Bmo-ZFEs) and substrates (BZ) were constructed 
(Supplementary Figure S5.1). We tested the activity of the GIY-ZFEs using a well-
described two-plasmid bacterial selection system, where survival is dependent on the 
endonuclease cleaving a target plasmid (30,31). Eight Tev-ZFEs were tested on seven TZ 
substrates cloned into the reporter plasmid (Figure 5.1B and C, Supplementary Table 
S5.1). In general, the survival of all Tev-ZFEs was highest against TZ substrates where 
the preferred CNNNG motif was positioned between 33 and 35-bp from the ryA binding 
site. Low survival (~4-6%) was observed for all Tev-ZFEs against the TZ1.32 substrate, 
while none survived on the TZ1.30 substrate. Likewise, there was no survival against the 
longer substrates, with the exception that the longest fusion (TevS206-ryA) exhibited 
~22% survival against the TZ1.36 substrate. No survival was observed when the Tev-
ZFEs were tested against the target plasmid without a target site (p11lacYwtx1). 
Mutation of the catalytic arginine 27 of the I-TevI nuclease domain to alanine to create 
TevR27A-ryAs showed that survival is dependent on GIY-YIG nuclease activity as none 
of the Tev-R27A constructs survived (Supplementary Table S5.1).  
We also constructed and tested a fusion of the TevN201 domain to a different 3-member 
zinc finger, the ryB zinc finger, creating TevN201-ryB. The TevN201-ryB showed 
survival in the bacterial selection assay against a corresponding TZ-ryB target, indicating 
that the I-TevI nuclease domain can function in the context of two different 3-member 
zinc fingers, but did not survive when tested against the TZ-ryA substrate (Figure 5.1D). 
Likewise, the TevN201-ryA fusion did not survive against the TZ-ryB substrate, 
indicating that the zinc finger alone directs DNA-binding. We also tested the Bmo-ZFEs 
in the genetic selection, but did not observe significant survival for any of the fusions, 
consistent with the ~750-fold reduced activity of wild-type I-BmoI relative to I-TevI 
(32). However, as described below, enzymatic activity was detected in vitro using 
purified Bmo-ZFEs. Collectively, these data show that two different GIY-YIG nuclease 
domains could be fused to zinc finger DNA binding domains to create active site-specific 
chimeric nucleases.  
162 
 
5.3.2 Tev-ZFEs function as monomers to cleave at a specific 
sequence 
To study the GIY-ZFE biochemical characteristics in more detail, we purified TevN201-
ryA for cleavage assays and in vitro mapping. We first performed cleavage assays to 
determine the relationship between TevN201-ryA enzyme concentration and initial 
reaction velocity using a plasmid substrate with a single TZ-ryA target site. The reaction 
progress curves indicated an initial burst of cleavage followed by a slower rate of product 
accumulation (Figure 5.2A), consistent with product release being the rate-limiting step.  
The initial burst phase was used to estimate initial velocity, and plotting against protein 
concentration yielded a linear relationship (Figure 5.2A), suggesting that DNA hydrolysis 
catalyzed by TevN201-ryA is first order with respect to protein concentration.  
The model TZ-ryA substrates were designed as a single ryA zinc finger site fused to the 
I-TevI target sequence. To determine if cleavage by TevN201-ryA was influenced by 
additional Tev-ryA target sites, we constructed two-site plasmids that differed in whether 
the target sites were in the same or opposite orientations relative to each other. The 
single- or two-site plasmids were used in time-course cleavage assays under single-
turnover conditions (~10-fold molar excess of protein to substrate) to determine reaction 
rates. As shown in Figure 5.2B, cleavage of the one-site plasmid yielded kobs(1-site) = 0.099 
± 0.001 s-1, and cleavage of the two-site plasmids with target sites in the opposite or same 
(Supplementary Figure S5.2B) orientations generated very similar rate constants, kobs(2-site) 
= 0.088 ± 0.001 s-1 and 0.089 ± 0.001 s-1, respectively, to the one-site plasmid. In 
contrast, similar experiments with FokI showed a significant rate enhancement for two-
site plasmids relative to one-site plasmids, consistent with FokI functioning as a dimer 
(33). We conclude that cleavage by TevN201-ryA is non-cooperative and that efficient 
DNA hydrolysis does not require two sites, consistent with TevN201-ryA functioning 
catalytically as a monomer. 
The I-TevI nuclease domain preferentially cleaves DNA within a 5’-CN↑NN↓G-3’ motif, 
with ↑ and ↓ representing the bottom- and top-strand nicking sites, respectively (22). I-
TevI defaults to cleave at the wild-type distance on substrates in vitro when this motif is 
moved closer to, or distant from, the primary binding site, whereas mutants in the I-TevI  
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Figure 5.2: TevN201-ZFE is a monomer with a preferred cleavage site 
(A) Left panel: plot of initial reaction progress for seven TevN201-ZFE concentrations 
expressed as percent linear product. Protein concentrations from highest to lowest are 47 
nM, 32.5 nM, 23 nM, 11nM, 6nM, 3 nM, and 0.7 nM. Right panel: graph of initial 
reaction velocity (nM s-1) versus TevN201-ZFE concentration (nM). (B) Graphical 
representation of cleavage assays with 90 nM TevN201-ZFE and 10 nM one- or two-site 
TZ1.33 plasmids (left and right panels, respectively). The two-site plasmid had the TZ-
ryA sites in the opposite (shown) or same (Fig. S2B) orientation. SC, supercoiled; OC, 
open-circle (nicked); FLL, full-length linear; L1+L2, linear products. (C) Mapping of 
TevN201-ZFE cleavage sites on the TZ1.33 substrate, with top and bottom cleavage sites 
indicated below on the TZ-ryA substrate by open and closed triangles, respectively. (D) 
Activity of TevN201-ZFE on the wild-type TZ1.33, or the TZ1.33 G5A and TZ1.33 
C1A/G5A mutant substrates. A graph of EC0.5max determinations for each substrate is 
shown to the right, with EC0.5max values in nM. Data are plotted as averages of three 
independent replicates with standard deviations   
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specific zinc finger cleave at the correct sequence rather than the wild-type distance on 
mutant substrates (34). To determine the cleavage preference of the TevN201-ryA 
construct, we mapped the bottom- and top-strand nicking sites using strand-specific end-
labeled substrates to the CNNNG motif (Figure 5.2C). Combined with data from the 
genetic assays showing no survival on substrates that displace the CNNNG motif from an 
optimal position, our data suggests that in the context of an ryA fusion, the 
TevN201domain acts as a molecular ruler with a distance preference.  
To further demonstrate TevN201-ryA cleavage preference, we introduced mutations in 
the CNNNG motif that were previously shown to drastically reduce I-TevI cleavage 
efficiency (Figure 5.2D) (21,22). Significantly, we observed no survival under selective 
conditions in the two-plasmid assay on plasmids carrying either the single G5A 
(CNNNA) or double C1A/G5A (ANNNA) substitutions (Figure 5.1C), equivalent to 
positions C-27 and G-23 of the I-TevI td substrate, respectively. We also performed in 
vitro cleavage assays on wild type and mutant substrates with increasing concentrations 
of TevN201-ZFE to determine the amount of protein required for half-maximal cleavage 
(EC0.5max). As shown in Figure 5.2D, ~60 fold and ~4.7 fold more protein were required 
to achieve half-maximal cleavage of the double- and single-mutant substrates relative to 
the wild-type substrate. The greater substrate discrimination observed in the genetic assay 
likely reflects lower in vivo protein concentrations than those used for in vitro cleavage 
assays. These results show that the TevN201-ryA fusion retains the cleavage specificity 
of the parental I-TevI enzyme and that double nucleotide substitutions significantly 
reduce cleavage efficiency. To determine if Bmo-ZFEs also retained substrate specificity, 
the bottom- and top-strand nicking sites of the BmoN221-ryA fusion were mapped to a 
5’-NN↑NN↓G-3’ motif, consistent with the cleavage site preference of I-BmoI 
(Supplementary Figure S5.1D) (19).  
5.3.3 Tev-ZFEs function in a yeast-based recombination assay 
To extend the in vivo relevance of the Tev-ZFE fusions, we utilized a well-described 
yeast-based recombination assay to test Tev-ZFE function in a eukaryotic system (35). 
This assay provides a quantitative β-galactosidase readout if the nuclease cleaves its 
target site that is positioned between a partially duplicated lacZ gene. Furthermore, the  
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Figure 5.3: Tev-ZFEs can induce recombination in an eukaryotic system 
Shown are normalized β-galactosidase units from a yeast-based recombination assay for 
the indicated nuclease/substrate combinations. Activity was normalized to a homodimeric 
FokI-Zif268 ZFN positive control. Data are plotted with standard deviation for n = 4.  
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assay allowed us to calibrate TevN201-ryA activity relative to a homodimeric FokI-
Zif268 control with previously measured in vivo activity sufficient to induce 
recombination events for genome engineering applications (35). As shown in Figure 5.3, 
the level of β-galactosidase activity for the TevN201-ryA fusion on its cognate TZ-ryA 
substrate was ~1.4-fold higher than the Zif268 ZFN control. The TevN201-ryA or Zif268 
ZFN constructs displayed no activity on each other’s substrates, and activity was 
dependent on a functional I-TevI nuclease domain, as the TevN201R27A catalytic mutant 
was unable to induce recombination. Furthermore, TevN201-ryA activity was not 
observed on mutant substrates where one or both of the critical residues of the CNNNG 
motif were mutated in the TZ1.33 substrate. Collectively, these assays show that the I-
TevI nuclease domain functions in a eukaryotic system with activity on par to a 
characterized ZFN.  
5.3.4 The I-TevI nuclease domain is portable to the LAGLIDADG 
architecture 
To demonstrate that the I-TevI nuclease domain functions in the context of DNA-
targeting platforms with greater specificity than 3-member zinc fingers, we constructed 
fusions of the domain to a catalytically inactive monomeric single-chain LAGLIDADG 
homing endonuclease (Tev-LHE). As with the Tev-ZFE constructs, we modeled a Tev-
LHE chimera using the co-crystal of I-OnuI with its DNA substrate such that the I-TevI 
nuclease and linker domains were fused to the N-terminus of I-OnuI, which is partially 
disordered in the structure (Figure 5.4A) (25). Based on this model, we fused TevN201G4 
and TevK203 fragments to a catalytically dead I-OnuI E1 E22Q mutant. A series of 
model DNA substrates were constructed by fusing the td target site to the I-OnuI E1 
binding site in the human MAO-B gene, differing in the position of the CNNNG cleavage 
motif relative to the I-OnuI E1 site (TO1.12 to TO1.30) (Figure 5.4B).  
In the bacterial two-plasmid selection, we found that the TevN201G4-Onu and TevK203-
Onu fusions were active against a range of DNA substrates. Notably, the fusions 
displayed maximal survival on longer targets (TO1.26, TO1.28, and TO1.30), and lower 
survival against shorter targets (TO1.18 and TO1.20 targets). The two groups of substrate 
differ by approximately one helical turn of DNA, meaning that the preferred CNNNG  
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Figure 5.4: Design and functionality of Tev-LHEs 
(A) Modeling of a Tev-Onu E1 fusion with DNA substrate (light green) using structures 
of the I-TevI catalytic domain in green (PDB 1MK0), the I-TevI DNA-binding domain 
co-crystal in blue (PDB 1I3J), and the I-OnuI co-crystal in red (PDB 3QQY). Shown are 
fusion points at which the I-TevI fragment has been shortened. (B) The Tev-Onu E1 (TO) 
substrate is colored according to the structural model. Shown is the top strand of the I-
TevI td homing site substrate fused to the 5’ end of the Onu E1-binding site. The 
substrates are numbered from the first base of the td homing site sequence and differ by 
the deletion of td nucleotides at the junction of the td/Onu E1 sites. (C) Percent survival 
of Tev-LHEs in the bacterial two-plasmid selection with various length target sites 
(TO1.12-1.30). All Tev-LHEs tested were in the I-OnuI E1 E22Q background. (D) 
Percent survival of TevR27A(N201G4)-OnuE1 and TevR27A(N201G4)-OnuE1(E22Q) 
on TO1.30, TO1.30G5A, and TZ1.33. Data are plotted with standard deviation for n = 3. 
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motif would be presented on the same face of the substrate even though the motif is 
closer to the I-OnuI E1 binding site on the shorter targets. Similar periodic cleavage 
patterns have been observed in vitro with I-TevI on substrates with a displaced CNNNG 
motif (36). This result also implies that the N-terminus of I-OnuI possesses inherent 
flexibility to allow the I-TevI nuclease domain to search out the CNNNG motif, in 
contrast to the ruler-like behaviour of the Tev-ZFE constructs, likely because the zinc 
finger N-terminus is inflexible. Importantly, the Tev-Onu fusions were not active against 
the TZ-ryA zinc finger substrates (Supplementary Table S5.2), showing that the LHE, 
and not the I-TevI linker, directs DNA targeting. Survival was also dependent on an 
active I-TevI nuclease domain, as TevR27A fusions in the context of the I-OnuI E22Q 
mutant did not survive (Figure 5.4D). Conversely, the targeting and activity of wild-type 
I-OnuI E1 was not affected by fusion of the I-TevI domain, as the TevR27A-OnuWT 
fusions survived against TO substrates (Figure 5.4D).  
The apparent flexibility of the N-terminus and the greater specificity of I-OnuI prompted 
us to test fusions containing shorter fragments of the I-TevI nuclease domain (Figure 
5.4A). Based on structural and genetic data, we constructed TevS114-Onu, TevD127-
Onu, TevN140-Onu, TevN169-Onu, and TevD184G2-Onu fusions, progressively 
removing amino acid residues of I-TevI that make specific base-pair contacts to the td 
substrate (Figure 5.4A) (28). Notably, the TevS114, TevD127, TevN140 and TevN169 
removed the α-helix that binds in the minor groove, as well as residues shown by 
structural data to make base-specific contacts (28). The TevS114 fusion point lies at the 
boundary of the deletion tolerant region of the I-TevI linker, and represents a functionally 
minimal GIY-YIG nuclease domain (36,37). We found that the shorter fusions were not 
active against the longer TO1.28 and TO1.30 substrates, yet displayed the same periodic 
activity on the shorter substrates (Figure 5.4C and Supplementary Table S5.2). A single 
exception was the TevD184G2 fusion that showed low survival against the TO1.22 
substrates, against which no other fusion survived. No survival was observed on mutant 
substrates that contained single (CNNNA) or double (ANNNA) mutations in the 
CNNNG motif, recapitulating the necessity for an appropriately positioned CNNNG as 
seen with the Tev-ZFE fusions. 
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5.3.5 I-TevI fusions to the TAL effector PthXo1 are functional 
To expand the binding capacity of chimeric I-TevI nucleases beyond that of engineered 
ZFEs and LHEs, the logical next step was to model fusions of the I-TevI nuclease domain 
with the recently solved crystal structure of the modular PthXo1 TAL effector DNA-
binding platform (Figure 5.5A) (38). The repetitive structure of TAL effectors can be 
exploited to assemble highly specific DNA-binding modules whose nucleotide specificity 
is dictated at a 1:1 ratio via the RVDs (repeat variable diresidues) within the repeated unit 
(2,7,35). To capitalize on the customizable specificity of TALs, multiple truncation 
points within the I-TevI linker and the N- and C-terminal ends of the PthXo1 backbone 
were explored to generate a set of I-TevI-PthXo1 fusions (Tev-TALs, Figure 5.5B). 
Additionally, model hybrid substrates comprising td and PthXo1 target site sequences 
with varied spacer lengths were cloned into the yeast based recombination assay vector to 
assess activity.  
Several constructs revealed appreciable in vivo activity, with the N169-T120 Tev-PthXo1 
fusion demonstrating the most robust activity across targets with varied spacer lengths 
(Figure 5.5C). The periodic activity of the N169 I-TevI truncation is reminiscent of the 
cleavage pattern observed for the similar Tev-LHE construct, though the magnitude of 
activity across a larger number of targets appears to be greater for the Tev-TAL platform. 
This may reflect an increased flexibility of the N169 fusion in the context of the TAL 
versus LHE platforms, or may result from greater sensitivity inherent to the in vivo 
activity assays (yeast reporter compared to survival in bacteria). Similar to the Tev-ZFEs 
tested in the yeast-based recombination system, the N169-T120 construct has activity on 
par with a ZFN pair that induces recombinogenic events at a level sufficient for gene 
targeting in plant and mammalian cells (35).   
5.3.6 Tev-TALs tolerate nucleotide substitutions in the DNA spacer 
To determine the tolerance of the Tev-TAL architecture to mutations that intervene the 
cleavage motif and substrate spacer, hybrid target sites were generated containing 
sequences from alternative bacteriophage thymidylate synthase alleles. The N169-T120 
construct efficiently cleaved most substrates with activity comparable to the cognate td   
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Figure 5.5: Design and functionality of Tev-TALs 
(A) Modeling Tev-PthXo1 fusions using structures of the I-TevI nuclease and DNA-
binding domains coloured in orange (PDB 1MK0 and 1I3J), aligned with the 
multicoloured PthXo1 cocrystal (PDB 3UGM). Various truncation points of I-TevI and 
PthXo1 were utilized to identify functional constructs (B) Tev-PthXo1 model substrates 
with td sequence coloured orange and the PthXo1 binding site coloured blue. Substrates 
are numbered from the first base of the td homing site and differ by the number of 
nucleotides included prior to the junction of the td/PthXo1 binding site. (C) Activity of 
the N169-T120 (I-TevI and N-terminal PthXo1 truncation points, respectively) 
TevPthXo1 construct on various model substrates, reported as β-galactosidase activity 
normalized to a Zif268 ZFN control. Substrates are numbered according to the length of 
the spacer sequence that intervenes the G of the CnnnG cleavage motif and the PthXo1 
binding site. (D) Normalized β-galactosidase activity of N169-T120 TevPthXo1 on 
mutant target sites generated from alternative thymidylate synthase alleles.   
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allele from bacteriophage T4 (Figure 5.5D). Observed exceptions included the Tu1a 
allele that displayed activity almost 2-fold greater than the td target, and the RB32 allele 
that was poorly cleaved. These results are consistent with previous in vitro results that 
suggested I-TevI is tolerant to nucleotide substitutions within its homing site (39). 
Interestingly, the nucleotide analogous to the critical G+7 anchor point observed for the 
GIY-YIG homing endonuclease I-BmoI was not mutated in any of the tested alleles 
(Figure 5.5D, see also Chapters 4.3.7 and 6.4). 
5.3.7 A 5’-CNNNG-3’ cleavage motif is not limiting for targeting 
An important consideration in the design of engineered GIY-YIG nucleases for genome-
editing applications is the targeting requirements, notably the need for the CNNNG di-
nucleotide cleavage motif (Figure 5.6A). In a complex genome of ~ 3x 109 bp, the 
statistically predicted occurrence of the CNNNG motif is once every 15 bp assuming a 
50% GC content. To determine if the frequency of the CNNNG motif would be limiting 
for targeting applications, we examined 35 bp flanking 8,829 computationally predicted 
ZFN sites on zebrafish chromosome 1 for the occurrence of the CNNNG motif (40). As 
shown in Figure 5.6B, the motif is highly represented at all positions within a 35-bp 
window relative to the ZFN sites. Of the 8,829 sites examined, 88% (7,845) of ZFN sites 
possessed at least one motif within 35 bp of the predicted binding site (Figure 5.6C). 
These requirements contrast sharply with those of the recently described PvuII-LHEs and 
PvuII-ZFNs that require the 6-bp 5’-CAGCTG-3’ PvuII site in addition to the LHE or ZF 
binding site (13,14). Of the 8,829 ZFN sites, 97% lacked a PvuII site within the 35-bp 
window (Supplementary Figure S5.3). Thus, the requirement for a di-nucleotide cleavage 
motif in the context of GIY-YIG engineered nucleases will not severely limit potential 
targeting sites.  
5.4 Discussion 
Here, we provide evidence that the GIY-YIG nuclease domain is a potential alternative to 
the currently used FokI nuclease domain for genome editing applications. We show that 
the I-TevI GIY-YIG nuclease domain is portable to the three reprogrammable DNA-
binding scaffolds utilized in the field, the 3-member zinc fingers, catalytically inactive  
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Figure 5.6: Cleavage requirements do not limit GIY-EN applicability 
(A) A diverse set of monomeric and sequence specific reagents can be generated by 
fusing distinct GIY-YIG domain linker lengths to engineered DNA-binding platforms, 
including zinc-finger arrays, inactive LAGLIDADGs, and TAL effectors (GIY-ENs). (B) 
Shown is the distribution of the CNNNG motif in a 35-bp window flanking 8,829 
predicted ZFN sites on zebrafish chromosome 1. The number of occurences of the ‘C’ of 
the motif at each distance is indicated. (C) Unique ZFN sites were grouped according to 
the number of occurences of the CNNNG motif in the 35-bp window. The red line is the 
expected number of ZFN sites for each group based on a binomial distribution. 
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LAGLIDADG homing endonucleases, and modular TAL effectors. The Tev-ZFE, Tev-
LHE, and Tev-TAL fusions are active in vitro and in vivo, with the activity of Tev-ZFEs 
and Tev-TALs in a yeast-based recombination assay on par with that of a characterized 
ZFN. We foresee the monomeric nature of the I-TevI fusions to each platform as a key 
advantage over existing ZFNs and TALENs, as a single fusion protein need be designed 
to target a given sequence, rather than two ZFNs or TALENs required to promote 
dimerization of the FokI nuclease domain (12). Moreover, the fact that the I-TevI 
nuclease domain possesses a preferred cleavage motif adds another layer of specificity to 
targeting requirements, potentially limiting DSBs at off-target sites that do not posses the 
cleavage motif.  
One targeting consideration for chimeric GIY-YIG endonucleases is the DNA sequence 
requirement of the I-TevI linker. The I-TevI linker is a complex structure, consisting of 
defined structural elements with distinct roles in I-TevI function (28,34,36). The primary 
role of the linker is to position the nuclease domain on substrate for cleavage at the 
CNNNG motif, which is found at a defined distance from the binding site on naturally 
occurring I-TevI substrates. However, the linker can direct the nuclease domain in vitro 
to search out displaced CNNNG motifs on both native and non-native substrates with 
insertions or deletions, albeit with reduced cleavage efficiency (39). Our Tev-LHE 
fusions recapitulate this distance versus sequence behaviour in vivo, as the fusions can 
cleave displaced CNNNG motifs with a periodicity that parallels the helical nature of 
DNA. We partially attribute this ability of the Tev-Onu fusions to the flexible N-terminus 
of I-OnuI. The substrate flexibility of different length Tev-Onu fusions is an important 
consideration for targeting, as CNNNG motifs at various positions relative to the LHE 
binding site would be accessible by the choice of the appropriate Tev-LHE fusion. In 
contrast, the apparently inflexible N-terminus of the 3-member zinc fingers constrains 
cleavage to a distance of 33-36 bp from the ryA-binding site, mimicking the spacing of 
the CNNNG motif on native td substrate. Our longest Tev-ZFE and Tev-LHE fusions 
encompass all the known elements of the I-TevI linker that make multiple base-specific 
and non-specific contacts to DNA (28). However, biochemical studies revealed that I-
TevI retains significant cleavage activity on substrates with multiple substitutions in the 
central region of its cognate DNA substrate that is contacted by the linker, equivalent to 
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positions 6-33 of our longest chimeric substrates (39). The shortest Tev-LHE fusions do 
not contain any linker elements that are known to make base-specific DNA contacts, and 
cleave only at the preferred CNNNG motif, implying that the I-TevI linker may contact 
substrate nucleotides adjacent to the CNNNG motif. The presumption the I-TevI linker 
can tolerate changes within the substrate spacer is supported by the fact that Tev-TAL 
fusions can cleave substrates composed of alternative thymidylate synthase alleles. The 
substrates examined, however, did not provide a saturating mutagenic approach making it 
difficult to draw conclusions about all nucleotide positions. Interestingly, no changes 
were made at a position equivalent to the G+7 nucleotide in the GIY-YIG homing 
endonuclease I-BmoI substrate that corresponds to a critical protein:DNA anchor 
(Chapter 4.3.7). Should this functional interaction be conserved within the context of I-
TevI chimeric nucleases, potential contacts may play a role in the positioning of the 
nuclease domain rather than being necessary for cleavage (36).    
Future work on Tev-ZFEs, Tev-LHEs, and Tev-TALs will require a more thorough 
dissection of binding affinity and specificity, and characterization of cellular toxicity that 
results from cleavage at off-target sites. In their current form, the targeting specificity of 
the Tev-ZFEs is a function of the 3-zinc finger domain, which could be further enhanced 
by addition of zinc fingers to generate a 4-, 5-, or 6-zinc finger fusion to increase 
specificity, as has been done with a variety of ZFNs (41). In contrast, the ~18-bp 
specificity of LHEs is sufficient to direct targeting and cleavage at endogenous loci in 
human cells. LHEs, however, are tolerant of nucleotide substitutions within their 
recognition sequence, and I-OnuI E1 cleaves off-target sites that differ by one or two 
nucleotide substitutions (25). In the context of Tev-LHEs, decoupling of DNA-cleavage 
and DNA-binding activity by using a catalytically dead LHE scaffold, combined with the 
requirement for a preferred I-TevI CNNNG cleavage motif, would significantly reduce 
cleavage at off-target sites (Supplementary Figure S5.4). Another advantage of the 
decoupled activities of Tev-LHEs is that they would not require re-optimization of 
catalytic activity that is often necessary in LHEs that have been reprogrammed to bind 
non-native target sites (25,42). The Tev-TAL platform, however, appears to be able 
provide the specificity required to target a monomeric nuclease within the human 
genome. Studies have shown that TALENs can be specifically targeted to sites in a 
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variety of organisms (7,35), and that assembly of custom DNA-binding units is relatively 
straightforward (2,35). Similar to the exploration of alternative DNA-binding platforms 
(2), it is imperative to incorporate nuclease domains with distinct biochemical properties 
into the genome engineering pipeline to create highly precise tools. With further 
optimization, the I-TevI nuclease domain may become an alternative to the FokI-derived 
ZFNs and TALENs. 
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Chapter 6  
6 Discussion 
Selfish mobile genetic elements (MGEs) that encode DNA endonucleases can initiate the 
lateral transfer of genetic material between organisms. Consequently, MGEs comprise a 
significant proportion of any given genome (1-3), subsets of which encode genes of site-
specific homing endonucleases (HEs) (4-6). HEs encode six distinct class-defining 
active-site motifs and differ from most other cellular endonucleases by targeting long 
recognition sites (14-36 base pairs) (5,7). While each family of HE utilizes a number of 
different strategies to cleave DNA, the mechanism by which GIY-YIG family homing 
endonucleases (GIY-HEs) initiate their own genomic mobility has remained poorly 
understood until now. Within this thesis I demonstrate that the model GIY-HE I-BmoI 
functions as a monomer and investigate the dynamic protein:DNA interactions that 
contribute to DNA-hydrolysis. Further, I explicitly test models for double-strand break 
(DSB) formation by monomeric nucleases to elucidate the mechanism by which single 
active site GIY-HEs cleave DNA. To apply these findings within the context of 
engineered nucleases, I demonstrate that the cleavage properties of GIY-HEs are 
recapitulated in the context of GIY-YIG engineered nucleases (GIY-ENs) when the 
nuclease domain of I-TevI is fused to three different re-targetable DNA-binding 
platforms. GIY-ENs are functional in vivo and operate via a different mechanism than 
canonical FokI nuclease domain fusions that constitute the majority of engineered 
nuclease architectures. Distinctly, GIY-ENs cleave at a preferred nucleotide motif and 
function as monomers, whereas FokI-derived nucleases cleave nonspecifically and 
function as dimers. These topics are elaborated further below, where I discuss the 
advantageous properties of GIY-ENs for genome editing applications.  
6.1 GIY-HE cleavage mechanism 
Unlike DNA hydrolysis mechanisms that have been established for other HE families 
(5,7), the inherently high nuclease activity of the GIY-HE I-TevI prohibited expression 
and purification from bacteria that would enable detailed in vitro or in vivo analyses. To 
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investigate the quarter-century old question of how GIY-HEs generate a DSB, I purified 
the related GIY-HE I-BmoI to study the sequential protein:DNA interactions that mediate 
DNA cleavage. DSB formation by I-BmoI proceeds through a number of substrate 
distortions that are dependent on contacts to nucleotides that surround the cleavage site 
(8,9). In Chapters 2 and 3, I investigated the contributions of amino acid and nucleotide 
positions to hydrolysis by generating mutations in the catalytic domain or substrate 
cleavage motif, respectively. In Chapter 4, I discovered additional protein:DNA 
interactions outside of the cleavage motif that act as an anchor point to position the I-
BmoI linker on substrate and initiate DNA distortions. Importantly, I determined that I-
BmoI functions as a monomer at all steps of the reaction pathway and does not hydrolyze 
DNA through protein- or DNA-mediated transesterification reactions. The cumulative 
evidence from Chapters 2, 3, and 4 suggests a highly dynamic monomeric cleavage 
mechanism and also validates predictions made previously for I-TevI (10). It is plausible 
that I-TevI is mechanistically comparable to I-BmoI, as they share high similarity in their 
nuclease domains and linkers (11-13), bind analogous thymidylate synthase alleles as 
monomers (10,14), encode single predicted active sites (9,13,15), and induce significant 
distortions in their respective substrates adjacent to their cleavage site (8,10). I therefore 
propose a model for DSB formation by GIY-HEs where the DNA-binding domain 
anchors the low-affinity GIY-YIG nuclease domain on substrate to sequentially nick both 
DNA strands at a preferred sequence (Figure 6.1).  
To further characterize the sequential conformational changes that mediate DSB 
formation, it may be possible to perform fluorescence resonance energy transfer (FRET) 
experiments as has been done to track changes in the PI-SceI:substrate complex through 
the cleavage reaction (16). I-BmoI contains a single cysteine within the nuclease domain 
(exposed on the surface opposite to the catalytic cleft), and one cysteine within the 
remainder of the protein located in the linker (which has previously been mutated to 
serine without affecting activity, Figure 4.5). Using FRET, the effects of amino acid 
mutations within the nuclease domain, roles of divalent metal and nucleotide 
substitutions at the cleavage site, and effects of substrate insertions within the spacer 
detailed in Chapters 2, 3, and 4, respectively, could be further examined and exploited to 
confirm the mechanistic predictions for GIY-HEs. 
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Figure 6.1: Conformational change DSB mechanism for I-BmoI 
I-BmoI utilizes multiple DNA-distortions and a critical anchor point within the linker to 
overcome the inherently weak DNA-binding affinity of the nuclease domain to hydrolyze 
DNA. 
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The proposed monomeric DSB mechanism for GIY-HEs contrasts with the models 
established for other endonucleases of the GIY-YIG family (17,18). As described in 
Chapter 1.2.2, other enzymes that contain the GIY-YIG motif have acquired context 
dependent adaptations that promote oligomeric assembly to nick both DNA strands (18-
22), or constitute components of larger architectures that allow the GIY-YIG domain to 
function as a nickase (23,24). The GIY-YIG nuclease domain is therefore highly 
adaptable and can function via context-dependent single- or double-strand hydrolysis 
mechanisms. Interestingly, studies that swapped the nuclease and DNA-binding domains 
of I-TevI and I-BmoI revealed that each domain retained their intrinsic functional 
properties when removed from their natural context (11). Additionally, the sequence-
tolerant DNA-binding domains utilized by I-BmoI and I-TevI display evidence of shared 
functionality with other enzymes, as similar NUMOD and helix-turn-helix modules are 
found in the ββα-Me HE family (5,25-28). These properties, along with the evolutionary 
flexibility and mechanistic plasticity of the nuclease motif, suggested the GIY-YIG 
domain as an ideal candidate to consider within the context of novel engineered 
nucleases.  
6.2 Considerations for engineered nucleases  
The ability to manipulate genomes for reverse genetics studies in model organisms or 
alter genes in human cell lines for the treatment of monogenic diseases has led to 
significant academic, clinical, and biotechnological interest in the development and 
implementation of engineered nucleases. Their application has been so widespread that in 
2011, Nature Methods chose genome editing with engineered nucleases as their Method 
of the Year (29). The efficacy of a zinc-finger nuclease (ZFN) mediated therapy to treat 
HIV-1 infection is currently the subject of a clinical trial (30). Unfortunately, the inherent 
biology of the FokI nuclease component of ZFNs was not rigorously understood prior to 
the study, with many suggesting inadequate fidelity of engineered ZFNs for human cell 
therapy (31,32). The requirement of the FokI nuclease domain to form a dimer and it’s 
ability to cleave DNA non-specifically has led to undesirable off-target DSBs in model 
systems. Off-target DSBs can occur when one ZFN module binds an unintended 
degenerate target site and recruits another ZFN to initiate cleavage (Figure 6.2A). In this  
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Figure 6.2: FokI requirements can lead to off-target DSBs 
(A) The dimerization mechanism of FokI and imperfect binding specificity of zinc-
fingers leads to promiscuous cleavage at off-target sites where either or both ZFN units 
interact with an unintended target. (B) ZFNs that contain an engineered obligate 
heterodimeric version of the FokI nuclease domain reduce mechanisms of off-target 
cleavage, but still remain prone to a subset of off-target DSBs. 
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scenario, the secondary ZFN molecule is not necessarily substrate-bound and can also 
result from homodimerization between the FokI domains of identical ZFN subunits. To 
circumvent undesirable homodimerization, studies have been conducted to engineer an 
obligate heterodimeric FokI dimer interface where a ‘left’ and ‘right’ ZFN interaction 
constitutes the only condition that is productive for cleavage (Figure 6.2B) (33). 
Unfortunately, dimerization can still occur between a DNA-bound left ZFN unit and a 
right ZFN that is weakly bound or in solution, leading to apprehension regarding the 
specificity of FokI-derived ZFNs and TALENs (TAL effector nucleases) (31,34). The 
frequencies of off-target DSBs at unintended sites are an important consideration for both 
platforms, as they can have toxic consequences in the form of severe adverse events 
(discussed in Chapter 1.5). 
Another aspect of genome editing procedures to consider is the ability to bias intrinsic 
cellular DNA-repair pathways to mutagenic nonhomologous end-joining (NHEJ) events 
in the absence of an exogenous template, or corrective homologous recombination (HR) 
pathways when an exogenous donor template is provided. NHEJ mediated events can 
either proceed through a classical mechanism that generally results in precise repair or 
through an alternative NHEJ pathway where DNA end-processing enzymes generate 
deletions and frameshifts (35,36). In scenarios where deleterious events are desired, 
studies have shown that engineered nucleases can be coupled with exonucleases to 
increase the frequency of mutagenic repair via alternative NHEJ pathways (37). 
Unfortunately, NHEJ-mediated repair events are often associated with significant 
genomic instability in the forms of sequence loss or chromosomal translocations. 
Consequently, there has been interest in the development of engineered site-specific 
nickases to circumvent these unfavourable outcomes, as they initiate HR at similar 
frequencies to cleavases, yet do not activate NHEJ (38). Nickase variants of engineered 
LAGLIDADG HEs (LHEs) and FokI-derived platforms have therefore been explored to 
more precisely modulate gene repair outcomes (39,40). As described in Chapter 6.3, it 
may also be possible to expand the potential of GIY-ENs by generating engineered GIY-
YIG nickases.  
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Another important consideration beyond the mutagenic event induced by each nuclease 
technology is the specificity associated with the three DNA-targeting platforms described 
within this thesis. The construction of highly precise zinc-finger arrays has not proven to 
be as trivial as once hoped as many nucleotide triplets remain inaccessible by engineered 
zinc-fingers (41), and the modular assembly of multiple fingers does not appear to 
circumvent their inherent promiscuous binding (32). These issues are further 
compounded by the fact that the specificity provided by an array of 4-5 zinc-fingers (that 
bind a 12-15 base pair target) within the context of a monomeric nuclease may be 
insufficient for targeting in human cells. Conversely, many LHEs offer the capacity to 
bind genomic sites with greater than 18 base pair specificity. Combined with their small 
size and potential to maintain a second active catalytic motif, engineered LHEs represent 
an interesting platform to continue to pursue within the context of GIY-YIG fusions. 
TAL effectors have shown great promise for the design and assembly of modules that can 
target virtually any sequence with binding sites that exceed 20 base pairs. While their 
large size and repetitive coding sequence may present challenges for viral based delivery 
approaches, monomeric GIY-YIG fusions to the TAL platform reduce the size and design 
complexity of TALENs by a factor of 2. At present it appears that TAL effectors may 
offer the most customizable and high fidelity option for specific binding (42), though the 
specificity and promiscuity of all platforms must be rigorously tested to determine the 
utility and relevance of each architecture. 
While the benefits and limitations of existing genome editing technologies are analyzed, I 
have been motivated to consider the GIY-YIG nuclease domain as an alternative nuclease 
module. In Chapter 5, I demonstrate that the I-TevI nuclease domain can be fused to three 
targetable DNA-binding platforms to generate functional I-TevI-zinc-finger (Tev-ZFE), 
I-TevI-LAGLIDADG (Tev-LHE), or I-TevI-TAL effector (Tev-TAL) engineered 
nucleases (collectively abbreviated Tev-ENs) (Figure 6.3A). Significantly, the intrinsic 
properties of I-TevI are recapitulated within the context of Tev-ENs as they function 
catalytically as monomers and require an appropriately spaced CnnnG cleavage motif to 
generate a DSB. Fusions of the I-BmoI nuclease domain to the zinc-finger architecture 
(to create Bmo-ZFEs, Supplementary Figure S5.1) hydrolyzed substrates in vitro at the 
preferred cleavage site, however significant activity in vivo was not detected. The failure 
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Figure 6.3: Design of engineered GIY-YIG endonucleases 
(A) Models of the Tev-ZFE, Tev-LHE, and Tev-TAL platforms. (B) Schematic 
illustrating the fundamental differences between engineered GIY-YIG and FokI nuclease 
platforms. 
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of Bmo-ZFEs in vivo can likely be attributed to the lack of structural information required 
to rationally design functional fusions to the zinc-finger domain, as well as the difference 
in specific activity versus I-TevI (~750-fold lower) (14). Nevertheless, Tev-ZFEs and 
Tev-TALs induce gene conversion events in yeast on par with an established ZFN pair 
(Figures 5.3 & 5.5), and Tev-LHEs have activity in bacteria comparable to the engineered 
catalytically active LHE alone (Figure 5.4). Overall, the presented results are encouraging 
as GIY-ENs are functionally robust and mechanistically distinct when compared to 
analogous FokI-derived nucleases. However, there are properties of the I-TevI GIY-YIG 
domain and linker that must be considered for GIY-ENs as an alternative genome editing 
technology. 
6.3 Implications of GIY-HEs for GIY-ENs 
A cautionary lesson stemming from the implementation of FokI-containing ZFNs and 
TALENs is that one must understand the inherent biology of a nuclease domain prior its 
application in engineered architectures (31). Consequently, I envision the monomeric and 
sequence-tolerant GIY-YIG domain as an alternative to the FokI nuclease domain due to 
their structural and mechanistic differences (Figure 6.3B).  One advantageous property of 
GIY-ENs is the decrease in design complexity by a factor of 2 versus FokI chimeras. Not 
only does this simplify the targeting of GIY-ENs to a single site, it also reduces the 
amount of fusion-encoding DNA that must be transfected into cells. This is an important 
consideration when utilizing the TALEN architecture, as the TAL domain is significantly 
larger than other DNA-binding platforms and a pair of nucleases must be transfected. 
Another advantageous property of GIY-ENs is the requirement to recognize a preferred 
nucleotide motif for cleavage (43,44). In scenarios where the DNA-binding module of a 
GIY-EN interacts with an unintended target site, the off-target site may be rendered 
immune to cleavage unless an appropriate cleavage motif is found within an appropriate 
linker/spacer distance (Supplementary Figure S5.4). Therefore, the monomeric 
mechanism and sequence preference by GIY-ENs offer advantages over ZFNs and 
TALENs by simplifying the assembly and delivery processes and potentially reducing 
off-target DSB frequencies. 
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One property observed for GIY-YIG family endonucleases by examining their natural 
functional diversity is the contextual ability to function as a nickase, as many GIY-YIG 
enzymes nick only a single strand of DNA (see also Chapter 1.2.2) (23,45,46). As 
described in Chapter 6.2, nickases represent a potentially safer nuclease mediated 
technology to induce desired gene conversion outcomes via HR. It may be possible to 
convert the GIY-YIG nuclease domain to a functional nickase through directed selection 
approaches or by altering the contextual modularity of the domain itself. For example, 
high-throughput selections and rational design methods have been utilized to convert 
both REs and LHEs into functional nickases (38-40,47-49). Conversely, additional DNA-
binding elements could be fused upstream of the GIY-YIG domain to constrain 
repositioning of the nuclease motif after nicking (similar to the modular structure of GIY-
YIG DNA-repair enzymes or the H-N-H HE I-HmuI) (28,50), or the nuclease domain 
could be fused to the C-terminal end of the LHE or TAL DNA-binding platforms to 
mimic the natural polarity of the LEM associated or Penelope nucleases (51,52). 
6.4 Potential of GIY-YIG engineered nucleases 
While progress has been made in assembling sequence-specific GIY-ENs that are distinct 
from FokI-derived chimeras, a number of properties must be further investigated for the 
technology to become widely applicable (Figure 6.4). Nucleotide requirements within the 
I-TevI cleavage motif and substrate spacer must be robustly investigated in both the LHE 
and TAL platforms to be able to predict which genomic sequences will be efficiently 
cleaved by Tev-ENs and whether additional targeting constraints exist.  Preliminary data 
with Tev-TALs suggest that the substrate spacer preference at G+7 observed for I-BmoI 
may be recapitulated within the context of Tev-ENs (Figures 4.8 & 5.5). This result must 
be reexamined in a more robust manner, however, as this screen was limited due to the 
codon conservation of the thymidylate synthase genes. An added nucleotide preference 
for I-TevI in the substrate spacer would increase the nuclease domain’s specificity from a 
CnnnG di-nucleotide to a tri-nucleotide motif. While this property may serve to further 
de-toxify GIY-ENs by conferring a more stringent cleavage preference, it may also limit 
the targeting capacity to fewer genomic sites.  Accordingly, it may be important to 
identify and modify the residues that form protein:DNA contacts at G+7 for I-BmoI or an 
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Figure 6.4: Considerations for engineered GIY-YIG nucleases 
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analogous position for Tev-ENs. If after further study the cleavage requirements of I-
TevI limit the targeting potential of Tev-ENs, it would be prudent to investigate the 
nucleotide preferences of additional GIY-HE nuclease domains. Preliminary results 
indicate that a nuclease domain from a GIY-HE similar to I-TevI (from the bacteriophage 
Tu1a) has substantially different nucleotide preferences in the substrate spacer (J. Wolfs, 
unpublished). Over 150 putative GIY-HEs with potentially different targeting constraints 
have been identified from bacteriophage, bacterial, eukaryotic, and marine metagenomic 
sequences, many of which could be used to expand the diversity and specificity of GIY-
ENs (13,17,53-55).  
Another important consideration is functionality in relevant cellular systems. Genome 
editing interventions using engineered nucleases are most prominently implemented in 
model organisms to understand biological processes, or within plant and human cells for 
agriculture or experimental medicine. While it is encouraging that GIY-ENs fused to all 
three DNA-binding platforms are functional in bacteria and yeast, it will be necessary to 
ensure that this functionality is preserved within all relevant organisms. At this point it 
remains unknown if endogenous expression pathways would express GIY-ENs or 
whether their presence would elicit an innate immune response. If DSB efficiencies to 
similar FokI-derived architectures can be achieved in the relevant systems, a head-to-
head comparison between the GIY-YIG and FokI platforms would be obligatory to 
compare on-target versus off-target cleavage rates. These studies would also elucidate 
whether the added specificity provided by GIY-ENs would detoxify existing 
technologies, or simply limit their targeting potential.  
The data presented within this thesis towards the development of a novel monomeric 
genome-editing platform is encouraging, as GIY-ENs may serve as an alternative genome 
editing technology to begin to answer interesting biological questions and treat 
monogenic diseases. Ultimately, however, further refinements of each GIY-EN platform 
will dictate the utility, safety, and potential of GIY-ENs.  
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Appendix S2: Supplementary information for Chapter 2 
S2 Supplementary materials and methods 
 
The WT, N12D, and I71N time-course data were fit via regularized nonlinear least-
squares to the first-order kinetic model 
C
k
1! "! N
k
2! "! L  
which describes the stepwise conversion of DNA from circular to nicked to linear form. 
Regression curves (Figure S4) are shown overlaid with data and empirical monotonic 
Hermite smoothing-spline interpolants. These figures show no inconsistency between the 
first order kinetic model and the observed data for WT, N12D and I71N proteins. 
 
In contrast, the first-order model above cannot account for the behavior of the I67N or 
S20Q mutants. Instead, values of k
1
 were estimated in the absence of nicked or linear 
forms. For S20Q, circular DNA concentrations were fit to the empirical formula 
C = C0 + exp(!"1t +" 2 ) +" 3  
where the comparable initial reaction velocity is given as k
1
=!
1
e
!
2 . This empirical 
model could not reproduce the dynamic behavior of the I67N mutant due to the rapid 
initial conversion of C to N. Instead, the initial reaction velocity was estimated by the 
slope of the smoothing spline at time zero. The empirical differences in reaction kinetics 
between the I67N and S20Q mutants suggest that each has distinct mechanistic changes 
compared to each other, not just WT. 
 
Since the total concentration of circular, nicked, and linear DNA is presumed constant, a 
ternary plot showing the relative proportion of each component is presented in Figure S4. 
Ternary-plot trajectories are displayed without regard to time, and the overall shapes of 
the reaction regression curves suggest mechanistic differences without regard to 
differences in reaction rate. Specifically, the plot suggests that the (WT, N12D, I71N), 
(I67N), and (S20Q) reaction curves are all mechanistically distinct since they group into 
three observably different classes. 
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S2 Supplementary figures 
 
Supplementary Figure S2.1: Comparison of the sequence of codon-optimized (CO) 
I-BmoI with the native sequence (Nat). Optimized codons for expression in E. coli 
are shown in red. 
 
Nat  ATGAAATCAGGCGTTTATAAAATAACAAATAAAAATACAGGGAAGTTTTATATTGGCAGTTCAGAAGAC 
CO   ATGAAATCTGGTGTTTACAAAATCACCAACAAAAACACCGGTAAATTCTACATCGGTTCTTCTGAAGAC 
     M  K  S  G  V  Y  K  I  T  N  K  N  T  G  K  F  Y  I  G  S  S  E  D   
 
Nat  TGTGAAAGTAGACTAAAAGTTCATTTTAGAAATCTAAAAAACAATAGACATATTAATAGATATTTAAAC 
CO   TGCGAATCTCGTCTGAAAGTTCACTTCCGTAACCTGAAAAACAACCGTCACATCAACCGTTACCTGAAC 
     C  E  S  R  L  K  V  H  F  R  N  L  K  N  N  R  H  I  N  R  Y  L  N   
Nat  AATTCGTTTAATAAACATGGAGAGCAGGTATTTATTGGAGAGGTAATTCATATTTTGCCCATAGAAGAG 
CO   AACTCTTTCAACAAACACGGTGAACAGGTTTTCATCGGTGAAGTTATCCACATCCTGCCGATCGAAGAA 
     N  S  F  N  K  H  G  E  Q  V  F  I  G  E  V  I  H  I  L  P  I  E  E   
 
Nat  GCTATAGCCAAGGAGCAATGGTATATTGATAATTTCTATGAAGAAATGTACAACATAAGTAAATCAGCT 
CO   GCTATCGCTAAAGAACAGTGGTACATCGACAACTTCTACGAAGAAATGTACAACATCTCTAAATCTGCT 
     A  I  A  K  E  Q  W  Y  I  D  N  F  Y  E  E  M  Y  N  I  S  K  S  A 
 
Nat  TACCATGGCGGAGACTTAACAAGCTATCACCCAGACAAACGAAACATCATCCTCAAAAGAGCCGACAGT 
CO   TACCACGGTGGTGACCTGACCTCTTACCACCCGGACAAACGTAACATCATCCTGAAACGTGCTGACTCT 
     Y  H  G  G  D  L  T  S  Y  H  P  D  K  R  N  I  I  L  K  R  A  D  S   
 
Nat  TTGAAGAAAGTTTATTTGAAGATGACATCTGAAGAAAAGGCTAAGCGATGGCAATGTGTTCAAGGAGAA 
CO   CTGAAAAAAGTTTACCTGAAAATGACCTCTGAAGAAAAAGCTAAACGTTGGCAGTGCGTTCAGGGTGAA 
     L  K  K  V  Y  L  K  M  T  S  E  E  K  A  K  R  W  Q  C  V  Q  G  E   
 
Nat  AATAATCCGATGTTTGGAAGAAAACATACAGAAACGACAAAGCTAAAGATTTCAAATCATAATAAGCTT 
CO   AACAACCCGATGTTCGGTCGTAAACACACCGAAACCACCAAACTGAAAATCTCTAACCACAACAAACTG 
     N  N  P  M  F  G  R  K  H  T  E  T  T  K  L  K  I  S  N  H  N  K  L   
 
Nat  TATTACTCAACTCACAAAAATCCATTTAAAGGTAAAAAACATAGTGAGGAGAGTAAGACTAAGTTGTCA 
CO   TACTACTCTACCCACAAAAACCCGTTCAAAGGTAAAAAACACTCTGAAGAATCTAAAACCAAACTGTCT 
     Y  Y  S  T  H  K  N  P  F  K  G  K  K  H  S  E  E  S  K  T  K  L  S   
 
Nat  GAATATGCTTCTCAAAGAGTGGGTGAAAAAAATCCGTTCTATGGAAAAACACACAGTGATGAATTTAAG 
CO   GAATACGCTTCTCAGCGTGTTGGTGAAAAAAACCCGTTCTACGGTAAAACCCACTCTGACGAATTCAAA 
     E  Y  A  S  Q  R  V  G  E  K  N  P  F  Y  G  K  T  H  S  D  E  F  K   
  
Nat  ACTTATATGTCTAAAAAGTTTAAAGGCAGAAAGCCAAAAAATTCAAGACCAGTTATCATAGATGGAACA 
CO   ACCTACATGTCTAAAAAATTCAAAGGTCGTAAACCGAAAAACTCTCGTCCGGTTATCATCGACGGTACC 
     T  Y  M  S  K  K  F  K  G  R  K  P  K  N  S  R  P  V  I  I  D  G  T   
 
Nat  GAATATGAAAGTGCTACAGAAGCTTCAAGACAGTTAAATGTAGTTCCTGCTACTATCCTCCATAGAATC 
CO   GAATACGAATCTGCTACCGAAGCTTCTCGTCAGCTGAACGTTGTTCCGGCTACCATCCTGCACCGTATC 
     E  Y  E  S  A  T  E  A  S  R  Q  L  N  V  V  P  A  T  I  L  H  R  I   
 
Nat  AAAAGTAAAAATGAAAAATACAGTGGATACTTTTACAAA 
CO   AAATCTAAAAACGAAAAATACTCTGGTTACTTCTACAAA 
     K  S  K  N  E  K  Y  S  G  Y  F  Y  K   
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Supplementary Figure S2.2: Nucleotide mutation frequencies.  
 
(A) Substitution frequencies from 87 selected and 62 unselected clones. (B) Predicted 
distributions based on simulations of the mutagenic method. 
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S2 Supplementary tables 
Supplementary Table S2.2: Oligonucleotides used in Chapter 2 
 
Name Sequence (5'-3') Notes 
DE-331 CGCGCGCGCCATATGAAATCTGGTGTTTACAAA
ATC 
NdeI site underlined 
DE-384 CGCGCGCGCCTCGAGTTATTATTTGTAGAAGTA
ACCAGAGTATTTTTCG 
XhoI site underlined 
DE-395 CTAGAAAGAGCCCGTAGTAATGACATGGCCTTG
GGAAATCCCTTCAATGTATTCCAGGCATG 
XbaI (5') and SphI (3') 
overhangs underlined 
DE-396 CCTGGAATACATTGAAGGGATTTCCCAAGGCCA
TGTCATTACTACGGGCTCTTT 
XbaI (5') and SphI (3') 
overhangs underlined 
DE-419 GAAGACTGCGAATCTGCCCTGAAAGTTCACTTC Alanine codon 
underlined for R27A 
DE-420 GAAGTGAACTTTCAGGGCAGATTCGCAGTCTTC Reverse complement of 
DE-419 
DE-429 CTAGAAACATAAGTGAGTAATGACATGGCCTTG
GGAAATCCCTTCAATGTATTCCAGGCATG 
XbaI (5') and SphI (3') 
overhangs underlined 
DE-430 CCTGGAATACATTGAAGGGATTTCCCAAGGCCA
TGTCATTACTCACTTATGTTT 
XbaI (5') and SphI (3') 
overhangs underlined 
DE-490 GTATAAGAAGGAGATATACATATG NdeI site underlined 
DE-491 TTCTTTACCAGACTCGAGTTATTA XhoI site underlined 
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Supplementary Table S2.3: EoS values and mutations for nuclease & linker residues 
 
Position Codon Residue log2_EoS Sel. clones Sel. clones  Unsel. clones  Unsel. clones  
        # sub.  #nonsynon. 
sub. 
# sub. #nonsynon. sub. 
1 ATG M 6.17 0 0 0 0 
2 AAA K 7.35 0 0 3 2 
3 TCT S 2.93 2 0 3 0 
4 GGT G 0.15 5 0 5 1 
5 GTT V 0.05 6 1 8 5 
6 TAC Y 5.77 0 0 1 1 
7 AAA K 7.21 0 0 6 4 
8 ATC I 5.75 1 0 6 6 
9 ACC T 2.91 0 0 3 2 
10 AAC N 5.84 1 0 2 2 
11 AAA K 3.49 2 1 3 3 
12 AAC N 3.26 10 10 8 7 
13 ACC T -0.56 4 2 4 4 
14 GGT G -0.50 2 1 4 1 
15 AAA K 1.52 2 2 4 3 
16 TTC F 2.19 1 1 4 4 
17 TAC Y 5.89 0 0 2 2 
18 ATC I 2.15 2 1 6 5 
19 GGT G -0.60 2 1 1 0 
20 TCT S 3.00 1 0 4 3 
21 TCT S 0.26 4 1 7 3 
22 GAA E 1.22 1 1 1 1 
23 GAC D 3.22 0 0 3 3 
24 TGC C 0.51 2 1 2 2 
25 GAA E -0.14 3 2 4 2 
26 TCT S 0.25 6 1 8 4 
27 CGT R 0.08 1 0 4 2 
28 CTG L 2.73 0 0 3 2 
29 AAA K 7.42 0 0 6 6 
30 GTT V 2.96 0 0 2 1 
31 CAC H 3.21 0 0 6 6 
32 TTC F 0.72 2 2 3 3 
33 CGT R 0.11 2 0 4 2 
34 AAC N 5.93 1 0 1 1 
35 CTG L 2.81 0 0 0 0 
36 AAA K 0.30 6 3 5 5 
37 AAC N -0.75 4 4 4 4 
38 AAC N 2.12 2 1 3 3 
39 CGT R 0.22 5 0 5 2 
40 CAC H 0.33 1 1 3 3 
41 ATC I 2.28 1 1 4 3 
42 AAC N 5.89 0 0 6 6 
43 CGT R 0.31 1 0 3 0 
44 TAC Y 0.61 2 2 1 1 
45 CTG L 2.81 1 0 6 6 
46 AAC N 2.35 1 1 6 6 
47 AAC N -0.34 3 3 5 5 
48 TCT S 3.12 2 0 3 1 
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49 TTC F -0.29 3 3 6 6 
50 AAC N 5.98 0 0 6 5 
51 AAA K 7.39 2 0 5 4 
52 CAC H 0.33 1 1 2 2 
53 GGT G 0.29 1 0 4 2 
54 GAA E 4.65 1 0 3 3 
55 CAG Q -0.30 5 4 3 2 
56 GTT V -0.40 6 2 6 2 
57 TTC F 6.00 0 0 5 5 
58 ATC I -0.58 5 4 6 6 
59 GGT G 0.11 1 0 4 1 
60 GAA E 0.11 2 2 1 1 
61 GTT V 2.79 3 0 4 4 
62 ATC I 2.01 1 1 4 4 
63 CAC H 0.32 1 1 1 1 
64 ATC I 0.53 3 2 7 6 
65 CTG L 2.74 0 0 3 3 
66 CCG P -0.47 2 1 1 1 
67 ATC I 5.67 0 0 2 2 
68 GAA E -0.14 3 2 3 1 
69 GAA E 0.08 2 2 3 2 
70 GCT A 0.06 1 0 3 1 
71 ATC I 5.66 1 0 4 4 
72 GCT A -0.57 2 1 1 0 
73 AAA K 1.45 5 2 6 5 
74 GAA E 4.69 1 0 2 1 
75 CAG Q 3.23 0 0 4 4 
76 TGG W 0.53 1 1 1 1 
77 TAC Y 2.27 1 1 2 2 
78 ATC I 2.13 1 1 5 5 
79 GAC D 3.18 0 0 3 2 
80 AAC N 5.87 0 0 2 2 
81 TTC F 0.67 2 2 5 5 
82 TAC Y 5.75 0 0 3 2 
83 GAA E 4.57 0 0 1 0 
84 GAA E 1.33 2 1 6 4 
85 ATG M 2.41 1 1 7 7 
86 TAC Y 5.98 0 0 5 5 
87 AAC N 5.93 1 0 6 6 
88 ATC I 2.13 1 1 5 5 
89 TCT S 2.82 0 0 4 4 
90 AAA K 3.52 1 1 2 2 
91	   TCT	   S	   2.95	   3	   0	   3	   2	  
92	   GCT	   A	   0.19	   0	   0	   5	   1	  
93	   TAC	   Y	   5.65	   1	   0	   0	   0	  
94	   CAC	   H	   3.30	   0	   0	   5	   5	  
95	   GGT	   G	   0.19	   3	   0	   4	   0	  
96	   GGT	   G	   0.13	   2	   0	   3	   1	  
97	   GAC	   D	   3.01	   0	   0	   5	   5	  
98	   CTG	   L	   2.56	   0	   0	   4	   4	  
99	   ACC	   T	   0.26	   2	   1	   1	   1	  
100	   TCT	   S	   0.24	   2	   1	   0	   0	  
101	   TAC	   Y	   2.18	   1	   1	   6	   6	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102	   CAC	   H	   3.26	   0	   0	   7	   6	  
103	   CCG	   P	   0.17	   1	   0	   0	   0	  
104	   GAC	   D	   3.23	   0	   0	   2	   2	  
105	   AAA	   K	   7.54	   1	   0	   7	   6	  
106	   CGT	   R	   0.17	   0	   0	   5	   1	  
107	   AAC	   N	   -­‐0.61	   5	   4	   6	   6	  
108	   ATC	   I	   2.08	   2	   1	   5	   3	  
109	   ATC	   I	   2.05	   3	   1	   5	   5	  
110	   CTG	   L	   0.10	   1	   1	   3	   3	  
111	   AAA	   K	   7.54	   1	   0	   12	   11	  
112	   CGT	   R	   -­‐0.48	   4	   1	   3	   1	  
113	   GCT	   A	   0.06	   2	   0	   3	   1	  
114	   GAC	   D	   3.30	   0	   0	   0	   0	  
115	   TCT	   S	   2.88	   0	   0	   3	   1	  
116	   CTG	   L	   2.74	   0	   0	   5	   5	  
117	   AAA	   K	   0.34	   4	   3	   14	   11	  
118	   AAA	   K	   3.47	   3	   1	   5	   4	  
119	   GTT	   V	   0.20	   2	   1	   8	   4	  
120	   TAC	   Y	   6.00	   0	   0	   3	   3	  
121	   CTG	   L	   2.24	   6	   6	   1	   1	  
122	   AAA	   K	   -­‐0.69	   6	   5	   12	   11	  
123	   ATG	   M	   2.54	   1	   1	   5	   5	  
124	   ACC	   T	   0.19	   1	   1	   3	   3	  
125	   TCT	   S	   0.09	   2	   1	   0	   0	  
126	   GAA	   E	   -­‐0.08	   3	   2	   8	   3	  
127	   GAA	   E	   4.53	   1	   0	   1	   0	  
128	   AAA	   K	   3.58	   1	   1	   3	   1	  
129	   GCT	   A	   0.25	   0	   0	   2	   1	  
130	   AAA	   K	   7.36	   1	   0	   8	   6	  
131	   CGT	   R	   0.23	   1	   0	   2	   0	  
132	   TGG	   W	   3.33	   0	   0	   3	   3	  
133	   CAG	   Q	   3.21	   0	   0	   2	   2	  
134	   TGC	   C	   0.34	   1	   1	   4	   4	  
135	   GTT	   V	   0.22	   5	   1	   8	   2	  
136	   CAG	   Q	   -­‐0.45	   2	   2	   5	   5	  
137	   GGT	   G	   -­‐0.38	   3	   1	   2	   0	  
138	   GAA	   E	   -­‐0.01	   3	   2	   3	   2	  
139	   AAC	   N	   5.84	   0	   0	   6	   6	  
140	   AAC	   N	   5.74	   0	   0	   1	   1	  
141	   CCG	   P	   0.00	   0	   0	   2	   1	  
142	   ATG	   M	   2.57	   1	   1	   6	   6	  
143	   TTC	   F	   0.59	   2	   2	   7	   6	  
144	   GGT	   G	   0.33	   1	   0	   1	   1	  
145	   CGT	   R	   -­‐0.59	   1	   1	   5	   0	  
146	   AAA	   K	   1.54	   2	   2	   6	   6	  
147	   CAC	   H	   0.31	   1	   1	   3	   3	  
148	   ACC	   T	   -­‐0.70	   3	   2	   3	   2	  
149	   GAA	   E	   -­‐0.03	   3	   2	   6	   5	  
150	   ACC	   T	   2.91	   0	   0	   4	   4	  
151	   ACC	   T	   0.25	   1	   1	   3	   3	  
152	   AAA	   K	   0.12	   4	   3	   7	   6	  
153	   CTG	   L	   2.65	   0	   0	   2	   2	  
154	   AAA	   K	   3.59	   1	   1	   9	   8	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Supplementary Table S2.4: Rationale for selecting co-evolving residues to 
investigate 
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Appendix S3: Supplementary information for Chapter 3 
S3 Supplementary tables 
Supplementary Table S3.1: Strains and plasmids used in this study 
Strains Description Source 
DH5α F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1 
Invitrogen 
ER2566 F- λ- fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 Δ(mcrC-
mrr)114::IS10 R(mcr-73::miniTn10-TetS)2 R(zgb-210::Tn10)(TetS) 
endA1 [dcm] 
N.E.B. 
Plasmids Description Source 
pTYBmoI pTYB1 derivative containing the 266 amino acid codon-optimized I-BmoI 
gene  
Ref 1. 
pBmoHS pBS derivative containing a 48-base pair XbaI/BamHI insert corresponding 
to the intronless B. mojavensis thyA gene 
Ref 2. 
pDE212 Similar to pBmoHS, with the intron-containing sequence upstream of the 
intron insertion site (substitutions relevant to this study are: T-1G, G-2T, 
C-3G, C-4A, C-5A, and G-6T) 
Ref 2. 
pDE213 Similar to pBmoHS, with a T-1G substitution Ref 2. 
pDE214 Similar to pBmoHS, with a G-2T substitution Ref 2. 
pDE215 Similar to pBmoHS, with a C-3G substitution Ref 2. 
pDE216 Similar to pBmoHS, with a C-4A substitution Ref 2. 
pDE217 Similar to pBmoHS, with a C-5A substitution Ref 2. 
pDE218 Similar to pBmoHS, with a G-6T substitution Ref 2. 
pDE219 Similar to pBmoHS, with T-1G and G-2T substitutions Ref 2. 
pDE220 Similar to pBmoHS, with G-2T and C-3G substitutions Ref 2. 
pDE221 Similar to pBmoHS, with G-2T and C-4A substitutions Ref 2. 
pDE222 Similar to pBmoHS, with G-2T and C-5A substitutions Ref 2. 
pDE223 Similar to pBmoHS, with C-3G and C-4A substitutions Ref 2. 
pDE224 Similar to pBmoHS, with C-3G and C-5A substitutions Ref 2. 
pDE225 Similar to pBmoHS, with C-4A and C-5A substitutions Ref 2. 
pDE227 Similar to pBmoHS, with T-1G, G-2T, and C-3G substitutions Ref 2. 
pDE228 Similar to pBmoHS, with T-1G, C-3G, and C-5A substitutions Ref 2. 
pDE229 Similar to pBmoHS, with G-2T, C-3G, and C-4A substitutions Ref 2. 
pDE230 Similar to pBmoHS, with G-2T, C-4A, and G-6T substitutions Ref 2. 
pDE231 Similar to pBmoHS, with C-3G, C-4A, and C-5A substitutions Ref 2. 
pDE232 Similar to pBmoHS, with C-4A, C-5A, and G-6T substitutions Ref 2. 
pDE233 Similar to pBmoHS, with G-2T, C-3G, C-4A, and C-5A substitutions Ref 2. 
 
1. Kleinstiver, B.P., Fernandes, A.D., Gloor, G.B. and Edgell, D.R. (2010) A unified genetic, 
computational and experimental framework identifies functionally relevant residues of the homing 
endonuclease I-BmoI. Nucleic Acids Res, 38, 2411-2427. 
2. Edgell, D.R., Stanger, M.J. and Belfort, M. (2003) Importance of a single base pair for discrimination 
between intron-containing and intronless alleles by endonuclease I-BmoI. Curr Biol, 13, 973-978. 
210 
 
Supplementary Table S3.2: Oligonucleotides used in Chapter 3 
 
 
  
Name Sequence (5'-3') Notes
DE-37 CCACCTTGAGGTAAGAGCCCGTAGTAATGACAT
GGCCTTGGGAAATCCCTTCAATGTATTCCAG
Top strand intronless thyA 64mer from +22 to -
42 relative to the intron insertion site
DE-38 CTGGAATACATTGAAGGGATTTCCCAAGGCCAT
GTCATTACTACGGGCTCTTACCTCAAGGTGG
Bottom strand intronless thyA 64mer from 
+22 to -42 relative to the intron insertion site
DE-116 AAACTCCACCTTGAGGTAAGAGCCCGTAGTAA
TGACATGGCCTTGGGAAATCCCTTCAATGTATT
CCAGTACAA
Top strand intronless thyA 74mer from +27 to -
47 relative to the intron insertion site
DE-117 TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTACGGGCTCTTACCTCAAGG
TGGAGTTT
Bottom strand intronless thyA 74mer from 
+27 to -47 relative to the intron insertion site
DE-444 AGTAGCGACTTCTACTGAACATAAGTGAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
Top strand intron-containing thyA 74mer from 
+27 to -47 relative to the intron insertion site
DE-445 TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTCACTTATGTTCAGTAGAAG
TCGCTACT
Bottom strand intron-containing thyA 74mer 
from +27 to -47 relative to the intron insertion 
site
DE-446 AAACTCCACCTTGAGGTAAGAGCCCTTAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
Top strand intronless thyA 74mer from +27 to -
47 relative to the intron insertion site, with a G-
2T substitution
DE-447 TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTAAGGGCTCTTACCTCAAGG
TGGAGTTT
Bottom strand intronless thyA 74mer from 
+27 to -47 relative to the intron insertion site, 
with a C-2A substitution
DE-459 AAACTCCACCTTGAGGTAAGAGCCCATAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
Top strand intronless thyA 74mer from +27 to -
47 relative to the intron insertion site, with a G-
2A substitution
DE-460 TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTATGGGCTCTTACCTCAAGG
TGGAGTTT
Bottom strand intronless thyA 74mer from 
+27 to -47 relative to the intron insertion site, 
with a C-2T substitution
DE-461 AAACTCCACCTTGAGGTAAGAGCCCCTAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
Top strand intronless thyA 74mer from +27 to -
47 relative to the intron insertion site, with a G-
2C substitution
DE-462 TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTAGGGGCTCTTACCTCAAGG
TGGAGTTT
Bottom strand intronless thyA 74mer from 
+27 to -47 relative to the intron insertion site, 
with a C-2G substitution
DE-463 AGTAGCGACTTCTACTGAACATAAGGGAGTAAT
GACATGGCCTTGGGAAATCCCTTCAATGTATTC
CAGTACAA
Top strand intron-containing thyA 74mer from 
+27 to -47 relative to the insertion site, with a 
A-2G substitution
DE-464 TTGTACTGGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTCCCTTATGTTCAGTAGAAGT
CGCTACT
Bottom strand intron-containing thyA 74mer 
from +27 to -47 relative to the insertion site, 
with a T-2C substitution
211 
 
Supplementary Table S3.3: Confidence intervals for rate constants determined on 
mutant substrates in low and high MgCl2 concentrations. 
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Appendix S4: Supplementary information for Chapter 4 
S4 Supplementary materials and methods 
DNA-binding affinity of I-BmoI domains. Binding reactions shown in Supplementary 
Figure S4.2 contained 200 mM NaCl, 50 mM tris pH 8.0, 5% glycerol, either 10 mM 
EDTA or 10 mM MgCl2, 6 µM thyA 74-mer substrate, and 12 µM full-length I-BmoI or 
domain truncation in 15 µl volumes. Reactions were incubated at room temperature for 
15 minutes, stopped by the addition of 5 µl loading buffer (10% glycerol, 100mM 
EDTA), and half of the reaction was loaded on a 10% native polyacrylamide (19:1) gel. 
Gels were stained in ethidium bromide (Caledon) prior to analysis on an 
AlphaImagerTM3400 (Alpha Innotech). 
Cross-linking reactions. Prior to cross-linking reactions, purified I-BmoI was dialyzed 
into 50 mM HEPES pH 8.0, 500 mM NaCl, and 5% glycerol. Typically, 20-µl reactions 
contained 7.6 µM I-BmoI, 15 mM MgCl2, and 1.125 µM thyA 74mer substrate (DE-
116/DE-117) when included. Reactions were supplemented with dilutions of 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide) (EDC, Fluka Analytical) from 144 µM to 48 mM 
in conjunction with N-Hydroxysuccinimide (NHS, Sigma-Aldrich Inc.) from 92 µM to 31 
mM. I-BmoI was the final component to be added to the reactions that were subsequently 
stopped by adding 12 µl of stop buffer (792 mM Tris-HCl pH 8.0, 4 % SDS, 20 % 
glycerol) at either 2, 5, or 10 minutes. Stopped reactions were run against a medium 
molecular weight ladder (PiNK plus, GeneDirex) and proteins were identified after 
electrophoresis on 15% SDS-PAGE gels either by coommassie stain (86 pmol I-BmoI per 
lane) or Western blot (3.6 pmol per lane, see below). Additional cross-linking reactions 
were conducted with a range of I-BmoI concentrations and were conditionally 
supplemented with 15 mM MgCl2, thyA 74-mer substrate (DE-116/DE-117), and various 
concentrations of EDC/NHS, bissulfosuccinimidyl suberate (BS3, Thermo Scientific), or 
glutaraldehyde (EM grade, Polysciences Inc.). 
For Western blot analysis, a polyclonal anti-N111 I-BmoI antibody (Pacific 
Immunology) was raised against the N111 truncation of I-BmoI. Electrophoresis of 3.5 
pmol of I-BmoI cross-linking reactions on a 15% SDS-PAGE gel was conducted prior to 
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transfer to a PVDF membrane (Pall Life Sciences) at 100V. Membranes were washed on 
a rocker in casein blocking buffer (Sigma) for 60 minutes, washed with a 1:10,000 
dilution of the anti-N111 antibody in TBST (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 
0.1% Tween 20) for 60 minutes, washed 4 x 5 minutes in TBST, exposed to a 1:10,000 
dilution of anti-rabbit IgG peroxidase conjugate (Sigma) for 60 minutes in TBST, and 
washed 4 x 5 minutes in TBST. Luminescent peptides were detected using ECL Plus (GE 
Healthcare) detection reagent and were visualized at 450 nM on a StormTM860 
(Molecular Dynamics).  
Substrate topology assays. Cleavage assays were performed similar to those described 
in the Methods section (Chapter 4.2), on supercoiled pLBmo, pLBmo linearized with 
SwaI, and the relaxed plasmids pLBmoNa, pLBmoNb, and pLBmo2N that were pre-
nicked by Nt.BbvCI (N.E.B.).  
Cleavage assays with immobilized substrates. The immobilized substrate consisted of 
duplex oligonucleotides, where the 5’ end of the top strand contained a biotin moiety 
(DE-746), and the bottom strand (DE-747) was 5’ labeled with γ32-P prior to annealing. 
Duplex oligonucleotides (0.32 pmol) were incubated with 10 µg streptavidin coated 
magnetic beads (binding capacity of 1 nmol/mg Promega) to achieve ~3% occupancy. 
The beads were subsequently washed in triplicate in 0.5x SSC (75 mM NaCl, 7.5 mM 
Na3Citrate) prior to excess I-BmoI (175 nM) binding in 50 mM Tris-HCl pH 8.0, 50 mM 
NaCl for 5 minutes at 37°C. Protein-substrate complexes were washed in triplicate in 
wash buffer (20 mM Tris-HCl pH 8.0, 250 mM NaCl, 5% glycerol, 10 mM EDTA) prior 
to the addition cleavage buffer (20 mM Tris-HCl pH 8.0, 250 mM NaCl, 5% glycerol, 10 
mM MgCl2). Cleavage by I-BmoI was determined by monitoring the release of radiolabel 
into the supernatant using a scintillation counter (Beckman Coulter CS5801). 
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S4 Supplementary figures 
 
Supplementary Figure S4.1: Time-course proteolysis of I-BmoI.  
(A) Images of coomassie stained SDS-gels of elastase and chymotrypsin limited 
proteolysis time-course experiments performed on I-BmoI and I-BmoI pre-incubated 
with intronless thyA substrate. Aliquots were removed at the indicated time points. In-gel 
trypsin digest followed by mass spectrometry was performed to identify the peptide 
products indicated with an asterisk (*). M, protein marker (sizes in kDa indicated to the 
left). (B) Western blot image of trypsin limited proteolysis time-course experiment. The 
western blot was performed with an antibody against N111 I-BmoI on a gel with aliquots 
of similar reactions to those shown in Figure 4.1A.  
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Supplementary Figure S4.2:  DNA-binding activity of full-length I-BmoI and 
purified domains.  
Image of a native polyacrylamide gel with binding reactions containing full length and 
truncated I-BmoI:thyA complexes, stained with ethidum-bromide. Binding reactions 
contained either 10 mM EDTA (E) or MgCl2 (M).  
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Supplementary Figure S4.3: Crosslinking of I-BmoI in solution and in complex with 
substrate.  
(top panels) Representative SDS-gel images of cross-linking reactions of I-BmoI or I-
BmoI:substrate complexes using (A) NHS and EDC, or (B) BS3. (bottom panels) Western 
blots using an anti-N111 I-BmoI antibody performed to detect cross-linked complexes 
below the detection limit of coomassie stain. (right panels) Positive control cross-linking 
reactions performed at equivalent protein:cross-linker ratios with the Aeh1 NrdA subunits 
that are known to associate (60). Molecular weight markers are shown beside the gels, in 
kDa.  
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Supplementary Figure S4.4: Substrate topology does not affect I-BmoI cleavage 
kinetics:  
(A) Representative gel images of in vitro time-course cleavage assays in 0.5 mM MgCl2 
on supercoiled, relaxed, or linear substrate (top, middle, and bottom panels, respectively). 
The left-most lane contains a DNA size marker, and the second lane from the left 
contains unreacted substrate (-). Relaxed (R), linear (L), supercoiled (S), and two linear 
product (L1, L2) DNA forms are indicated on the right, with product species for each 
reaction boxed and colored according to reaction progress curves in (B). (B) Plots of 
product formation for cleavage assays with 0.5 mM, 2 mM, and 10 mM MgCl2 (top, 
middle, and bottom panels, respectively) on supercoiled, relaxed, or linear substrate (blue 
box, red diamond, and green circle, respectively). The average and standard deviation of 
three replicates is shown. 
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Supplementary Figure S4.5: I-BmoI cleavage of a double target-site plasmid.  
Plot of reaction progress for in vitro cleavage assays on the two-site substrate plasmid 
with the target sites in the same orientation. Cleavage assays were performed in triplicate. 
L1+L2, linear products from 2-site plasmid cleavage. 
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Supplementary Figure S4.6: Immobilized substrates are cleaved by I-BmoI.  
Schematic of the assembly of immobilized I-BmoI:thyA substrate complexes using 
streptavidin coated magnetic beads. Cleavage was detected by measuring the release of 
radiolabel into solution. (B) Graph of cleavage activity between various primary and 
secondary treatments, reported as cleavage normalized relative to EcoRI (an EcoRI site is 
found between the biotin tag and the I-BmoI cleavage site). Secondary treatments 
containing I-BmoI were performed with excess I-BmoI. At least two replicates were 
performed for the trials where standard error is shown, otherwise only one replicate.  
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Supplementary Figure S4.7: Gel images of I-BmoI cleavage assays on supercoiled 
substrates with nucleotide insertions.  
Cleavage reactions contained (A) 0.5 mM, (B) 2 mM, or (C) 10 mM MgCl2, and 
substrates described in Figure 7A. The left lane contains DNA size marker, and the 
second lane from the left contains unreacted substrate (-). Relaxed (R), linear (L), and 
supercoiled (S) DNA forms are shown to the right.  
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Supplementary Figure S4.8: Frequency of nucleotides in the survivor pool.  
(A) Sequencing results from cleavable targets represented as a position-specific scoring 
matrix. (B) Plots to compare the change in nucleotide proportion in the randomized target 
site for survivor versus input and survivor versus dead plasmid pools (top and bottom 
panels, respectively). 
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Supplementary Figure S4.9: Limited proteolysis of 130C I-BmoI.  
(A) Coomassie stained SDS-gel of trypsin proteolysis time-course experiments 
performed with 130C I-BmoI:substrate and 130C:G+7T substrate complexes. Aliquots 
were removed at the indicated time points prior to electrophoresis. M, protein marker 
(sizes in kDa indicated to the left). (B) Plot of the fraction of 130C I-BmoI remaining 
over time for reactions shown in panel (A). Disappearance of 130C I-BmoI is calculated 
as the fraction remaining after normalization to the untreated lane, with error bars and 
standard deviation of two replicates. 
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S4 Supplementary tables 
SupplementaryTable S4.1: Strains and plasmids used in Chapter 4 
Strains Description Source 
DH5α F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1 
Invitrogen 
ER2566 F- λ- fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 Δ(mcrC-
mrr)114::IS10 R(mcr-73::miniTn10-TetS)2 R(zgb-210::Tn10)(TetS) 
endA1 [dcm] 
N.E.B. 
BW25141 (λDE3) F- lacIq rrnBT14 DlacZWJ16 DphoBR580 hsdR514 DaraBADAH33 
DrhaBADLD78 galU95 endABT333 uidA(DMluI)::pir+ recA1,  λDE3 
lysogen 
Ref 28. 
Plasmids Description Source 
pTYB1 oriM13, amp N.E.B. 
pTYBmoI pTYB1 derivative containing the 266 amino acid codon-optimized I-
BmoI gene  
Ref 28. 
pTYBmoIR27A Similar to pTYBmoI, with an R27A mutation to knockout catalytic 
activity 
Ref 34. 
pTYBmoN92 pTYB1 derivative containing residues 1-92 of codon-optimized I-
BmoI (cloned NdeI/XhoI) 
This study 
pTYBmoN111 pTYB1 derivative containing residues 1-111 of codon-optimized I-
BmoI (cloned NdeI/XhoI) 
This study 
pTYBmoN130 pTYB1 derivative containing residues 1-130 of codon-optimized I-
BmoI (cloned NdeI/XhoI) 
This study 
pTYBmoN154 pTYB1 derivative containing residues 1-154 of codon-optimized I-
BmoI (cloned NdeI/XhoI) 
This study 
pTYBmo92C pTYB1 derivative containing residues 92-266 of codon-optimized I-
BmoI (cloned NdeI/XhoI) 
This study 
pTYBmo106C pTYB1 derivative containing residues 106-266 of codon-optimized I-
BmoI (cloned NdeI/XhoI) 
This study 
pTYBmo130C pTYB1 derivative containing residues 130-266 of codon-optimized I-
BmoI (cloned NdeI/XhoI) 
This study 
pBmoHS pBS derivative containing a 54-base pair XbaI/BamHI insert 
corresponding to the intronless B. mojavensis thyA gene 
Ref 31. 
LITMUS28i oriM13, amp N.E.B. 
pLBmo LITMUS28i derivative, with the PvuII fragment of pBmoHS 
(containg the 54 bp I-BmoI thyA target site) subcloned into PvuII 
This study 
pLBmo2a pLBmo derivative containing a second I-BmoI target site cloned into 
SwaI using oligos DE-906/907 (sites in the opposite orientation)  
This study 
pLBmo2b Similar to pLBmo2a, except that the I-BmoI target sites are in the 
same orientation 
This study 
pLBmoNa pLBmo derivative that contains an Nt.BbvCI nicking site 1082 base 
pairs away from the I-BmoI top-strand cleavage site.  
This study 
pLBmoNb pLBmo derivative that contains an Nt.BbvCI nicking site 60 base 
pairs away from the I-BmoI top-strand cleavage site. 
This study 
pLBmo2N pLBmo derivative that contains Nt.BbvCI nicking sites 1082 and 60 
base pairs away from the I-BmoI top-strand cleavage site. 
This study 
p11-lacY-wtx1 oripBR322, amp Ref 40. 
pTox p11-lacY-wtx1 derivative with EcoRI site destroyed and new EcoRI 
site between the XbaI and SphI sites using oligos DE-1173/ 1174 
This study 
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pToxBmoHS p11-lacY-wtx1 plus 52bp intronless thyA homing site insert in XbaI 
and SphI sites 
Ref 28. 
pToxBmoIn+ p11-lacY-wtx1 plus 52bp intron-containing homing site insert in 
XbaI and SphI sites 
Ref 28. 
pKox pTox derivative that has the kanamycin promoter and gene blunt 
cloned into the ScaI site 
This study 
pKoxBmoHS pKox derivative that contains a 52bp intronless thyA homing site 
insert in XbaI and SphI sites 
This study 
pKoxBmoIn+ pKox derivative that contains a 52bp intron-containing homing site 
insert in XbaI and SphI sites 
This study 
pToxBmoG+7A pTox derivative that has the I-BmoI target site with a G+7A 
mutation, cloned into the XbaI and EcoRI sites 
This study 
pToxBmoG+7C pTox derivative that has the I-BmoI target site with a G+7C 
mutation, cloned into the XbaI and EcoRI sites 
This study 
pToxBmoG+7T pTox derivative that has the I-BmoI target site with a G+7T mutation, 
cloned into the XbaI and EcoRI sites 
This study 
pLBmoG+7A LITMUS28i derivative that has the I-BmoI target site with a G+7A 
mutation, cloned into the XbaI and EcoRI sites 
This study 
pLBmoG+7C LITMUS28i derivative that has the I-BmoI target site with a G+7C 
mutation, cloned into the XbaI and EcoRI sites 
This study 
pLBmoG+7T LITMUS28i derivative that has the I-BmoI target site with a G+7T 
mutation, cloned into the XbaI and EcoRI sites 
This study 
pLBmo+5T LITMUS28i derivative that has the I-BmoI target site with a TATTT 
insertion between base pairs +8 and +9, cloned into XbaI/EcoRI  
This study 
pLBmo+5C LITMUS28i derivative that has the I-BmoI target site with a CGCCC 
insertion between base pairs +8 and +9, cloned into XbaI/EcoRI  
This study 
pLBmo+3Ta LITMUS28i derivative that has the I-BmoI target site with a TTT 
insertion between base pairs +8 and +9, cloned into XbaI/EcoRI 
This study 
pLBmo+3Ca LITMUS28i derivative that has the I-BmoI target site with a CCC 
insertion between base pairs +8 and +9, cloned into XbaI/EcoRI 
This study 
pLBmo+3Tb LITMUS28i derivative that has the I-BmoI target site with a TTT 
insertion between base pairs +4 and +5, cloned into XbaI/EcoRI  
This study 
pLBmo+3Cb LITMUS28i derivative that has the I-BmoI target site with a CCC 
insertion between base pairs +4 and +5, cloned into XbaI/EcoRI 
This study 
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Supplementary Table S4.2: Oligonucleotides used in Chapter 4 
Name Sequence (5'-3') Notes 
DE-116 AAACTCCACCTTGAGGTAAGAGCCCG
TAGTAATGACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA 
Top strand intronless I-BmoI thyA 
target  74-mer from +27 to -47 relative 
to the intron insertion site 
DE-117 TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTCATTACTACGGG
CTCTTACCTCAAGGTGGAGTTT 
Bottom strand intronless I-BmoI thyA 
target 74-mer from +27 to -47 relative 
to the intron insertion site 
DE-123 TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTCATTACTACGG 
Bottom strand intronless thyA 51-mer 
from   -4 to -47, relative to the intron 
insertion site 
DE-124 TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTCATTACTACG 
Bottom strand intronless thyA 50-mer 
from   -3 to -47, relative to the intron 
insertion site 
DE-125 GCTCTTACCTCAAGGTGGAGTTT Bottom strand intronless thyA 23-mer 
from +27 to +5, relative to intron 
insertion site  
DE-130 GAGCCCGTAGTAATGACATGGCCTTG
GGAAATCCCTTCAATGTATT 
Top strand intronless I-BmoI thyA 46-
mer from +8 to -38 relative to the 
intron insertion site 
DE-131 AATACATTGAAGGGATTTCCCAAGGC
CATGTCATTACTACGGGCTC 
Bottom strand intronless I-BmoI thyA 
46-mer from +8 to -38 relative to the 
intron insertion site 
DE-144 AATTGTGAATTTAATTATCCGTGACG
AAGCCATCACGGCGTATATGTCGGAT
TGTTAGCTCAGGAGATT 
Top strand non-specific 69-mer  
DE-144 GC AATCTCCTGAGCTAACAATCCGACAT
ATACGCCGTGATGGCTTCGTCACGGA
TAATTAAATTCACAATT 
Bottom strand non-specific 69-mer  
DE-331 CGCGCGCGCCATATGAAATCTGGTGT
TTACAAAATC 
NdeI site; for N-terminal cloning of I-
BmoI  & truncations into pTYB1 
DE-444 AGTAGCGACTTCTACTGAACATAAGT
GAGTAATGACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA 
Top strand intron-containing I-BmoI 
target 74-mer from +27 to -47 relative 
to the intron insertion site 
DE-445 TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTCATTACTCACTT
ATGTTCAGTAGAAGTCGCTACT 
Bottom strand intron-containing I-
BmoI target 74-mer from +27 to -47 
relative to the intron insertion site 
DE-498 CGCGCGGGTACCCTTGGCAAAGCATT
TGTAGAAGTAACCAGAGTATTTTTCG 
KpnI site; for C-terminal cloning of I-
BmoI & truncations into pTYB1 
DE-680 CGCGGGTACCCTTGGCAAAGCAAGCA
GATTTAGAGATGTTGTACATTTCTTCG 
KpnI site; for C-terminal cloning of 
N92 I-BmoI into pTYB1 to create 
pTYBmoN92 
DE-681 CGCGGGTACCCTTGGCAAAGCATTTC
AGGATGATGTTACGTTTGTCCGGG 
KpnI site; for C-terminal cloning of 
N111 I-BmoI into pTYB1 to create 
pTYBmoN111 
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DE-682 CGCGGGTACCCTTGGCAAAGCATTTA
GCTTTTTCTTCAGAGGTCATTTTCAGG 
KpnI site; for C-terminal cloning of 
N130 I-BmoI into pTYB1 to create 
pTYBmoN130 
DE-683 CGCGGGTACCCTTGGCAAAGCATTTC
AGTTTGGTGGTTTCGGTGTGTTTACGA
CCG 
KpnI site; for C-terminal cloning of 
N154 I-BmoI into pTYB1 to create 
pTYBmoN154 
DE-684 CGCGCCATATGGCTTACCACGGTGGT
GACCTGACCTC 
NdeI site; for N-terminal cloning of 
92C I-BmoI into pTYB1 to create 
pTYBmo92C 
DE-685 CGCGCCATATGCGTAACATCATCCTG
AAACGTGCTG 
NdeI site; for N-terminal cloning of 
106C I-BmoI into pTYB1 to create 
pTYBmo106C 
DE-686 CGCGCCATATGAAACGTTGGCAGTGC
GTTCAGGGTG 
NdeI site; for N-terminal cloning of 
130C I-BmoI into pTYB1 to create 
pTYBmo130C 
DE-746 (biotin)GCGAATTCGTAAGAGCCCGTA
GTAATGACATGGCCTTGGGAAATCCC
TTCAATGTATTCCA 
Top strand (5’-biotin) modified 
intronless thyA I-BmoI homing site 
from -12 to +41 with EcoRI site 
DE-747 TGGAATACATTGAAGGGATTTCCCAA
GGCCATGTCATTACTACGGGCTCTTA
CGAATTCGC 
Bottom strand intronless thyA I-BmoI 
homing site from -12 to +41 with 
EcoRI site 
DE-906 AGAGCCCGTAGTAATGACATGGCCTT
GGGAAATCCCTTCAATGTATTCC 
Top strand intronless I-BmoI thyA 
target  49-mer from +9 to -40  
DE-907 GGAATACATTGAAGGGATTTCCCAAG
GCCATGTCATTACTACGGGCTCT 
Bottom strand intronless I-BmoI thyA 
target  49-mer from +9 to -40  
DE-945 CCGAAGGTAACTGGCCTCAGCAGAG
CGCAGATACC 
Top strand Quikchange primer to add 
an Nt.BbvCI site to pLBmo to make 
pLBmo2a 
DE-946 GGTATCTGCGCTCTGCTGAGGCCAGT
TACCTTCGG 
Bottom strand Quikchange primer to 
add an Nt.BbvCI site to pLBmo to 
make pLBmo2a 
DE-956 GCTCGGAATTAACCCTCAGCAAAGG
GAACAAAAGCTTGC 
Top strand Quikchange primer to add 
an Nt.BbvCI site to pLBmo to make 
pLBmo2b 
DE-957 GCAAGCTTTTGTTCCCTTTGCTGAGG
GTTAATTCCGAGC 
Bottom strand Quikchange primer to 
add an Nt.BbvCI site to pLBmo to 
make pLBmo2b 
DE-1171 CACTATAGGGAGACCGGATTTCCTGG
CACGACAGG 
Top strand Quikchange primer to 
remove the EcoRI site from p11-lacY-
wtx1 
DE-1172 CCTGTCGTGCCAGGAAATCCGGTCTC
CCTATAGTG 
Bottom strand Quikchange primer to 
remove the EcoRI site from p11-lacY-
wtx1 
DE-1173 CTAGACATACGGAATTCCATACGCAT
G 
Top strand oligo containing an EcoRI 
site to be cloned into p11-lacY-wtx1 
XbaI/SphI 
DE-1174 TGTATGCCTTAAGGTATGC Bottom oligo containing an EcoRI site 
to be cloned into p11-lacY-wtx1 
XbaI/SphI 
DE-1228 GCGGAATTCGANNNNGNNNNNNNNN
CATGGCCTTGGGAAATCCCTTCAATG
TATTCCGGCATG 
Top strand oligo with randomized base 
pairs in the I-BmoI thyA target site (G-
2 fixed); EcoRI site and SphI overhang 
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DE-1229 CCGGAATACATTGAAGGG Bottom strand primer with SphI site 
used to fill in DE-1228 
DE-1230 AATTCGAGCCCGTAGTAATGATATTT
CATGGCCTTGGGAAATCCCTTCAATG
TATTCCGGCATG 
Top strand 49-mer thyA target with 
TATTT insertion between +8/+9, 
EcoRI/SphI  
DE-1231 CCGGAATACATTGAAGGGATTTCCCA
AGGCCATGAAATATCATTACTACGGG
CTCG 
Bottom strand 49-mer thyA target with 
AAATA insertion between +8/+9, 
SphI/ EcoRI 
DE-1232 AATTCGAGCCCGTAGTAATGACGCCC
CATGGCCTTGGGAAATCCCTTCAATG
TATTCCGGCATG 
Top strand 49-mer thyA target with 
CGCCC insertion between +8/+9, 
EcoRI/SphI 
DE-1233 CCGGAATACATTGAAGGGATTTCCCA
AGGCCATGGGGCGTCATTACTACGG
GCTCG 
Bottom strand 49-mer thyA target with 
GGGCG insertion between +8/+9, 
SphI/ EcoRI 
DE-1234 CTAGAGAGCCCGTAGTAATGATTTCA
TGGCCTTGGGAAATCCCTTCAATGTA
TTCCGG 
Top strand 49-mer thyA target with 
TTT insertion between +8/+9, 
XbaI/EcoRI 
DE-1235 AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGAAATCATTACTACG
GGCTCT 
Bottom strand 49-mer thyA target with 
AAA insertion between +8/+9, 
EcoRI/XbaI 
DE-1236 CTAGAGAGCCCGTAGTAATGACCCC
ATGGCCTTGGGAAATCCCTTCAATGT
ATTCCGG 
Top strand 49-mer thyA target with 
CCC insertion between +8/+9, 
XbaI/EcoRI 
DE-1237 AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGGGGTCATTACTACG
GGCTCT 
Bottom strand 49-mer thyA target with 
GGG insertion between +8/+9, 
EcoRI/XbaI 
DE-1238 CTAGAGAGCCCGTAGTATTTATGACA
TGGCCTTGGGAAATCCCTTCAATGTA
TTCCGG 
Top strand 49-mer thyA target with 
TTT insertion between +4/+5, 
XbaI/EcoRI 
DE-1239 AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTCATAAATACTACG
GGCTCT 
Bottom strand 49-mer thyA target with 
AAA insertion between +4/+5, 
EcoRI/XbaI 
DE-1240 CTAGAGAGCCCGTAGTACCCATGAC
ATGGCCTTGGGAAATCCCTTCAATGT
ATTCCGG 
Top strand 49-mer thyA target with 
CCC insertion between +4/+5, 
XbaI/EcoRI 
DE-1241 AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTCATGGGTACTACG
GGCTCT 
Bottom strand 49-mer thyA target with 
GGG insertion between +4/+5, 
EcoRI/XbaI 
DE-1280 CCATCTCATCCCTGCGTGTCTCCGACT
CAGTTGGTGGATAACAGGGTAATAT
CACGC 
Primer with left adaptor for Ion Torrent 
sequencing, barcode, and 
complementarity to pKox (for the 
substrate library) 
DE-1281 CCATCTCATCCCTGCGTGTCTCCGACT
CAGTCTTCGGATAACAGGGTAATATC
ACGC 
Primer with left adaptor for Ion Torrent 
sequencing, barcode, and 
complementarity to pKox (for the non-
survivor library) 
DE-1282 CCATCTCATCCCTGCGTGTCTCCGACT
CAGTCAAGGGATAACAGGGTAATAT
CACGC 
Primer with left adaptor for Ion Torrent 
sequencing, barcode, and 
complementarity to pKox (for the 
survivor library) 
DE-1289 CCTCTCTATGGGCAGTCGGTGATGCA
TGCCGGAATACATTGAAGGG 
Primer with right adaptor for Ion 
Torrent sequencing and 
complementarity to pKox 
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DE-1348 CTAGAGAGCCCGTAGTAATAACATGG
CCTTGGGAAATCCCTTCAATGTATTC
CGG 
Top strand 49 mer thyA target with 
G+7A mutation, XbaI/EcoRI ends 
DE-1349 AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTTATTACTACGGGC
TCT 
Bottom strand 49 mer thyA target with 
G+7A mutation, EcoRI/XbaI ends 
DE-1350 CTAGAGAGCCCGTAGTAATCACATGG
CCTTGGGAAATCCCTTCAATGTATTC
CGG 
Top strand 49 mer thyA target with 
G+7C mutation, XbaI/EcoRI ends 
DE-1351 AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTGATTACTACGGGC
TCT 
Bottom strand 49 mer thyA target with 
G+7C mutation, EcoRI/XbaI ends 
DE-1352 CTAGAGAGCCCGTAGTAATTACATGG
CCTTGGGAAATCCCTTCAATGTATTC
CGG 
Top strand 49 mer thyA target with 
G+7T mutation, XbaI/EcoRI ends 
DE-1353 AATTCCGGAATACATTGAAGGGATTT
CCCAAGGCCATGTAATTACTACGGGC
TCT 
Bottom strand 49 mer thyA target with 
G+7T mutation, EcoRI/XbaI ends 
DE-1356 AAACTCCACCTTGAGGTAAGAGCCCG
TAGTAATAACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA 
Top strand intronless I-BmoI thyA 
target  74-mer from +27 to -47 relative 
to the intron insertion site, with G+7A 
mutation 
DE-1357 TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTTATTACTACGGG
CTCTTACCTCAAGGTGGAGTTT 
Bottom strand intronless I-BmoI thyA 
target 74-mer from +27 to -47 relative 
to the intron insertion site, with C+7T 
mutation 
DE-1358 AAACTCCACCTTGAGGTAAGAGCCCG
TAGTAATCACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA 
Top strand intronless I-BmoI thyA 
target  74-mer from +27 to -47 relative 
to the intron insertion site, with G+7C 
mutation 
DE-1359 TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTGATTACTACGGG
CTCTTACCTCAAGGTGGAGTTT 
Bottom strand intronless I-BmoI thyA 
target 74-mer from +27 to -47 relative 
to the intron insertion site, with C+7G 
mutation 
DE-1360 AAACTCCACCTTGAGGTAAGAGCCCG
TAGTAATTACATGGCCTTGGGAAATC
CCTTCAATGTATTCCAGTACAA 
Top strand intronless I-BmoI thyA 
target  74-mer from +27 to -47 relative 
to the intron insertion site, with G+7T 
mutation 
DE-1361 TTGTACTGGAATACATTGAAGGGATT
TCCCAAGGCCATGTAATTACTACGGG
CTCTTACCTCAAGGTGGAGTTT 
Bottom strand intronless I-BmoI thyA 
target 74-mer from +27 to -47 relative 
to the intron insertion site, with C+7A 
mutation 
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Supplementary Table S4.3: KD values (µM) for I-BmoI truncations on DNA 
substrates 
 I-BmoI domain 
substrate N92 N111 N130 N154 
intronless thyA > 23 > 35 > 15 0.50 ± 0.05 
intron-containing > 23 > 35 > 15 0.44 ± 0.05 
non-specific > 23 > 35 > 42 > 15 
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Appendix S5: Supplementary information for Chapter 5 
S5 Supplementary materials and methods 
Bacterial strains and plasmid construction. Escherichia coli strains DH5α and ER2566 
(New England Biolabs) were used for plasmid manipulations and protein expression, 
respectively. E.coli strain BW25141(λDE3) was used for genetic selection assays (1). A 
complete description of all plasmids used in this study are listed in Supplementary Table 
S5.3, and oligonucloetides are listed in Supplementary Table S5.4. The ryA and ryB zinc-
finger genes were synthesized by Integrated DNA Technologies with 5’-BamHI and 3’-
XhoI sites and a C-terminal 6-histidine tag, and cloned into pACYCDuet-1 to generate 
pACYCryAZf+H and pACYCryBZF+H, respectively. A stop codon was introduced at 
the 3’ end of the ryAZf gene using Quikchange (Stratagene) to generate pACYCryAZf. 
To create GIY-ZFEs, the I-TevI and I-BmoI GIY-YIG domains were PCR amplified 
from bacteriophage T4 gDNA and pACYCIBmoI, respectively, and cloned into the 
NcoI/BamHI sites of pACYCryAZf+H, pACYCryAZf, and pACYCryBZf+H. TevN201-
ryA and TevN201R27A were subcloned into the XbaI and EcoRV sites of pTAL3 to 
generate the expression plasmids for the yeast reporter assay (pYTZN201 and 
pYTZN201R27A). To generate Tev-LHEs, the I-OnuI E1 gene was amplified with 
BamHI and SalI ends to clone into the BamHI and XhoI sites of pACYCDuet-1(PciI) to 
create pACYCOnuE1(+H). This vector was subsequently Quikchanged to introduce an 
E22Q mutation in I-OnuI E1 to create pACYCOnuE1E22Q (+H). I-TevI catalytic 
domains were amplified as above and cloned into PciI/BamHI of pACYCOnuE1E22Q 
(+H). The R27A mutants of Tev-ZFEs and Tev-LHEs were generated using Quikchange 
mutagenesis. Hybrid GIY-ZFE and Tev-LHE target sites (Fig. 5.1B and 5.4B, 
Supplementary Tables S5.1 and S5.2) were cloned into the toxic plasmid p11-lacY-wtx1 
to generate reporter plasmids for the bacterial selection. Tev-ryA and Bmo-ryA target 
sites were cloned into pSP72 for in vitro cleavage assays. The Tev-ryA site hybrid 
homing site was also cloned into LITMUS28i using BamHI and XhoI to generate 
pTZHS1.35. The two-site Tev-ZF plasmids were created by sub-cloning the PvuII/HpaI 
fragment from pTZHS1.35 into the SwaI site of pTZHS1.35 to generate pTZHS2.35 and 
pTZHS3.35 (with the second TZHS in either orientation). The G5A or C1A/G5A 
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mutations were introduced into pToxTZ and pTZHS plasmids by Quikchange 
mutagenesis. To generate the target plasmids for the yeast reporter assay, the TZ-ryA 
target sites from toxic plasmids containing TZ1.33, TZ1.33G5A, and TZ1.33C1A/G5A 
were amplified and cloned into the BglII and SpeI sites of pCS753. All constructs were 
verified by sequencing. 
Two-plasmid genetic selection. The two plasmid genetic selection was performed as 
described (1), with toxic (reporter) plasmids containing hybrid TZ-ryA, TZ-ryB, BZ-ryA, 
TO target sites (Supplementary Tables S5.1 and S5.2), mutant target sites (with G5A or 
C1A/G5A substitutions), or plasmids lacking a target site (p11-lacY-wtx1).  Survival 
percentage was calculated by dividing the number of colonies observed on selective by 
those observed on non-selective plates.  
Yeast reporter assay. Transformants of S.cerevisiae YPH500(α) with Tev-ZFE or Tev-
TAL constructs and YPH499(a)  with target constructs were grown overnight (~230 rpm) 
at 30°C in synthetic complete medium lacking histidine (Tev-ZFEs and Tev-TALs) or 
lacking tryptophan and uracil (targets). Tev-ZFEs and targets were mated by adding 
equal densities (~400 µl) of overnight culture to 1 ml YPD and left stationary for 5-6 
hours at 30°C. Cells harvested by centrifugation were washed in 1 ml and resuspended in 
4 ml of synthetic medium lacking histidine and tryptophan prior to shaking overnight at 
30°C. Cells were harvested by centrifugation, washed in 1 ml Z buffer (60 mM Na2PO4, 
40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0), and suspended in 250 µl Z 
buffer. The suspension was diluted 20-fold into 1 ml Z buffer containing 0.27% β-
mercaptoethanol, and 75 µl CHCl3 and 45 µl 0.1% SDS were added prior to vortexing. 
Lysates were pre-incubated at 30°C prior to the addition of 100 µl 4 mg/ml ONPG. 
Reactions proceeded until a yellow colour developed whereby progress was stopped by 
the addition of 300 µl 1M Na2CO3. Stopped reactions were pelleted and the absorbance of 
the supernatant was analyzed at 420 nm and 550 nm. 
Protein purification. Cultures overexpressing either TevN201-ZFE or BmoN221-ZFE 
were grown at 37°C to an OD600 ~0.5 and expression induced by 0.5 mM IPTG (Bio 
Basic Inc.) overnight at 15°C. Cells were harvested by centrifugation at 8983 x g for 12 
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minutes, re-suspended in binding buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 10 mM 
imidazole, 5% glycerol, and 1 mM DDT), and lysed by homogenization at 15,000 psi.  
The cell lysate was clarified by centrifugation at 20400 x g, followed by sonication for 30 
seconds, and centrifugation at 20400 x g for 15 minutes. The clarified lysate was loaded 
onto a 1 mL HisTrap-HP column (GE Healthcare), washed with 15 mL binding buffer 
and then 10 mL wash buffer (20 mM Tris-HCl (pH 8.0), 500 mM NaCl, 50 mM 
imidazole, 5% glycerol, and 1 mM DTT). Bound proteins were eluted in 1.5 mL fractions 
in four 5 mL step elutions with increasing concentrations of imidazole. Fractions 
containing GIY-ZFEs were dialyzed twice against 1L dialysis buffer (20 mM Tris-HCl 
(pH 8.0), 500 mM NaCl, 5% glycerol, and 1 mM DDT) prior to storage at -80°C. 
Cleavage assays. Single time-point cleavage assays to determine the EC0.5max of 
TevN201-ryA were performed in buffer containing 20 mM Tris-HCl pH 8.0, 100 mM 
NaCl, 10 mM MgCl2, 5% glycerol, 1 mM DTT and 10 nM pTZHS1.33. Reactions were 
incubated for 3 minutes at 37°C, stopped with 5 µl stop solution (100 mM EDTA, 40% 
glycerol, and bromophenol blue), and electrophoresed on a 1% agarose gel prior to 
staining with ethiduium bromide and analysis on an AlphaImager™3400 (Alpha 
Innotech). The EC0.5max was determined by fitting the data to the equation
  
where f([endo]) is the fraction of substrate cleaved at concentration of TevN201-ryA [endo], 
fmax is the maximal fraction cleavage, with 1 being the highest value, and H is the Hill 
constant that was set to 1. The initial reaction velocity was determined using supercoiled 
plasmid substrate with varying concentrations of TevN201-ryA (0.7 nM to 47 nM) and 
buffer as above. Aliquots were removed at various times, stopped and analyzed as above. 
The data for product appearance was fitted to the equation   
where P is product (in nM), A is the magnitude of the initial burst, k1 is the rate constant 
(s-1) of the initial burst phase and k2 is the steady state rate constant (s-1). The two-site 
plasmid cleavage assays were conducted as above, using 10 nM pTZHS2.33 or 
pTZHS3.33 as substrates, and ~90 nM purified TevN201-ryA. The kobs rate constants 
were calculated from the decay of supercoiled substrate by fitting to the equation 
€ 
f ([endo]) = f max∗[endo]
H
EC0.5max +[endo]H
€ 
P = A(1− e−k1t ) + k 2t
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where [C] is the concentration (nM) of supercoiled plasmid at time t, [C0] is the initial 
concentration of supercoiled substrate (nM), and k1 is the first order rate constant (in s-1). 
At least 3 independent trials were conducted for each data set.  
Cleavage mapping. Mapping of cleavage sites was performed as described (2). Briefly, 
primers were individually end-labeled with γ -32P ATP, and used in PCR reactions with 
pTox or pSP72 plasmids carrying TZ-ryA or BZ-ryA target sites to generate strand-
specific substrates. The substrates were incubated with purified protein as above, and 
electrophoresed in 8% denaturing gels alongside sequencing ladders generated by cycle 
sequencing with the same end-labeled primers (US Biologicals). 
Bioinformatics. The distribution of the CNNNG cleavage motif was examined using a 
custom Perl script in a 35-bp window of ZFN sites predicted for Dania rerio 
chromosome 1 (Ensembl release 51) (6). Briefly, 40 bp flanking the downstream region 
of each predicted ZFN was extracted from the corresponding zebrafish chromosome 1 
cDNA, and searched for position i = C and position i+4 = G, with the occurrences of each 
CNNNG reported at position i (the C of the motif). The number of CNNNG motifs for 
unique ZFN sites was fit to a binomial distrubtion, and plotted in R.   
 
  
€ 
[C] = [C0]exp(−k1t)
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S5 Supplementary figures 
 
 
Supplementary Figure S5.1: Design and functionality of Bmo-ZFEs.  
 
(A) Schematic of Bmo-ZFE constructs, with I-BmoI protein and substrate shown in grey, 
and the ryA protein and binding site shown in red and yellow, respectively. Top panel, 
the fusion points for each of the Bmo-ZFEs are indicated as the last I-BmoI amino acid, 
with or without a 2xGlycine or 4xGlycine linker. Constructs were made with a 6xHis tag 
on the C-terminal end. Bottom panel, the substrate shown consists of 33-nts of the top 
strand I-BmoI thyA target site (BZ1.33), fused to the 5’ end of the ryA binding site. 
Substrates tested differ by the insertion of one or two T nucleotides at the junction of the 
thyA/ryA sites. (B) Purification of His-tagged BmoN221-ryA. Shown is a representative 
SDS-PAGE gel; M, marker with molecular weights in kDa indicated on the left; UN, 
uninduced culture; IND, induced culture; C, crude lysate; FT, flow-through from metal-
affinity column; W, wash; E, elution. (C) BmoN221-ryA cleavage specificity. Shown are 
representative agarose gels of cleavage assays with 10 nM pBZ1.33 or pSP72 (no target 
site) substrates and the indicated concentrations of BmoN221-ryA under standard assay 
conditions for 10 minutes. BmoN221-ryA cleaves the BZ-ryA target site plasmid 
(BZ1.33) but not the control plasmid (pSP72) lacking the target site. N, nicked; L, linear; 
SC, supercoiled. (D) Mapping of BmoN221-ryA cleavage sites on the BZ1.33 substrate, 
with top and bottom cleavage sites indicated by open and closed triangles, respectively. 
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Supplementary Figure S5.2: TevN201-ryA purification for in vitro experiments.  
 
(A) Purification of TevN201-ryA. Shown is a representative SDS-PAGE gel; M, marker 
with molecular weights in kDa indicated on the left; UN, uninduced culture; IND, 
induced culture; C, crude lysate; FT, flow-through from metal-affinity column; W, wash; 
E, elution. (B) Graphical representation of cleavage assays with 90 nM TevN201-ZFE 
and 10 nM two-site pTZ1.33 plasmid with target sites in the same orientation. Data are 
plotted as averages of three independent replicates with standard deviations; SC, 
supercoiled; OC, open-circle (nicked); FLL, full-length linear; L1+L2, linear products. 
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Supplementary Figure S5.3: PvuII site analysis.  
 
(A) Shown is the distribution of the 5’-CAGCTG-3’ motif in a 35-bp window flanking 
8,829 predicted ZFN sites on zebrafish chromosome 1 (6). The number of occurences of 
the ‘C’ of the motif at each distance is indicated. (B) Unique ZFN sites were grouped 
according to the number of occurences of the 5’-CAGCTG-3‘ motif in the 35-bp window.  
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Supplementary Figure S5.4: Occurrence of the 5’-CNNNG-3’ motif upstream of I-
OnuI E1 off-target sites.  
 
Shown is 37-nt of upstream sequence adjacent to the 22-nt I-OnuI E1 MAO-B target site, 
along with 19 predicted off-target sites (3). CNNNG motifs are highlighted in red, with 
only 3 of 19 predicted I-OnuI E1 off target sites containing a CNNNG motif at a 
targetable distance by Tev-LHE fusions. Nucleotide differences of the off-target sites to 
the I-OnuI E1 site are indicated in magenta lower case font. 
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S5 Supplementary tables 
Supplementary Table S5.1: Tev-ZFE selection data 
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Supplementary Table S5.2: Tev-LHE selection data  
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Supplementary Table S5.3: Strains and plasmids used in Chapter 5 
Strains Description Source 
E.coli - DH5α F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1 
Invitrogen 
E.coli - ER2566 F- λ- fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 Δ(mcrC-
mrr)114::IS10 R(mcr-73::miniTn10-TetS)2 R(zgb-
210::Tn10)(TetS) endA1 [dcm] 
N.E.B. 
E.coli - 
BW25141(λDE3) 
F- lacIq rrnBT14 DlacZWJ16 DphoBR580 hsdR514 DaraBADAH33 
DrhaBADLD78 galU95 endABT333 uidA(DMluI)::pir+ recA1,  λDE3 
lysogen 
Ref (1),(4) 
S.cerevisiae - 
YPH499 
MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-
Δ200 leu2-Δ1 
Dr. Bogdanove 
Ref (5) 
S.cerevisiae - 
YPH500 
MATα ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-
Δ200 leu2-Δ1 
Dr. Bogdanove 
Ref (5) 
Plasmids Description Source 
pACYCDuet-1 orip15A, cm Novagen 
pACYCDuet-1(PciI) orip15A, cm, pACYCDuet-1 with a PciI site substituted for the 
NcoI site 
Novagen 
p11-lacY-wtx1 oripBR322, amp Ref (4) 
pSP72 oripBR322, amp Promega 
LITMUS28i oripMB1, amp N.E.B. 
pACYCIBmoI pACYCDuet-1, containing the 798bp codon optimized I-BmoI 
gene in the NdeI and XhoI sites 
Ref (1) 
pryAzf oripUC, kan I.D.T. 
pTAL3 oripBR322, amp Dr. Bogdanove 
pCP5.1 pCP5 derivative, amp, with ColE1 origin from pBluescript IIKS(-
), reporter plasmid for the yeast based recombination assay, see 
[5] 
Dr. Bogdanove 
pOnuE1 oripBR322, amp Ref (3) 
pACYCryAZf+H pACYCDuet-1, containing the ryA zinc-finger gene with a c-
terminal 6-histidine tag cloned into the BamHI and XhoI sites 
This study 
pACYCryAZf pACYCDuet-1, containing the ryA zinc-finger gene cloned into 
the BamHI and XhoI sites 
This study 
pACYCryBZf+H pACYCDuet-1, containing the ryB zinc-finger gene with a c-
terminal 6-histidine tag cloned into the BamHI and XhoI sites 
This study 
pTevN201-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-N201 of I-TevI 
(DE832/840) cloned into the NcoI and BamHI sites (+/- 6xHis) 
This study 
pTevN201-ryB (or 
+H) 
pACYCryBZf (or +H), with residues 1-N201 of I-TevI 
(DE832/840) cloned into the NcoI and BamHI sites (+/- 6xHis) 
This study 
pTevN201G2-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-N201 of I-TevI 
(DE833/840) + 2 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pTevN201G4-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-N201 of I-TevI 
(DE834/840) + 4 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pTevK203-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-K203 of I-TevI 
(DE835/840) cloned into the NcoI and BamHI sites (+/- 6xHis) 
This study 
pTevK203G2-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-K203 of I-TevI 
(DE836/840) + 2 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
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pTevK203G4-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-K203 of I-TevI 
(DE837/840) + 4 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pTevS206-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-S206 of I-TevI 
(DE838/840) cloned into the NcoI and BamHI sites (+/- 6xHis) 
This study 
pTevS206G2-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-S206 of I-TevI 
(DE839/840) + 2 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pBmoN221-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-N221 of I-BmoI 
(DE841/849) cloned into the NcoI and BamHI sites (+/- 6xHis) 
This study 
pBmoN221G2-ZFE 
(or +H) 
pACYCryAZf (or +H), with residues 1-N221 of I-BmoI 
(DE842/849) + 2 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pBmoN221G4-ZFE 
(or +H) 
pACYCryAZf (or +H), with residues 1-N221 of I-BmoI 
(DE843/849) + 4 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pBmoR223-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-R223 of I-BmoI 
(DE844/849) cloned into the NcoI and BamHI sites (+/- 6xHis) 
This study 
pBmoR223G2-ZFE 
(or +H)  
pACYCryAZf (or +H), with residues 1-R223 of I-BmoI 
(DE845/849) + 2 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pBmoR223G4-ZFE 
(or +H)  
pACYCryAZf (or +H), with residues 1-R223 of I-BmoI 
(DE846/849) + 4 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pBmoI226-ZFE (or 
+H) 
pACYCryAZf (or +H), with residues 1-I226 of I-BmoI 
(DE847/849) cloned into the NcoI and BamHI sites (+/- 6xHis) 
This study 
pBmoI226G2-ZFE (or 
+H)  
pACYCryAZf (or +H), with residues 1-I226 of I-BmoI 
(DE848/849) + 2 glycine residues cloned into the NcoI and 
BamHI sites (+/- 6xHis) 
This study 
pTevN201R27A Similar to pTevN201-ZFE, with an R27A mutation This study 
pTevN201G2R27A Similar to pTevN201G2-ZFE, with an R27A mutation This study 
pTevN201G4R27A Similar to pTevN201G4-ZFE, with an R27A mutation This study 
pTevK203R27A Similar to pTevK203-ZFE, with an R27A mutation This study 
pTevK203G2R27A Similar to pTevK203G2-ZFE, with an R27A mutation This study 
pTevK203G4R27A Similar to pTevK203G4-ZFE, with an R27A mutation This study 
pTevS206R27A Similar to pTevS206-ZFE, with an R27A mutation This study 
pTevS206G2R27A Similar to pTevS206G2-ZFE, with an R27A mutation This study 
pToxTZ1.35 p11-lacY-wtx1, that contains a 44-bp hybrid I-TevI/ryA zinc-
finger homing site (td bases -27 to +8 fused to the 9-bp ryAZf 
site) cloned XbaI/SphI (DE824/825) 
This study 
pToxBZ1.35 p11-lacY-wtx1, that contains a 44-bp hybrid I-BmoI/ryA zinc-
finger site (thyA bases -6 to +27 fused to the 9-bp ryAZf site) 
cloned XbaI/SphI (DE826/827) 
This study 
pSP-TZHS1.35 pSP72, that contains a 44-bp hybrid I-TevI/ryA zinc-finger 
homing site (td bases -27 to +8 fused to the 9-bp ryAZf site) 
cloned XbaI/SphI (DE824/825) 
This study 
pTZHS1.35 LITMUS28i, with the 44-bp hybrid I-TevI/ryA zinc-finger site (td 
bases -27 to +8 fused to the 9-bp ryAZf site) sub-cloned from 
pSP-TZHS1.35 into BamHI/XhoI 
This study 
pBZHS1.35 pSP72, that contains a 44-bp hybrid I-BmoI/ryA zinc-finger 
homing site (thyA bases +6 to -27 fused to the 9-bp ryAZf site) 
cloned XbaI/SphI (DE826/827) 
This study 
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pTZHS2.35 Similar to pTZHS1.35, with a second Tev-ZFE1.35 target site 
sub-cloned from pSP-TZHS1.35 (using PvuII/HpaI) into the SwaI 
site 
This study 
pTZHS3.35 Similar to pTZHS2.35, with the second Tev-ZFE1.35 target site 
in the alternate orientation 
This study 
pToxTZ1.35G5A Similar to pToxTZ1.35, with a G5A substitution (DE917/918) This study 
pToxTZ1.35C1A/G5
A 
Similar to pToxTZ1.35, with C1A and G5A substitutions 
(DE919/920) 
This study 
pTZHS1.35G5A Similar to pTZHS1.35, with a G5A substitution This study 
pTZHS1.35C1A/G5A Similar to pTZHS1.35, with C1A and G5A substitutions This study 
pToxTZ1.34 p11-lacY-wtx1, that contains a 43-bp hybrid I-TevI/ryA zinc-
finger homing site (td bases -27 to +7 fused to the 9-bp ryAZf 
site) cloned XbaI/SphI  
This study 
pToxTZ1.34G5A Similar to pToxTZ1.34, with G5A substitution This study 
pToxTZ1.34C1A/G5
A 
Similar to pToxTZ1.34, with C1A and G5A substitutions This study 
pToxTZ1.33 p11-lacY-wtx1, that contains a 42-bp hybrid I-TevI/ryA zinc-
finger homing site (td bases -27 to +6 fused to the 9-bp ryAZf 
site) cloned into the XbaI and SphI sites  
This study 
pToxTZ1.33G5A Similar to pToxTZ1.33, with G5A substitution This study 
pToxTZ1.33C1A/G5
A 
Similar to pToxTZ1.33, with C1A and G5A substitutions This study 
pToxTZ1.33-ryB p11-lacY-wtx1, that contains a 42-bp hybrid I-TevI/ryB zinc-
finger homing site (td bases -27 to +6 fused to the 9-bp ryBZf 
site) cloned into XbaI/SphI sites  
This study 
pToxBZ1.34 p11-lacY-wtx1, that contains a 43-bp hybrid I-BmoI/ryA zinc-
finger site (thyA bases -6 to +26 fused to the 9-bp ryAZf site) 
cloned XbaI/SphI (DE826/827) 
This study 
pToxBZ1.33 p11-lacY-wtx1, that contains a 42-bp hybrid I-BmoI/ryA zinc-
finger site (thyA bases -6 to +25 fused to the 9-bp ryAZf site) 
cloned into XbaI/SphI (DE826/827) 
This study 
pTZHS1.34 Similar to pTZHS1.35, with a 43-bp hybrid I-TevI/ryA zinc-
finger homing site (td bases -27 to +7 fused to the 9-bp ryAZf 
site) 
This study 
pTZHS1.33 Similar to pTZHS1.35, with a 42-bp hybrid I-TevI/ryA zinc-
finger homing site (td bases -27 to +6 fused to the 9-bp ryAZf 
site) 
This study 
pBZHS1.34 Similar to pBZHS1.35, with a 43-bp hybrid I-BmoI/ryA zinc-
finger homing site (thyA bases +6 to -26 fused to the 9-bp ryAZf 
site) 
This study 
pBZHS1.33 Similar to pBZHS1.35, with a 42-bp hybrid I-BmoI/ryA zinc-
finger homing site (thyA bases +6 to -25 fused to the 9-bp ryAZf 
site) 
This study 
pTZHS2.34 Similar to pTZHS2.35, with both Tev-ZFE target sites as 43-bp 
hybrid I-TevI/ryA zinc-finger homing site (td bases -27 to +7 
fused to the 9-bp ryAZf site) 
This study 
pTZHS3.34 Similar to pTZHS3.35, with both Tev-ZFE target sites as 43-bp 
hybrid I-TevI/ryA zinc-finger homing site (td bases -27 to +7 
fused to the 9-bp ryAZf site) 
This study 
pTZHS2.33 Similar to pTZHS2.35, with both Tev-ZFE target sites as 42-bp 
hybrid I-TevI/ryA zinc-finger homing site (td bases -27 to +6 
fused to the 9-bp ryAZf site) 
This study 
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pTZHS3.33 Similar to pTZHS3.35, with both Tev-ZFE target sites as 42-bp 
hybrid I-TevI/ryA zinc-finger homing site (td bases -27 to +6 
fused to the 9-bp ryAZf site) 
This study 
pTZHS1.34G5A Similar to pTZHS1.34, with a G5A substitution This study 
pTZHS1.33G5A Similar to pTZHS1.33, with a G5A substitution This study 
pTZHS1.34C1A/G5A Similar to pTZHS1.34, with C1A and G5A substitutions This study 
pTZHS1.33C1A/G5A Similar to pTZHS1.33, with C1A and G5A substitutions This study 
pToxTZ1.30 p11-lacY-wtx1, that contains a 39-bp hybrid I-TevI/ryA zinc-
finger site (td bases -27 to +3 fused to the 9-bp ryAZf site) cloned 
XbaI/SphI (DE1085/1086) 
This study 
pToxTZ1.32 p11-lacY-wtx1, that contains a 41-bp hybrid I-TevI/ryA zinc-
finger site (td bases -27 to +5 fused to the 9-bp ryAZf site) cloned 
XbaI/SphI (DE1087/1088) 
This study 
pToxTZ1.36 p11-lacY-wtx1, that contains a 45-bp hybrid I-TevI/ryA zinc-
finger site (td bases -27 to +9 fused to the 9-bp ryAZf site) cloned 
XbaI/SphI (DE1134/1135) 
This study 
pToxTZ1.38 p11-lacY-wtx1, that contains a 47-bp hybrid I-TevI/ryA zinc-
finger site (td bases -27 to +11 fused to the 9-bp ryAZf site) 
cloned XbaI/SphI (DE1136/1137) 
This study 
pToxTZ1.33ryB p11-lacY-wtx1, that contains a 42-bp hybrid I-TevI/ryB zinc-
finger homing site (td bases -27 to +6 fused to the 9-bp ryBZf 
site) cloned XbaI/SphI  
This study 
pToxTO1.12 p11-lacY-wtx1, that contains a 34-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to -16  fused to the I-OnuI E1 site) cloned 
XbaI/SphI (DE1072/1073) 
This study 
pToxTO1.14 p11-lacY-wtx1, that contains a 36-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to -14  fused to the I-OnuI E1 site) cloned 
XbaI/SphI (DE1070/1071) 
This study 
pToxTO1.16 p11-lacY-wtx1, that contains a 38-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to -12  fused to the I-OnuI E1 site) cloned 
XbaI/SphI (DE1068/1069) 
This study 
pToxTO1.18 p11-lacY-wtx1, that contains a 40-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to -10  fused to the I-OnuI E1 site) cloned 
XbaI/SphI (DE1066/1067) 
This study 
pToxTO1.20 p11-lacY-wtx1, that contains a 42-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to -8  fused to the I-OnuI E1 site) cloned into the 
XbaI and SphI (DE1064/1065) 
This study 
pToxTO1.22 p11-lacY-wtx1, that contains a 44-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to -6  fused to the I-OnuI E1 site) cloned 
XbaI/SphI (DE1062/1063) 
This study 
pToxTO1.24 p11-lacY-wtx1, that contains a 46-bp hybrid I-TevI/I-OnuI E1 
homing site (td bases -27 to -4  fused to the I-OnuI E1 site) cloned 
XbaI/SphI (DE1060/1061) 
This study 
pToxTO1.26 p11-lacY-wtx1, that contains a 48-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to -2  fused to the I-OnuI E1 site) cloned into the 
XbaI and SphI (DE1058/1059) 
This study 
pToxTO1.28 p11-lacY-wtx1, that contains a 50-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to +1  fused to the I-OnuI E1 site) cloned into 
the XbaI and SphI (DE1056/1057) 
This study 
pToxTO1.30 p11-lacY-wtx1, that contains a 52-bp hybrid I-TevI/I-OnuI E1 
site (td bases -27 to +3  fused to the I-OnuI E1 site) cloned into 
the XbaI and SphI (DE976/977) 
This study 
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pToxTO1.18C1A/G5
A 
Similar to pToxTO18, with C1A and G5A 
substitution(DE1154/1155) 
This study 
pToxTO1.20 
C1A/G5A 
Similar to pToxTO20, with C1A and G5A 
substitution(DE1156/1157) 
This study 
pToxTO1.26 
C1A/G5A 
Similar to pToxTO26, with C1A and G5A 
substitution(DE1158/1159) 
This study 
pToxTO1.30 G5A Similar to pToxTO30, with a G5A substitution This study 
pToxTO1.30 
C1A/G5A 
Similar to pToxTO30, with C1A and G5A substitution This study 
pACYCOnuE1(+H) pACYCDuet-1(PciI), containing the I-OnuI E1 gene cloned into 
the BamHI and XhoI sites 
This study 
pACYCOnuE1(E22Q
) (+H) 
pACYCDuet-1(PciI), containing the I-OnuI E1 gene with a E22Q 
mutation cloned into the BamHI and XhoI sites 
This study 
pTevK203-
OnuE1(E22Q) 
pACYCOnuE1(E22Q)(+H), with residues 1-K203 of I-TevI (DE) 
cloned into the PciI and BamHI sites 
This study 
pTevN201G4-
OnuE1(E22Q) (+H) 
pACYCOnuE1(E22Q)(+H), with residues 1-N201 of I-TevI + 4 
glycine residues (DE) cloned into the PciI and BamHI sites 
(+6xHis) 
This study 
pTevD184G2-
OnuE1(E22Q) (+H) 
pACYCOnuE1(E22Q)(+H), with residues 1-D184G2 of I-TevI + 
2 glycine residues (DE) cloned into the PciI and BamHI sites 
(+6xHis) 
This study 
pTevN169-
OnuE1(E22Q) (+H) 
pACYCOnuE1(E22Q)(+H), with residues 1-N169 of I-TevI (DE) 
cloned into the PciI and BamHI sites (+6xHis) 
This study 
pTevN140-
OnuE1(E22Q) (+H) 
pACYCOnuE1(E22Q)(+H), with residues 1-N140 of I-TevI (DE) 
cloned into the PciI and BamHI sites (+6xHis) 
This study 
pTevD127-
OnuE1(E22Q) (+H) 
pACYCOnuE1(E22Q)(+H), with residues 1- D127 of I-TevI (DE) 
cloned into the PciI and BamHI sites (+6xHis) 
This study 
pTevS114-
OnuE1(E22Q) (+H) 
pACYCOnuE1(E22Q)(+H), with residues 1- S114 of I-TevI (DE) 
cloned into the PciI and BamHI sites (+6xHis) 
This study 
pTevN201G4R27A-
OnuE1(+H) 
pACYCOnuE1(+H), with residues 1-N201 of I-TevI + 4 glycine 
residues (DE) with a R27A mutation in I-TevI (+6xHis) 
This study 
pTevN201G4R27A-
OnuE1(E22Q) (+H) 
pACYCOnuE1(E22Q)(+H), similar to  pTevN201G4-
OnuE1(E22Q) (+H) with an R27A mutation in I-TevI 
This study 
pZif268 pTAL3 expression vector containing homodimeric FokI-Zif268 
ZFN 
Dr. Bogdanove 
Ref (5) 
pZif268target pCS753 reporter plasmid with a homodimeric FokI-Zif268 target 
site interrupting a partially duplicated lacZ gene 
Dr. Bogdanove 
Ref (5) 
pYTZN201 pTAL3, with TevN201-ryA cloned in XbaI/EcoRV using 
DE1121/1128 
This study 
pYTZN201R27A Similar to pYTZN201, with an R27A I-TevI mutation This study 
pTZYHS1.33 pCS753, with the 42-bp hybrid I-TevI/ryA zinc-finger homing 
site cloned into the BglII/SpeI sites using DE1117/1118 
This study 
pTZYHS1.33G5A Similar to PTZYHS1.33, with G5A substitution This study 
pTZYHS1.33C1A/G5
A 
Similar to PTZYHS1.33, with C1A and G5A substitutions This study 
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Supplementary Table S5.4: Oligonucleotides used in Chapter 5 
Name Sequence (5'-3') Notes 
DE410 GGAAGAAGTGGCTGATCTCAGC Forward primer to generate all cycle-seq products for 
target sites cloned into pTox 
DE411 CAGACCGCTTCTGCGTTCTG Reverse primer to generate all cycle-seq products for 
target sites cloned into pTox 
DE613 GCTAAAGATTTTGAAAAGGCATGG
AAGAAGCATTTTAAAG 
Forward quikchange primer to create R27A Tev-ZFEs 
DE614 CTTTAAAATGCTTCTTCCATGCCTT
TTCAAAATCTTTAGC 
Reverse quikchange primer to create R27A Tev-ZFEs 
DE824 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCGTTTCCCACGCC
GCATG 
Top-strand oligo to clone the hybrid 35-bp I-TevI/9-bp 
ryAZf using XbaI and SphI 
DE825 CGGCGTGGGAAACGGTAGACCCAA
GAAAACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 35-bp I-TevI/9-
bp ryAZf using XbaI and SphI 
DE826 CTAGAGCCCGTAGTAATGACATGG
CCTTGGGAAATCCCTTTCCCACGCC
GCATG 
Top-strand oligo to clone the hybrid 35-bp I-BmoI/9-bp 
ryAZf using XbaI and SphI 
DE827 CGGCGTGGGAAAGGGATTTCCCAA
GGCCATGTCATTACTACGGGCT 
Bottom-strand oligo to clone the hybrid 35-bp I-BmoI/9-
bp ryAZf using XbaI and SphI 
DE832 CCGCGGATCCATTACTAGGCTTTT
TACC 
Reverse primer for TevN201-ZFE cloning, BamHI site 
underlined 
DE833 CCGCGGATCCACCACCATTACTAG
GCTTTTTACC 
Reverse primer for TevN201G2-ZFE cloning, BamHI 
site underlined 
DE834 CCGCGGATCCACCACCACCACCAT
TACTAGGCTTTTTACC 
Reverse primer for TevN201G4-ZFE cloning, BamHI 
site underlined 
DE835 CCGCGGATCCTTTAATATTACTAG
GCTTTTTAC 
Reverse primer for TevK203-ZFE cloning, BamHI site 
underlined 
DE836 CCGCGGATCCACCACCTTTAATAT
TACTAGGCTTTTTAC 
Reverse primer for TevK203G2-ZFE cloning, BamHI 
site underlined 
DE837 CCGCGGATCCACCACCACCACCTT
TAATATTACTAGGCTTTTTAC 
Reverse primer for TevK203G4-ZFE cloning, BamHI 
site underlined 
DE838 CCGCGGATCCTGAAATCTTTTTAA
TATTACTAGGC 
Reverse primer for TevS206-ZFE cloning, BamHI site 
underlined 
DE839 CCGCGGATCCACCACCTGAAATCT
TTTTAATATTACTAGGC 
Reverse primer for TevS206G2-ZFE cloning, BamHI site 
underlined 
DE840 GCCGCCATGGGTAAAAGCGGAATT
TATCAGATT 
Forward primer for Tev-ZFE cloning, NcoI site 
underlined 
DE841 CCGCGGATCCGTTTTTCGGTTTAC
GACC 
Reverse primer for BmoN221-ZFE cloning, BamHI site 
underlined 
DE842 CCGCGGATCCACCACCGTTTTTCG
GTTTACGACC 
Reverse primer for BmoN221G2-ZFE cloning, BamHI 
site underlined 
DE843 CCGCGGATCCACCACCACCACCGT
TTTTCGGTTTACGACC 
Reverse primer for BmoN221G4-ZFE cloning, BamHI 
site underlined 
DE844 CCGCGGATCCACGAGAGTTTTTCG
GTTTACG 
Reverse primer for BmoR223-ZFE cloning, BamHI site 
underlined 
DE845 CCGCGGATCCACCACCACGAGAGT
TTTTCGGTTTACG 
Reverse primer for BmoR223G2-ZFE cloning, BamHI 
site underlined 
DE846 CCGCGGATCCACCACCACCACCAC
GAGAGTTTTTCGGTTTACG 
Reverse primer for BmoR223G4-ZFE cloning, BamHI 
site underlined 
DE847 CCGCGGATCCGATAACCGGACGA
GAGTTTTTCGG 
Reverse primer for BmoI226-ZFE cloning, BamHI site 
underlined 
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DE848 CCGCGGATCCACCACCGATAACCG
GACGAGAGTTTTTCGG 
Reverse primer for BmoI226G2-ZFE cloning, BamHI 
site underlined 
DE849 GCCGCCATGGGTAAATCTGGTGTT
TACAAAATC 
Forward primer for Bmo-ZFE cloning, NcoI site 
underlined 
DE850 CTTGGGTCTACCGTTCCCACGCCGC
ATG 
Forward quikchange primer to make the 1.34 I-TevI/ryA 
zinc-finger target site 
DE851 CATGCGGCGTGGGAACGGTAGACC
CAAG 
Reverse quikchange primer to make the 1.34 I-TevI/ryA 
zinc-finger target site 
DE852 CTTGGGTCTACCGTCCCACGCCGC
ATG 
Forward quikchange primer to make the 1.33 I-TevI/ryA 
zinc-finger target site 
DE853 CATGCGGCGTGGGACGGTAGACCC
AAG 
Reverse quikchange primer to make the 1.33 I-TevI/ryA 
zinc-finger target site 
DE854 GCCTTGGGAAATCCCTTCCCACGC
CGCATG 
Forward quikchange primer to make the 1.34 I-BmoI/ryA 
zinc-finger target site 
DE855 CATGCGGCGTGGGAAGGGATTTCC
CAAGGC 
Reverse quikchange primer to make the 1.34 I-BmoI/ryA 
zinc-finger target site 
DE856 GCCTTGGGAAATCCCTCCCACGCC
GCATG 
Forward quikchange primer to make the 1.33 I-BmoI/ryA 
zinc-finger target site 
DE857 CATGCGGCGTGGGAGGGATTTCCC
AAGGC 
Reverse quikchange primer to make the 1.33 I-BmoI/ryA 
zinc-finger target site 
DE858 CAGAAACAGCTGGTTTAATAACAT
CATCACCACtaactcg 
Forward quikchange primer to add stops to the 3’-end of 
the ryA zinc-finger 
DE859 cgagttaGTGGTGATGATGTTATTAAA
CCAGCTGTTTCTG 
Reverse quikchange primer to add stops to the 3’-end of 
the ryA zinc-finger 
DE917 CTAGACAACACTCAGTAGATGTTT
TCTTGGGTCTACCGTTTCCCACGCC
GCATG 
Top strand oligo similar to DE824 with G-23A 
substitution 
DE918 CGGCGTGGGAAACGGTAGACCCAA
GAAAACATCTACTGAGTGTTGT 
Bottom strand oligo similar to DE825 with C-23T 
substitution 
DE919 CTAGAAAACACTCAGTAGATGTTT
TCTTGGGTCTACCGTTTCCCACGCC
GCATG 
Top strand oligo similar to DE824 with G-23A and C-
27A substitutions 
DE920 CGGCGTGGGAAACGGTAGACCCAA
GAAAACATCTACTGAGTGTTTT 
Bottom strand oligo similar to DE825 with C-23T and 
G-27T substitutions 
DE973 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCGTTAGCTACTAC
GCATG 
Top-strand oligo to clone the hybrid 33-bp I-TevI/9-bp 
ryBZf using XbaI and SphI 
DE974 CGTAGTAGCTAACGGTAGACCCAA
GAAAACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 33-bp I-TevI/9-
bp ryBZf using XbaI and SphI 
DE976 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTAGGTCCACATATTTAA
CCTTTTGCATG 
Top strand oligo to clone the hybrid 30-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE977 CAAAAGGTTAAATATGTGGACCTAG
ACCCAAGAAAACATCTACTGAGCG
TTGT 
Bottom strand oligo to clone the hybrid 30-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE978 CTAGACAACACTCAGTAGATGTTT
TCTTGGGTCTAGGTCCACATATTTAA
CCTTTTGCATG 
Top strand oligo similar to DE976 with G5A substitution 
DE979 CAAAAGGTTAAATATGTGGACCTA
GACCCAAGAAAACATCTACTGAGT
GTTGT 
Bottom strand oligo similar to DE977 with G5A 
substitution 
DE980 CTAGAAAACACTCAGTAGATGTTT
TCTTGGGTCTAGGTCCACATATTTAA
CCTTTTGCATG 
Top strand oligo similar to DE976 with C1A and G5A 
substitution 
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DE981 CAAAAGGTTAAATATGTGGACCTAG
ACCCAAGAAAACATCTACTGAGTG
TTTT 
Bottom strand oligo similar to DE977 with C1A and 
G5A substitution 
DE982 CGGTTTCGCCGACGCGCAAGGCTC
CTTTTTGCTGCG 
Forward quikchange primer to create E22Q I-OnuI E1 
mutant 
DE983 CGCAGCAAAAAGGAGCCTTGCGC
GTCGGCGAAACCG 
Reverse quikchange primer to create E22Q I-OnuI E1 
mutant 
DE991 CGCGTCGACTTAGAATACTCTGCC
CTTGTTC 
Reverse primer to amplify the I-OnuI E1 gene with a 3’ 
SalI site 
DE1017 CGCGGATCCACCACCGTCTGAATG
CTTATGATTAAAG 
Reverse primer for TevD184G2 cloning, BamHI site 
underlined 
DE1040 CGCGGATCCAGAACGTTTCTTAAT
AATTTC 
Reverse primer for TevS114 cloning, BamHI site 
underlined 
DE1042 CGCGGATCCATCAGGTCCAAGTTT
AAGC 
Reverse primer for TevD127 cloning, BamHI site 
underlined 
DE1044 CGCGGATCCGTTTTTACTTCCGGG
TTTAC 
Reverse primer for TevN140 cloning, BamHI site 
underlined 
DE1045 CGCGGATCCATTTCTGCATTTACT
ACAAG 
Reverse primer for TevN169 cloning, BamHI site 
underlined 
DE1056 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCGGTCCACATATTTAACC
TTTTGCATG 
Top-strand oligo to clone the hybrid 28-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1057 CAAAAGGTTAAATATGTGGACCGAC
CCAAGAAAACATCTACTGAGCGTT
GT 
Bottom-strand oligo to clone the hybrid 28-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1058 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGGGTCCACATATTTAACCTT
TTGCATG 
Top-strand oligo to clone the hybrid 26-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1059 CAAAAGGTTAAATATGTGGACCCCCA
AGAAAACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 26-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1060 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCCACATATTTAACCTTTT
GCATG 
Top-strand oligo to clone the hybrid 24-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1061 CAAAAGGTTAAATATGTGGACCCAA
GAAAACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 24-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1062 CTAGACAACGCTCAGTAGATGTTT
TCTGGTCCACATATTTAACCTTTTGC
ATG 
Top-strand oligo to clone the hybrid 22-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1063 CAAAAGGTTAAATATGTGGACCAGA
AAACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 22-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1064 CTAGACAACGCTCAGTAGATGTTT
TGGTCCACATATTTAACCTTTTGCAT
G 
Top-strand oligo to clone the hybrid 20-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1065 CAAAAGGTTAAATATGTGGACCAAA
ACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 20-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1066 CTAGACAACGCTCAGTAGATGTTG
GTCCACATATTTAACCTTTTGCATG 
Top-strand oligo to clone the hybrid 18-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1067 CAAAAGGTTAAATATGTGGACCAAC
ATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 18-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1068 CTAGACAACGCTCAGTAGATGGGT
CCACATATTTAACCTTTTGCATG 
Top-strand oligo to clone the hybrid 16-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1069 CAAAAGGTTAAATATGTGGACCCATC
TACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 16-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
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DE1070 CTAGACAACGCTCAGTAGAGGTCC
ACATATTTAACCTTTTGCATG 
Top-strand oligo to clone the hybrid14-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1071 CAAAAGGTTAAATATGTGGACCTCTA
CTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 14-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1072 CTAGACAACGCTCAGTAGGTCCAC
ATATTTAACCTTTTGCATG 
Top-strand oligo to clone the hybrid 12-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1073 CAAAAGGTTAAATATGTGGACCTACT
GAGCGTTGT 
Bottom-strand oligo to clone the hybrid 12-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1074 CGCGTCGACTTAGTGGTGATGATGG
TGATGGAATACTCTGCCCTTGTTC 
Reverse primer to amplify the I-OnuI E1 gene with a 3’ 
his-tag and SalI site 
DE1082 GCGAGATCTGGTTCCGCCTATATG
TCCCG 
Forward primer to amplify the I-OnuI E1 gene with a 5’ 
BamHI site 
DE1085 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCTCCCACGCCGCA
TG 
Top-strand oligo to clone the hybrid 32-bp I-TevI/9-bp 
ryAZf using XbaI and SphI 
DE1086 CGGCGTGGGAGGTAGACCCAAGA
AAACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 32-bp I-TevI/9-
bp ryAZf using XbaI and SphI 
DE1087 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTATCCCACGCCGCATG 
Top-strand oligo to clone the hybrid 30-bp I-TevI/9-bp 
ryAZf using XbaI and SphI 
DE1088 CGGCGTGGGATAGACCCAAGAAA
ACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 30-bp I-TevI/9-
bp ryAZf using XbaI and SphI 
DE1117 GCAGATCTCTAGCATTACGCTAGG
G 
Forward primer to amplify target site in pTox with 5’ 
BglII site to clone into pCS753 
DE1118 GCACTAGTCTTCTCTCATCCGCC Reverse primer to amplify target site in pTox with 3’ 
SpeI site to clone into pCS753 
DE1121 CGTCTAGAATGAAAAGCGGAATTT
ATCAGATT 
Forward primer to amplify I-TevI with 5’ XbaI site to 
clone into pTAL3 
DE1128 CGGATATCTTATTAAACCAGCTGT
TTCTGACGCAGG 
Reverse primer to amplify ryAZF with 3’ EcoRV site to 
clone into pTAL3 
DE1134 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCGTTTTCCCACGC
CGCATG 
Top-strand oligo to clone the hybrid 36-bp I-TevI/9-bp 
ryAZf using XbaI and SphI 
DE1135 CGGCGTGGGAAAACGGTAGACCCA
AGAAAACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 36-bp I-TevI/9-
bp ryAZf using XbaI and SphI 
DE1136 CTAGACAACGCTCAGTAGATGTTT
TCTTGGGTCTACCGTTTCCCACGCC
GCATG 
Top-strand oligo to clone the hybrid 38-bp I-TevI/9-bp 
ryAZf using XbaI and SphI 
DE1137 CGGCGTGGGAAACGGTAGACCCAA
GAAAACATCTACTGAGCGTTGT 
Bottom-strand oligo to clone the hybrid 38-bp I-TevI/9-
bp ryAZf using XbaI and SphI 
DE1154 CTAGAAAACACTCAGTAGATGTTT
TCTTGGGGGTCCACATATTTAACCTT
TTGCATG 
Top-strand oligo to clone the hybrid 26-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1155 CAAAAGGTTAAATATGTGGACCCCCA
AGAAAACATCTACTGAGTGTTTT 
Bottom-strand oligo to clone the hybrid 26-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1156 CTAGAAAACACTCAGTAGATGTTT
TGGTCCACATATTTAACCTTTTGCAT
G 
Top-strand oligo to clone the hybrid 20-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1157 CAAAAGGTTAAATATGTGGACCAAA
ACATCTACTGAGTGTTTT 
Bottom-strand oligo to clone the hybrid 20-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
DE1158 CTAGAAAACACTCAGTAGATGTTG
GTCCACATATTTAACCTTTTGCATG 
Top-strand oligo to clone the hybrid 18-bp I-TevI/22-bp 
I-OnuI E1 using XbaI and SphI 
DE1159 CAAAAGGTTAAATATGTGGACCAAC
ATCTACTGAGTGTTTT 
Bottom-strand oligo to clone the hybrid 18-bp I-TevI/22-
bp I-OnuI E1 using XbaI and SphI 
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BmoI. Recombination, replication, repair, and chromosomal 
segregation conference, University of Western Ontario, London, 
Ontario. July 2008 (invited speaker) 
AWARDS            Alexander Graham Bell Canada Graduate; value $105,000 
May 2010-April 2013, National Science and Engineering Research 
Council of Canada 
 
Western Graduate Research Scholarship; value $7000 / year 
September 2007-April 2013, Department of Biochemistry, U.W.O. 
 
Schulich Graduate Thesis Research Fund; value $510 
 September 2012, Department of Biochemistry, U.W.O 
 
 Workshop on Genome Engineering Award; value $800 
 November 2011, Northwest Genome Engineering Consortium 
 
New England Biolabs Award; value $430 
August 2010, Jacobs University 
 
Workshop on Genome Engineering Award; value $1300 
 November 2010, Northwest Genome Engineering Consortium 
 
Ontario Graduate Scholarship; value $15,000 (declined) 
May 2010-April 2011, Government of Ontario 
 
Schulich Graduate Thesis Research Fund; value $770 
August 2010, Department of Biochemistry, U.W.O. 
 
Workshop on Genome Engineering Award; value $1200 
 November 2009, Northwest Genome Engineering Consortium 
 
Ontario Graduate Scholarship; value $15,000 
May 2009-April 2010, Government of Ontario 
254 
 
Ontario Graduate Scholarship in Science and Technology; value 
$15,000 
May 2008-April 2009, Government of Ontario 
 
Regents In-Course Scholarship; value $1000 
September 2007-April 2007, University of Toronto 
 
TEACHING  2011 Biochemistry 3380G*, University of Western Ontario 
   2010 Biochemistry 4445F*, University of Western Ontario 
2010 Biochemistry 3380G*, University of Western Ontario 
2009 Biochemistry 4445F, University of Western Ontario 
*nominated for teaching award 
 
COMMITTEES  University Council on Research Ethics, 2009-2011 
   Society of Graduate Students, 2009-2012 
   Biochemistry Department Graduate Studies, 2010-2012 
   Exam Proctor Committee, 2009-2013 
   Biochemistry Graduate Student Treasurer, 2010-2012 
   Area, Safety, and Equipment, 2011-2012 
   Biochemistry Department Social Committee, 2010-2012 
  
 
 
 
